Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)
Appears in 4 contracts
Samples: Agreement and Plan of Merger (Mill Road Capital II, L.P.), Agreement and Plan of Merger (Skullcandy, Inc.), Agreement and Plan of Merger (Mill Road Capital II, L.P.)
Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Definition Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Amgen 2.5.2 Amgen Agreement Section 6.2(c)(ii2.5.2 Annual [***] 3.3.2 Assigned Kiniksa Agreements 8.3(e)(ii) Antiboycott Rules Section 4.22(aAssumed Liabilities 2.3 ATCC Agreement Schedule E Bioequivalence 5.3.2(c) Board Recommendation Section 2.2(bBioequivalent 5.3.2(c) Cancelled Company Shares Section 3.7(a)(iiBiogen Preamble Biogen Indemnified Parties 9.2 Biogen Product 8.3(e)(iv) Certificate CDA Effective Date CDA definition Change of Merger Section 3.2 Certificates Section 3.8(cControl Transaction 3.4.2 Claims 9.2 Competing Drug 5.3.2(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dConfidential Information 7.1 CTA IND definition Data Package 3.4.1(b) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aDiligence Period 3.4.1(c) Effective Time Section Date Preamble Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. Confidential Treatment Requested by Kiniksa Pharmaceuticals, Ltd. Exchange Act 3.4.2 Excluded Assets 2.2 Excluded Liabilities 2.4 Exclusivity Period 2.7 Exclusivity Term 3.4.1(d) Exempt Transaction 3.4.3 Gross Sales Definition of Net Sales ICH 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bInfringement 4.2.1 Infringement Notice 4.2.1 Infringement Response 4.2.2 Issuing Party 7.5.2 Kiniksa Preamble Kiniksa Election Notice 8.4 Kiniksa Indemnified Parties 9.3 Kiniksa Supply Agreement 8.3(e)(vi) Exchange Fund Section 3.8(bLosses 9.2 Negotiation Notice 3.4.1(b) Expiration Time Section 2.1(d)(iNon-Assignable Kiniksa Agreements 8.3(e)(ii) Financial Statements Incipio Incipio Merger Notice Review Period 3.4.1(b) Party/Parties Preamble Patent Assignment Agreement Section 4.7(b2.6.2 Purchased Assets 2.1 Recovery 4.2.5 Release 7.5.2 Report 3.3.1 Retained Contract Payments 5.4 Reviewing Party 7.5.2 Right of First Negotiation 3.4 ROFN Transaction 3.4.1(a) Recitals Recitals Indemnified Persons Section 7.8(aSales Returns and Allowances Definition of Net Sales Sigma Agreement Schedule E Technology Transfer Fees 5.1.2 Term 8.1 Transfer Taxes 5.8.2 Trigger Notice 3.4.1(a) Inventions Section 1.1 Material Contract Section 4.18(aUnsolicited Offer 3.4.1(b) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Upfront Fee 5.1.1
Appears in 3 contracts
Samples: Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.), Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.), Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.11(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.19 Book-Entry Shares 3.9(c) Board Recommendation Section 2.2(bCapitalization Date 4.4(a) Cancelled Company Shares Section 3.7(a)(ii) Capitalization Representation Annex A Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Claims Annex A Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.17(a) Company Preamble Company Common Stock Recitals Board Recommendation 2.2(a)(iv) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Company License-In Agreements Section 4.16(gRegistered Intellectual Property 4.20(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRepresentatives 7.1(b) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Stockholders 2.1(f)(ii) Company Stockholders’ Meeting 7.3(a) Compensation Committee 4.3(c) Xxxx Xxxxxxx Reference Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Directors 2.3(a) Continuing Employees 7.11(a) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.16(a) Employment Agreement Recitals ESPP 3.8(c) eScription Transition Condition Annex A Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iFinal Exercise Date 3.8(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bForeign Employees 4.16(k) Recitals Recitals Funded International Employee Plan 4.16(b) Government Conditions 7.5(f) Indemnified Persons Section 7.8(aParties 7.12(a) Inventions Section 1.1 International Employee Plans 4.16(a) IP Contracts 4.20(h) Lazard 4.26 Leased Real Property 4.18(b) Leases 4.18(b) Material Contract Section 4.18(a4.11(a) Material Customer 4.23(a) Material Supplier 4.23(b) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)
Appears in 3 contracts
Samples: Agreement and Plan of Merger (Nuance Communications, Inc.), Agreement and Plan of Merger (Nuance Communications, Inc.), Agreement and Plan of Merger (Transcend Services Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Index of Defined Terms A&R Partnership Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Recitals Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Financing Section 6.19(a) BAM Letter Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Recitals Cancelled Company Shares Section 3.7(a)(ii2.07(a)(ii) Capitalization Date Section 3.06(a) Cash Electing Share Section 2.03(d)(1) Cash Election Section 2.03(d)(1) Certificate of Merger Section 3.2 2.02 Certificates Section 3.8(c2.09(c) Changes Section 1.1 Charter Closing Section 3.3 2.03(a) Charter Closing Date Section 3.3 COBRA 2.03(a) Charter Effective Time Section 4.11(d2.03(a) Citigroup Section 3.25 Class B Exchange Recitals Class B Exchange Agreement Section 2.03(b) Class B Exchange Closing Section 2.03(b) Class B Exchange Effective Time Section 2.03(b) Collective Bargaining Agreement Section 3.19(a) Committed Financing Section 4.29 Company Preamble Company Common Stock Benefit Plans Section 3.18(a) Company Board Recitals Company Board Recommendation Section 3.02 Company Board Recommendation Change Section 5.03(c) Company Board Recommendation Notice Section 5.03(f) Company Budget Section 5.01(a) Company Charter Recitals 22 Company Disclosure Letter Article IV III Company License-In Agreements Related Parties Section 4.16(g8.03(d) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.08 Company Securities Section 4.2(a3.06(c) Company Shares Special Distribution Section 5.01(a) Company Stockholder Meeting Section 3.02 Company Stockholders Recitals Competing Acquisition Transaction Section 8.03(b)(ii) Competing Proposal Section 5.03(b) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 9.04 Consent Section 7.8(c3.05 Continuing Employees Section 6.08(a) Customs Laws Converted Option Section 4.22(a2.07(d)(ii) Debt Financing Dispute Converted Restricted Stock Section 10.9(a2.07(e)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.07(c)(i) EAR Election Deadline Section 4.22(a2.08(b) Effective Time Election Form Section 3.2 2.08(a) Election Form Record Date Section 2.08(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.02 Escrow Account Section 4.15(b2.09(a) Escrow Agent Section 2.09(a) Escrow Agreement Section 2.09(a) Exchange Fund Section 3.8(b2.09(b) Expiration Time Expenses Section 2.1(d)(i8.03(a) Financial Statements Incipio Incipio Merger Agreement Fee Letter Section 4.7(b4.29 Final Offering Section 2.07(g) Recitals Recitals Financing Commitment Section 4.29 Financing Commitment Papers Section 4.29 Form F-4 Section 4.23 Form S-4 Section 3.28 Fraud and Bribery Laws Section 3.21(b) Xxxxxxx Xxxxx Section 3.25 Indemnified Persons Parties Section 7.8(a6.07(a) Inventions Mailing Date Section 1.1 2.08(a) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.12(a) Merger Recitals Merger Closing Section 2.03(e) Merger Closing Date. Section 2.03(e) Merger Consideration Section 3.7(a)(i2.07(a)(i) Minimum Condition Merger Effective Time Section 2.1(a)(i2.02 New Plans Section 6.08(b) Multiemployer Plan Non-Electing Shares Section 4.11(c2.08(b) Notice Period Section 5.03(g) Old Plans Section 6.08(b) Operating Partnership Recitals Owned Real Property Section 3.13(a) Parent Preamble Parent Capitalization Date Section 4.06 Parent Common Units Election Section 2.08(b) Parent Common Units Election Share Section 2.08(b) Parent Common Units Exchange Section 2.03(f) Parent Disclosure Letter Article IV Parent Material Contract Section 4.12(a) Parent Related Parties Section 8.03(d) Parent SEC Reports Section 4.08 Parent Securities Section 4.06(c) Parent Subsidiary Securities Section 4.07(c) Parent Unitholder Consent Section 4.04 Parent Unitholder Meeting Section 6.16 Partnership Agreement Amendment and Restatement Recitals Payment Agent Section 2.09(a) Per Restricted Share Cash Consideration Section 2.07(e)(i) Permits Section 3.20 Pre-Closing Dividend Section 2.03(d) Prorated Per Share Cash Dividend Section 2.03(d)(1) Prorated Per Share Stock Dividend Section 2.03(d)(2) Proxy Statement Section 3.28 PTP Qualifying Income Section 8.03(b)(iv)(1) Qualifying Income Section 8.03(c)(i) Qualifying Income Section 8.03(b)(iv)(3) REIT Affiliate Section 8.03(b)(iv)(3) REIT Subsidiary Section 3.17(f) Representatives Section 5.03(a) Requested Transactions Section 6.14 Requested Transactions Closing Section 2.03(c) Requested Transactions Effective Time Section 2.03(c) Requisite Stockholder Approval Section 3.03 Retention Program Section 6.08(d) Rev. Proc. 93-27 Section 3.06(b) Reverse Termination Fee Section 8.03(c) Rights Agreement Recitals Schedule 13E3 Section 4.23 Shelf Registration Statement(s) Section 7.03(e) Short Taxable Year Section 7.02(d) Special Committee Recitals Specified JV Agreements Section 6.19(c) Specified JV Consent Section 6.19(c) Specified JV Party Section 6.19(c) Stock Electing Share Section 2.03(d)(2) Stock Election Section 2.03(d)(2) Subsidiary Interests Section 6.14 Subsidiary Securities Section 3.07(c) 24 Surviving Corporation Section 2.01 Surviving Debt Section 6.19(b) Surviving Debt Consent Section 6.19(b) Surviving Debt Party Section 6.19(b) Tail Period Section 8.03(b)(ii) Tail Policy Section 6.07(b) Tax Protection Agreement Section 3.17(j) Tax Sharing Agreement Section 3.17(j) Termination Date Section 8.01(a)(ii) Termination Fee Section 8.03(b)(i) Uncertificated Shares Section 2.09(c) Voting Agreement Recitals Voting Parties Recitals WARN Section 3.19(c)
Appears in 3 contracts
Samples: Agreement and Plan of Merger (Brookfield Property Partners L.P.), Agreement and Plan of Merger (Brookfield Asset Management Inc.), Agreement and Plan of Merger (GGP Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aCertificates 2.12(c)(i) Board Recommendation Section 2.2(bCFIUS Filing 6.2(c) Cancelled Company Shares Section 3.7(a)(iiChosen Courts 9.12(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.6 Closing Date Section 3.3 COBRA Section 4.11(d2.6 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Benefit Plan Expiration Date 6.11(b) Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Breach Notice Period 8.1(g) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gPlans 6.11(c) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(e) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSoftware 3.15(j) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stock-Based Award Consideration 2.11(a) Company D&O Insurance Section 7.8(cTrade Secrets 3.15(i) Customs Laws Section 4.22(aComparable Plans 6.11(c) Debt Financing Dispute Section 10.9(aContributor 3.15(h) DGCL Recitals Copyrights 1.1(eee) Dissenting Company Shares Section 3.7(c)(i2.10(c)(i) EAR Section 4.22(aDissenting Shareholder Statute 2.10(c)(i) Draft CFIUS Filing 6.2(c) DTC Payment 2.12(d) XXXXX 3.8 Effect 1.1(x) Effective Time Section 2.5 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEvent Notice Period 5.3(d)(i)(1) Exchange Fund Section 3.8(b2.12(b) Excluded Benefits 6.11(c) Expiration Date 2.1(c) Expiration Time Section 2.1(d)(iAnnex I Extension Deadline 2.1(d)(ii) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Expiration Date 2.1(c) International Company Benefit Plans 3.18(a) Joinder 9.7 Lease 3.13(b) Leased Real Property 3.13(b) Marks 1.1(eee) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Sub Recitals Minimum Condition Section 2.1(a)(iAnnex I New Plans 6.11(d) Multiemployer Plan Section 4.11(cOffer Recitals Offer Acceptance Consideration 2.2(a)(iii) Offer Acceptance Time 2.2(a)(iii) Offer Commencement Date 2.1(f)(i) Offer Conditions 2.1(b)(i) Offer Documents 2.1(f)(i)
Appears in 3 contracts
Samples: Agreement and Plan of Merger (Zix Corp), Agreement and Plan of Merger (True Wind Capital, L.P.), Agreement and Plan of Merger (Open Text Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Stockholder Approvals 3.4(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCARES Act 3.18(h) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.9(c)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date 2.3 Commitment Letters 4.10(a) Term Section 3.3 COBRA Section 4.11(d) Reference Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g1.3(u) Company License-Out Agreements Section 4.16(hIntellectual Property 3.17(b) Company Financial Advisor Section 4.10 Option 2.8(c)(i) Company Privacy Policy 3.17(m) Company PSU 2.8(b)(i) Company Recommendation 3.3(a) Company Recommendation Change 5.4(c)(i) Company RSU 2.8(a)(i) Company SEC Reports Section 4.7(a3.8(d) Company Securities Section 4.2(a3.7(b) Company Shares Special Committee Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aContinuing Employees 6.11(b) Converted Cash Award 2.8(a)(ii) Copyrights 1.1(hhh) Covenant Exceptions 5.1(a) Debt Commitment Letter 4.10(a) Debt Fee Letter 6.6(b)(ii) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(d)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Elephant Recitals Enforcement Expenses 8.3(e) Equity Commitment Letters 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Arrangements 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 4.10(a) Founder Recitals Guarantees Recitals Guarantors Recitals Indemnified Party Proceeding 6.10(b) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.19(a) IP Contracts 3.17(d) KKR Recitals Labor Agreements 3.20(a) Lease 3.15(b) Leased Real Property 3.15(b) Marks 1.1(hhh) Maximum Annual Premium Section 7.8(c6.10(b) Merger Recitals Merger Sub Preamble Term Section Reference Merger Sub Stockholder Approval 6.19 New Plans 6.11(a) Notice Period 5.4(d)(ii)(2) Old Plans 6.11(a) Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Divesture Obligations 6.2(b) Party or Parties Preamble Patents 1.1(hhh) Payment Agent 2.9(a) Per Share Price 2.7(a)(iii) Promissory Note 6.22 Proxy Statement 6.3(a) Reimbursement Obligations 6.6(h) Reinvestment Shareholders Recitals Required Amount 4.10(a) Required Permits 3.20(c) Restraint 7.1(b) Rollover Shares Recitals Statutory Stockholder Approval 3.4(a) Support Agreements Recitals Surviving Corporation Recitals Tail Policy 6.10(b) Technical Deficiencies 3.17(l) Termination Date 8.1(b) Trade Controls 3.22(b) Trade Secrets 1.1(hhh) Transaction Matters 9.12(a) Uncertificated Shares 2.9(c)(ii) Unvested Company Option 2.8(c)(ii) Unvested Company PSU 2.8(b)(i) Unvested Company RSU 2.8(a)(ii) Vested Company Option 2.8(c)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(c)(i) Minimum Condition Section 2.1(a)(iVested Company PSU 2.8(b)(i) Multiemployer Plan Section 4.11(c)Vested Company PSU Consideration 2.8(b)(i) Vested Company RSU 2.8(a)(i) Vested Company RSU Consideration 2.8(a)(i) Vista Recitals
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Vepf Vii SPV I, L.P.), Agreement and Plan of Merger (KnowBe4, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery Laws 3.22(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Balance Sheet Date 1.1 Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Change of Recommendation/Termination Notice 5.3(c) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collaboration Agreement 3.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 3.2(b) Company Financial Advisor Section 4.10 3.11 Company Program Party 3.20(e) Company Program Requirements 3.20(d) Company Programs 3.20(d) Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Company Stockholders’ Meeting 6.12(b) Company Trade Secrets 3.17(i) Confidentiality Agreement Section 10.4 9.4 Current Company D&O Insurance Section 7.8(c6.8(b) Customs Laws Section 4.22(aD&O Tail Insurance 6.8(b) Debt Financing Dispute Section 10.9(a) Data 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.2 Effects 1.1 Enforceability Exceptions Section 4.4 3.4 Environmental Permits Section 4.15(b) 3.16 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals FFDCA 1.1 GDPR 1.1 -13- Indemnified Persons Section 7.8(a6.7(a) Internet Properties 1.1 Inventions Section 1.1 IP Contracts 3.17(k) Leased Real Property 3.18(b) Material Contract Section 4.18(a3.19(a)(xix) Maximum Annual Premium Section 7.8(cAmount 6.7(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Money Laundering Laws 3.22(b) Multiemployer Plan Section 4.11(c)New Plans 6.8(b) Old Plans 6.8(b) Option Consideration 2.7(d) Parent Preamble Parent Disclosure Letter 1.1 Paying Agent 2.8(a) Predecessor Registrant 3.7(a) Real Property Leases 3.18(b) Regulatory Agency 3.20(b) Regulatory Permits 3.20(b) Reorganization Date 3.7(c) RSU Consideration 2.7(e) Specified Governmental Authority 7.2 Subsidiary Securities 3.2(e) Surviving Corporation 2.1 Termination Date 8.1(b)(i) Termination Fee 8.3(b) Trade Secret 1.1 Trademarks 1.1 Uncertificated Shares 2.8(c) Works of Authorship 1.1
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Ambrx Biopharma, Inc.), Agreement and Plan of Merger (Ambrx Biopharma, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 7.12(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 4.21 Certificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.19(a) Company Preamble Company Common Stock Recitals Acquisition Transaction 9.4(b) Company Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Preamble Company License-In IP Agreements Section 4.16(g4.22(e) Company License-Out Agreements Section 4.16(hProducts 4.22(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRestricted Stock 3.7(e) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidentiality Agreement 7.9 Term Section 10.4 Current Company Reference Consent 4.5(b) Continuing Directors 2.3(a) D&O Insurance Section 7.8(c7.13(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(c) Recitals Recitals Foreign Employees 4.18(l) Funded International Employee Plan 4.18(b) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Initial Termination Date 9.1(c) International Employee Plans 4.18(a) Leased Real Property 4.20(b) Leases 4.20(b) Material Contract Section 4.18(a4.11(a) Maximum Annual Premium Section 7.8(c7.13(b) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Section 4.11(cNet Cash Position 4.7(h)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Spectralink Corp), Agreement and Plan of Merger (Polycom Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 2.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery/AML Laws 3.19(a) Antiboycott Rules Section 4.22(aBorrower 4.7(a) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Change of Control Payment 3.15(a)(xii) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 6.1(a) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 6.1(b) Company ESPP Rights 2.7(e) Company Financial Advisor Section 4.10 Advisors 3.21 Company Financial Statements 3.5(b) Company Plans 6.9(c) Company Related Parties 8.4(c) Company SEC Reports Section 4.7(a3.5(a) Company Securities Section 4.2(a3.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Company Termination Fee 8.4(a) Competing Acquisition Transaction 8.4(a)(i) Current Company D&O Insurance Section 7.8(c6.4(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.7(a) Debt Financing Dispute Section 10.9(a4.7(a) DGCL Recitals Disclosure Schedule Article III Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b)(i) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 3.2 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i1.1(c)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 2.7(e) Recitals Recitals Financing Agreements 6.16(d) Financing Sources 8.5 In-bound License 3.14(b) In-the-money Option 2.7(c) Indemnified Persons Section 7.8(a6.4(a) Indemnified Proceeding 6.4(b) Inventions Section 1.1 Article X Know-How Article X Labor Agreements 3.15(a)(xvii) Labor Organizations 3.16(i) Material Contract Section 4.18(a3.15(a) Maximum Annual Premium Section 7.8(c6.4(c) Merger Recitals Term Section Reference Merger Consideration Section 3.7(a)(i2.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i1.1(a)(i) Multiemployer Plan Section 4.11(c)3.16(c) New Plans 6.9(c) Notice of Intended Recommendation Change 6.1(c) Offer Recitals Offer Commencement Date 1.1(a) Offer Conditions Annex A Offer Documents 1.1(e)(i) Offer Price Recitals Offer to Purchase 1.1(a) Old Plans 6.9(c) Option Consideration 2.7(c) Out-bound License 3.14(b) Parent Preamble Payment Agent 2.8(a) Payoff Amount 2.7(f) Payoff Letter 2.7(f) Plans 3.16(a) Principal Stockholders Recitals Real Property Leases 3.13(b) Representatives 5.3 Restraint 7.1(b) Regulatory Authorities 3.17(b) Regulatory Permits 3.17(b) Required Information 6.16(a)(iv) Restricted Benefits 3.19(b) RSU Consideration 2.7(d) Schedule 14D-9 1.2(a) Schedule TO 1.1(e)(i) Software Article X Stockholder List Date 1.2(b) Surviving Corporation 2.1 Termination Date 8.1(b) Termination Fee 8.4(a)(i) Trademarks Article X Uncertificated Shares 2.8(c) Works of Authorship Article X
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Horizon Pharma PLC), Agreement and Plan of Merger (Raptor Pharmaceutical Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.12(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i409A Authorities 4.11(f) Action 4.9 Affiliate Transaction 4.24 Agents 4.20(d) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDate Preamble Appointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Arrangements 7.17 Book Entry Shares Section 3.7(a)(ii3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Bylaws 4.1(b) Company Charter 4.1(b) Company Compensation Committee 7.17 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEscrow Agreement 4.18(l) Company License-Out Agreements Section 4.16(hInsurance Policies 4.16 Company International Plan 4.11(g) Company Financial Advisor Section 4.10 Plans 4.11(a) Company Registered IP 4.18(b) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(aDocuments 4.6(a) Company Shares Recitals Company Stockholder Approval 4.4(a) Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidential Customer Information 4.18(m) Confidentiality Agreement Section 10.4 Current Company 7.9 Continuing Director 2.3(a) Covered Securityholders 7.17 D&O Insurance Section 7.8(c7.13(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployment Compensation Arrangement 7.17 ESPP 7.11(g) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(b) Recitals Recitals FAR 4.20(c) Final Exercise Date 7.11(g) Indebtedness 6.2(h) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Independent Directors 2.3(b) Initial Termination Date 9.1(b) Leased Real Property 4.17(a) Material Contract Section 4.18(a4.15(a) Maximum Annual Premium Section 7.8(c7.13(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Xxxxxx Xxxxxxx 4.25 Nonqualified Deferred Compensation Plan Section 4.11(c4.11(f) Offer Recitals Offer Documents 2.1(f)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Hewlett Packard Co), Agreement and Plan of Merger (ArcSight Inc)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(D) Additional Study Section 3.3 Additional Study Approval Section 3.3(c) Affiliate Master Agreement Agreement Preamble Allocable Overhead Exhibit D Allowable Expenses Exhibit D Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.7(a) Audit Rights Holder Section 9.7(e) Auditee Section 9.7(e) DEFINITION SECTION Bankruptcy Code Section 8.8 Barred Indication Section 8.6(b)(vii) Business Day Master Agreement CCB Program MTA Master Agreement Celgene Preamble Celgene Indemnified Parties Section 13.2 Celgene Independent Product Master Agreement Challenge Section 14.3(d) Challenging Party Section 14.3(d) Change of Control Master Agreement Clinically Develop Section 8.6(a) Co-Co Buy-In Section 3.4 Combination Product Section 1.41 Commercialization/Commercialize Master Agreement Commercialization Budget Section 6.2(c) Commercialization Costs Section 6.5(c) Commercialization Plan Section 6.2(a) Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGS Exhibit D Cover/Covering/Covered Master Agreement CPI Section 1.29 Cure Period Section 14.3(b)(i) Damages Master Agreement Deemed Buy-In Section 3.3(c) Develop/Development Master Agreement Development Budget Section 3.1(a)(i) Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 [Distinct Product Master Agreement] [Distinct Product Catch-Up Payments Section 9.2(a)(iii)] Distribution Costs Exhibit D Earlier Patent Section 10.7 Electronic Delivery Section 15.16 Enabling Manufacturing Section 8.6(a) Execution Date Preamble FDA Master Agreement FDCA Master Agreement Finance Working Group Section 2.2(f) force majeure event Section 15.7 DEFINITION SECTION Functional Phenotypic Assay Similarity Criteria Master Agreement Global Safety Database Section 5.3 Gross Profit Exhibit D Incentive Compensation Section 6.5(b)(v) IND Master Agreement Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.8(b)(i) Indication Master Agreement Information Request Section 6.5(b)(vii) Initial Enforcement Party Section 10.3(b) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement Licensed Branding Section 6.6(c) Licensing Party Section 8.5(c) Lump Sum Section 3.3(c) Manufacture/Manufacturing Master Agreement Manufacturing Costs Exhibit D Marketing Costs Exhibit D Master Agreement Introduction Material Breach Section 14.3(b)(i) Non-Proposing Party Section 3.3 Operating Profits or Losses Exhibit D Opt-In Right Master Agreement Other Operating Income/Expense Exhibit D Party or Parties Preamble Patent Officers Master Agreement Patent Prosecution Expenses Section 10.2(c) Patent Master Agreement Payee Party Section 9.8(b)(i) Paying Party Section 9.8(b)(i) Permitted Indication Section 8.6(b)(vii) Person Master Agreement Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit D Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Pivotal Clinical Trial Master Agreement Product Recall Expenses Exhibit D Product Trademarks Section 6.6(a) Profit & Loss Share Section 9.3(a) Program Assets Section 12.4(a) DEFINITION SECTION DEFINITION SECTION Program Compound Master Agreement Program Product Master Agreement Program Target Master Agreement Proposing Party Section 3.3 Prosecuting Party Section 10.2(d)(ii) Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Expenses Exhibit D Regulatory Interactions Section 5.1(b) Report Exhibit D Requesting Party Section 11.3(b)(iii) Royalty Rate Section 9.4(a) Royalty Term Section Reference Acceptable Confidentiality 9.4(b) Sales Costs Exhibit D Sales Milestone Condition Section 9.2(b) SEC Section 11.3(b)(i) Selected Target Master Agreement Selling Party Section 1.41 Separate Program Master Agreement Separate Program Product Section 8.6(b)(vii) Step-In Enforcement Party Section 10.3(d) Sublicense Revenues Exhibit D Subsequent Third Party Agreement Section 6.2(e)(iii9.5(b) Acquisition Proposal Term Section 6.2(e)(i14.1 Third Party Contractors Section 8.2(a)(ii) Acquisition Sub Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4 Third Party Products Liability Action Section 13.5(a) Vividion Preamble Adverse Recommendation Change Vividion Indemnified Parties Section 6.2(c)(i13.1 Vividion Opt-Out Notice Section 2.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Vividion Opt-Out Date Section 3.3 COBRA Section 4.11(d2.3(b) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)II
Appears in 2 contracts
Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Vividion Therapeutics, Inc.)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.8 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(4) Affiliate Master Agreement Agreement Preamble Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.5(a) Bankruptcy Code Section 8.8 Business Day Master Agreement CCB Program Master Agreement Celgene Preamble Celgene Independent Product Master Agreement Celgene Indemnified Parties Section 13.2(a) Celgene Manufacturing Responsibilities Section 4.1(a) Challenge Section 14.3(d) Challenging Party Section 14.3(d) Clinically Develop Section 8.6(a) Combination Product Section 1.34 Commercialization/Commercialize Master Agreement Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) DEFINITION SECTION Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Compound Master Agreement Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Cover/Covering/Covered Master Agreement Cure Period Section 14.3(b)(i) Deal Target Master Agreement Deal Target Program Master Agreement Develop/Development Master Agreement Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 Distinct Product Master Agreement Distinct Product Catch-Up Payments Section 9.1(a)(iv) Earlier Patent Section 10.8 Electronic Delivery Section 15.14 Enabling Manufacturing Section 8.6(a) Execution Date Preamble E3 Ligase Program Master Agreement FDA Master Agreement First Program Master Agreement force majeure event Section 15.5 Functional Phenotypic Assay Similarity Criteria Master Agreement Implementation Date Master Agreement IND Master Agreement Indication Master Agreement Indirect Taxes Section 9.6(a) Invalidity Claim Section 10.4(b) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement Licensed Branding Section 6.2(c) Licensed Product Data Section 14.4(c) Licensed Program Introduction Manufacture/Manufacturing Master Agreement Master Agreement Introduction Material Breach Section 14.3(b)(i) Opt-In Right Master Agreement Party/Parties Preamble Patent Master Agreement Payee Party Section 9.6(a) Paying Party Section 9.6(a) Person Master Agreement DEFINITION SECTION Permitted Indication Section 8.6(b)(vii) Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Product Trademarks Section 6.2(a) Program Assets Section 12.4 Program Compound Master Agreement Prosecution/Prosecute Master Agreement Publication Master Agreement Publication Purpose Section 11.4(a) Pursuing Party Section 14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.2 Requesting Party Section 11.3(b)(iii) Royalty Term Section Reference Acceptable Confidentiality 9.2(b) SEC Section 11.3(b)(i) Separate Program Master Agreement Separate Program Product Section 6.2(e)(iii8.6(b)(vii) Acquisition Proposal Selling Party Section 6.2(e)(i1.34 Target Master Agreement Term Section 14.1 Third Party Master Agreement Third Party Contractors Section 8.2(b) Acquisition Sub Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4(a) Vividion Preamble Adverse Recommendation Change Vividion Cereblon Program Master Agreement Vividion Indemnified Parties Section 6.2(c)(i13.1(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company LicenseVividion Opt-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Notice Master Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Article II.
Appears in 2 contracts
Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Vividion Therapeutics, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble 90% Top-Up Option 1.4 90% Top-Up Option Shares 1.4 90% Top-Up Exercise Notice 1.4 90% Top-Up Notice Date 1.4 90% Top-Up Closing 1.4 90% Top-Up Notice Receipt 1.4 Adverse Recommendation Change Section 6.2(c)(i) Regulatory Condition Annex A Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 1.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.20 Capitalization Representation Annex A Certificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.2 Change in Control Agreement 6.13(d) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.18(a) Company Preamble Company Common Stock Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Disclosure Schedule Article III Preamble Company IP Agreements 3.21(f) Company Representative 6.1(b) Company Rights Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Rights Plan Recitals Company Securities Section 4.2(a3.4(c) Company Shares Recitals Company Stockholders 1.1(f) Term Section Reference Company Stockholders’ Meeting 6.3(a) Compensation Committee 3.3(d) Computershare Recitals Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) Continuing Directors 1.3(a) Covered Securityholders 4.9 D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aDistribution Date 3.3(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExclusivity Agreement 6.10 Export Controls 3.22 FIN 48 3.15(o) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.17(b) Recitals Recitals Import Restrictions 3.22 Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 International Employee Plans 3.17(a) Leased Real Property 3.19(b) Leases 3.19(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger Recitals 2.1 Merger Consideration Section 3.7(a)(i2.7(a) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c1.1(a)(i)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Autodesk Inc), Agreement and Plan of Merger (Moldflow Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Corruption Law 3.18(b) Antiboycott Rules Section 4.22(aAntitrust Laws 7.2(a) Board Recommendation Section 2.2(bAssumed Option 2.7(d) Assumed Unit 2.7(d)(ii) Barclays 3.26 Book-Entry Shares 2.8(b)(i) Cancelled Company Shares Section 3.7(a)(ii2.7(b)(iv) Cash Consideration 2.7(b)(i) Certificate 2.8(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3(a) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Code Recitals Company Preamble Company Common Stock Recitals 2001 Plan 3.4(a) Company 2007 Director Plan 3.4(a) Company 2007 Plan 3.4(a) Company 2012 Inducement Plan 3.4(a) Company Board Recommendation 6.4(a) Company Board Recommendation Change 6.4(b) Company Capitalization Representations 8.2(a)(ii) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gExpense Reimbursement 9.3(c)(vi) Company License-Out Agreements Section 4.16(hFundamental Representations 8.2(a)(i) Company Financial Advisor Section 4.10 In Licenses 3.12(e) Company IP Licenses 3.12(f) Company Material Contract 3.13(a) Company Non-U.S. Employee Plans 3.15(i) Company Out Licenses 3.12(f) Company Permits 3.19 Company Qualified Plan 3.15(e) Company Real Property Leases 3.10 Company Registered Intellectual Property Rights 3.12(a) Company SEC Reports 3.6 Term Section 4.7(aReference Company Stock Awards 3.4(c) Company Securities Section 4.2(aStock Option 2.7(d)(i) Company Shares Recitals Stock Plans 3.4(b) Company Stockholder Meeting 7.4(a) Company Subsidiary Documents 3.1(b) Company Terminating Plans 7.7(a) Company Voting Proposal 3.2(b) Confidentiality Agreement Section 10.4 Current Company 7.5(h) D&O Insurance Section 7.8(cPolicy 7.8(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) DLLCA Recitals Xxxx-Xxxxx Act 3.6 EAR Section 4.22(a3.18(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cECCNs 3.18(c)(ii)
Appears in 2 contracts
Samples: Agreement and Plan of Merger and Reorganization (Entropic Communications Inc), Agreement and Plan of Merger and Reorganization (Maxlinear Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement in which such terms are defined, for reference purposes as set forth opposite each of the capitalized terms below: Term Section Reference 102 Amounts 2.8(d)(i) 104H Tax Ruling 6.18(c) Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.01(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.01(b) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.24 Approval 6.7(a) Board Recommendation Section 2.2(bAssumed RSU 6.14(a) Bankruptcy and Equity Exceptions 3.3(a) Cancelled Company Shares Section 3.7(a)(iiOption 6.14(b)(i) Cash Merger Consideration Recitals Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Charter Documents 3.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.18(a) Commitment Letter 4.8(b) Companies Registrar 2.2 Company Preamble Company Common Stock 102 Compensatory Awards 2.8(d)(i) Company 102 Shares 2.8(b) Company 401(k) Plan 6.15(e) Company Board Recitals Company Disclosure Letter Article IV Board Recommendation Recitals Company License-In Agreements Section 4.16(gFinancial Advisors 3.28 Company Financial Statements 3.7(a) Company LicenseForm 20-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 F Article III Company SEC Reports Section 4.7(a3.6(a) Company Securities Section 4.2(a3.4(d) Company Shares Share Recitals Company Shareholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company 6.12 Consent 3.5(b) Converted Option 6.14(a)(ii) Xxxx Xxxxxxx Reference Covered Persons 6.16(a) Customer Contracts 3.10(a)(ix) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.16(c) Debt Financing Dispute Section 10.9(a4.8(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iDebt Letters 4.8(b) EAR Section 4.22(aDefinitive Financing Agreement 6.11(h) DPAS 3.26(h) Dual Listing 6.6(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electing Holder 6.19(c) Electronic Delivery 9.12 Exchange Fund 2.8(b) Exchange Fund Section 3.8(bAgent 2.8(b) Expiration Time Section 2.1(d)(iExisting Indemnification Agreements 6.16(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Deliverables 6.11(h) Financing Information 6.11(h) Financing Sources 6.11(h) Funded International Employee Plan 3.17(b) Governmental Plan 3.17(j) ICL Recitals Recitals Indemnified Persons Section 7.8(aIndependent Contractor 3.10(a)(iii) Inventions Section 1.1 Information Agent 2.8(a) Insurance Matter 6.3 Interim Option Tax Ruling 6.18(a) ISA Exemption 6.6(b) Israeli Employees 3.18(c) Israeli Prospectus 6.6(c) Israeli Offering Exemption 6.6(a) Israeli Options Exemptions 6.6(b) ITA 2.13(a) Labor Organization 3.18(a) Leased Real Property 3.19 (b) Leases 3.19(b) Letter of Transmittal 2.8(c)(i) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.10(a) Merger Recitals Merger Consideration Recitals Merger Proposal 6.4(a)(i) Merger Proposal Submission Date 6.4(a)(iii) Merger Sub Preamble Option Consideration 6.14(b)(i) Option Tax Ruling 6.18(a) Outbound Lease 3.19(b) Outbound Leased Property 3.19(b) Owned Real Property 3.19(a) Parent Preamble Term Section 3.7(a)(iReference Parent Charter Documeֵnts 4.1 Parent SEC Reports 4.6(a) Minimum Condition Parent Securities 4.5(b) Parties Preamble Paying Agent 2.8(a) Payor 2.13(a) Permits 3.12 Privacy Requirements 3.21(l) Proxy Statement 6.5(a) Real Property 3.19(c) Redacted Fee Letter 4.8(b) Regulatory Approvals 7.1(b) Replacement RSU 6.14(a)(ii) Requisite Shareholder Approval 3.3(c) Section 2.1(a)(i14 Arrangement 3.18(c) Multiemployer Plan Section 4.11(cSignificant Customer 3.14(a) Significant Supplier 3.14(b) Specified Auditor Assistance 6.11(h) Stock Merger Consideration Recitals Subsidiary Securities 3.2(c) Substantial Creditors 6.4(a)(iii)(D) Superior Proposal Notice Period 6.2(c) Surviving Company 2.1 Takeover Law 3.29(a) Termination Date 8.1(d) Uncertificated Shares 2.8(c)(i) Voting Agreement Recitals Withholding Drop Date 2.13(b) Withholding Tax Ruling 6.18(b)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Gilat Satellite Networks LTD), Agreement and Plan of Merger (Gilat Satellite Networks LTD)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(c)(ii) Antiboycott Rules Section 4.22(aAlternative Financing 6.5(b) Board Recommendation Section 2.2(bAnti-Corruption Laws 3.26(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) 22 Chosen Courts 9.12 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letters 4.11(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gOption Consideration 2.9(a) Company License-Out Agreements Section 4.16(hPBRSU Consideration 2.9(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e) Company RSU Consideration 2.9(b) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Agreements 9.6 Consent 3.6 Copyrights 1.1(bbb) D&O Insurance Section 7.8(c6.9(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.11(a) Debt Financing Dispute Section 10.9(a4.11(a) Definitive Financing Agreements 6.5(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDTC 2.10(d) DTC Payment 2.10(d) XXXXX 1.3(q) Effect 1.1(s) Effective Time Section 2.2 Electronic Delivery 9.15 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter 4.11(a) Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iFairness Opinions 3.3(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.11(a) Fee Letters 6.5(a) Financing 4.11(a) Guarantee Recitals Holdings Recitals Holdings Subsidiary Recitals Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.18(a) IP Contracts 3.16(f) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(bbb) Maximum Annual Premium Section 7.8(c6.9(c) Maximum Company Liability Amount 8.3(e) Maximum Parent Liability Amount 8.3(a) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble New Plan 6.10(c) Minimum Condition Section 2.1(a)(iNon-Recourse Party 9.18 Other Required Company Filing 6.3(b) Multiemployer Plan Section Other Required Parent Filing 6.3(c) Owned Company Share 2.7(a)(ii) Owned Real Property 3.14(a) Parent Preamble Parent Disclosure Letter Article IV Parent Related Parties 8.3(a) Parties Preamble Party Preamble Patents 1.1(bbb) Payment Agent 2.10(a) Payoff Letters 6.19 Per Share Price 2.7(a)(iv) Permits 3.20 Proxy Statement 6.3(a) Recent SEC Reports Article III Recommendation Change 5.3(c)(i) Repaid Indebtedness 6.19 Required Amount 4.11(c) Requisite Stockholder Approval 3.4 Reverse Termination Fee 8.3(a) Rollover Agreements Recitals Rollover Shares 2.7(a)(ii) Rollover Stockholders Recitals SaaS 3.16(f) Schedule 13e-3 6.3(a) Special Committee Recitals Special Committee Recommendation 3.3(a) Sublease 3.14(c) Subsidiary Owned Share 2.7(a)(iii) Support Agreement Recitals Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Trade Control Laws 3.26(a) Uncertificated Shares 2.10(c) Written 1.3(r)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (R1 RCM Inc. /DE), Agreement and Plan of Merger (R1 RCM Inc. /DE)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(m) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation Notice 7.4(b)(ii) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.4(a) Company Board Recommendation Change 7.4(b) Company Common Stock Recitals Company Compensation Committee 4.17(m) Company Disclosure Letter Article IV Term Section Reference Company License-In Agreements Section 4.16(gFinancial Advisors 4.25 Company IP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.10(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.8(a) Company Shares Recitals Competing Acquisition Transaction 9.3(b)(iii) Competing Party 9.3(b)(iii) Confidentiality Agreement Section 10.4 Consent 4.5 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.9(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Employee Plan 4.17(a) Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(m) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Limitations 4.2 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGrant Date 4.6(e) Recitals Recitals Indemnified Persons Section 7.8(a7.9(a) Inventions Section 1.1 Leased Real Property 4.13(b) Leases 4.13(b) LKQ Preamble Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.9(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Modified Terms 7.4(c) New Plans 7.10(c) Offer Recitals Offer Documents 2.1(g)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.10(c) Option Consideration 3.7(d) Outside Date 9.1(b) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Representatives 6.2(b) Restraint 8.1(b) Schedule 14D-9 2.2(b) Schedule TO 2.1(g)(i) Stockholder List Date 2.2(c) Subsidiary Securities 4.7(c) Term Section 4.11(cReference Support Agreement Recitals Surviving Corporation 3.1 Tax Returns 4.16(a) Termination Fee 9.3(b)(i) Uncertificated Shares 3.8(c) Union 4.18(a)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (LKQ Corp), Agreement and Plan of Merger (Coast Distribution System Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti Bribery Laws 3.20(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(bArticles of Merger 2.2 Assets 3.14 Assumed Restricted Stock Unit Award 2.7(d)(ii) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.6(a) Cash Consideration 2.7(a)(i) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Commitment Letter 4.28 Company Preamble Company Annual Report Article III Company Board Recommendation Recitals Company Board Recommendation Change 6.5(a) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEmployee Plans 3.17(a) Company License-Out Agreements Section 4.16(hERISA Affiliate 3.17(a) Company ESPP Rights 2.7(f) Company Financial Advisor Section 4.10 3.25 Company International Employee Plans 3.17(a) Company Material Contract 3.12(a) Company Material Customer 3.30(a) Company Material Supplier 3.30(b) Company Plans 6.12(a) Company Related Parties 8.3(b)(v) Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSource Code 3.15(o) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stockholder Approval 3.3 Company Stockholder Meeting 6.4(a) Company Subsidiary Securities 3.7(c) Consent 3.5 Contaminants 3.15(n) Copyrights 1.1 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.11(b) DGCL Recitals 2.1 Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aECCN 3.20(i) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Exchange Agent 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iexport 3.20(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.27 Final Exercise Date 2.7(f) Recitals Recitals Financing 4.28(a) Financing Documents 4.28(a) Financing Failure Termination Fee 8.3(c)(iii) Form S-4 3.28 FSE List 3.20(i) Fractional Share Cash Amounts 2.11 FY2019 Plans 6.12(c) Government Officials 3.20(d) Grant Date 3.6(e) Indemnified Persons Section 7.8(a6.11(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Termination Date 8.1(b)(i) Joint Proxy Statement/Prospectus 3.28 Leased Real Property 3.13(b) Leases 3.13(b) Lenders 4.28 Maximum Annual Premium Section 7.8(c6.11(b) MBCA Recitals Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Plans 6.12(b) Multiemployer Old Plans 6.12(b) Owned Real Property 3.13(a) Parent Preamble Parent Annual Report Article IV Parent Board Recommendation Recitals Parent Board Recommendation Change 6.6(a) Parent Capitalization Date 4.6(a) Parent Common Stock Recitals Parent Common Stock Issuance Recitals Parent Disclosure Letter Article IV Parent Financial Advisor 4.24 Parent Grant Date 4.6(e) Parent Related Parties 8.3(c)(iii) Parent SEC Reports 4.8 Parent Securities 4.6(c) Parent Stockholder Approval 4.3 Parent Stockholder Meeting 6.4(c) Parent Subsidiary Securities 4.7(c) Patents 1.1 Permits 3.19 Regulatory Filings 6.2(a) Repatriation Notice 6.20 Replacement Bonus Plan Section 4.11(c6.12(c) Representatives 5.3(a) Restricted Stock Unit Consideration 2.7(d)(i) Reverse Termination Fee 8.3(c)(i) SDN List 3.20(i)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Xcerra Corp), Agreement and Plan of Merger (Cohu Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2023 Bonus Plan 7.9(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bAntitrust Clearance Condition Annex A Balance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) Cash Amount Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c3.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section Date. 3.3 COBRA Section 4.11(dCollaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.23 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.2(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Covered Entity 4.20(j) CVR Recitals CVR Agreement Recitals D&O Insurance Section 7.8(cIndemnified Party 7.8(a) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aData 1.1 Depository Agent 3.8(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect 1.1 Effective Time Section 3.2 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Existing Payment Period 3.7(h) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFDCA 4.20(a) Recitals Recitals Indemnified Persons Section 7.8(aForeign Antitrust Laws 4.6 French Tax Code 10.14 GDPR 1.1 Internet Properties 1.1 Inventions 1.1 Leased Real Property 4.18(b) Inventions Section 1.1 Material Contract Section 4.18(a4.19(a) Maximum Annual Premium Section 7.8(cMedical Device 4.20(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Milestone Option Amount 3.7(d)(ii) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) No Antitrust Proceedings Condition Annex A No Legal Restraint Condition Annex A Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Owned Real Property 4.18(a) Parent Preamble Paying Agent 3.8(a) Proprietary Information 1.1 PSU Consideration 3.7(f) Real Property 4.18(a) Real Property Leases 4.18(b) Regulatory Permits 4.20(i) Remedy Action 7.2(a) Rights Agent Recitals RSU Consideration 3.7(e) Schedule TO 2.1(f)(i) Schedule 14D-9 2.2(a) Social Security Act 4.20(e) Subsidiary Securities 4.2(e) Surviving Corporation. 3.1 Termination Condition Annex A Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c)(ii) Works of Authorship 1.1
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Johnson & Johnson), Agreement and Plan of Merger (Johnson & Johnson)
Additional Definitions. The For the purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto meaning specified in the respective sections of this Agreement Section set forth opposite each of the capitalized terms belowto such term: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Aggregate Merger Consideration 3.1 Alternative Acquisition Agreement Section 6.2(c)(ii7.2(d)(i)(D) Antiboycott Rules Section 4.22(aCompany Agreement Amendment 2.4 Applicable Date 5.5(a) Board Recommendation Section 2.2(bBankruptcy and Equity Exception 5.3(a) Cancelled Company Shares Section 3.7(a)(ii) Book-Entry Share 3.2 Certificate 3.2 Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3 Change of Recommendation 7.2(d)(i)(D) Changes Section 1.1 Chosen Courts 10.4(b) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Approvals 5.4(a) Company Board Recitals Company Disclosure Letter Article IV ARTICLE V Company License-In Agreements Section 4.16(gMaterial Contracts 5.12(a) Company License-Out Agreements Section 4.16(hRecommendation Recitals Company Reports 5.5(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) DLLCA Recitals EECI Preamble Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.3 Eligible Shares 3.1 Encumber 5.11 Encumbrance 5.11 Exchange Agent 4.1 Exchange Fund Section 3.8(b4.1 Exchange Ratio 4.1 Indemnified Parties 7.10(a) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(cLetter of Transmittal 4.2(a) Merger Recitals Merger Consideration Section 3.7(a)(i3.1 Merger Sub Preamble Non-DTC Book-Entry Share 4.2(b) Minimum Condition Section 2.1(a)(iOriginal Date 7.4(b) Multiemployer Plan Section 4.11(cOutside Date 9.2(a) Parent Preamble Parent Approvals 6.4 Parent Board Recitals Parent Capital Stock 6.2(a) Parent Common Stock Recitals Parent Disclosure Letter ARTICLE VI Parent Material Contract 6.12(a) Parent Reports 6.5(a) Party/Parties Preamble Preference Shares 6.2(a) Proxy/Prospectus 7.3(a) Public Shareholders Recitals Registration Statement 7.3(a) Requisite Company Vote 5.3(a) Special Committee Recitals Surviving Entity 2.1 Tail Period 7.10(b) Transaction Litigation 7.13 Transactions Recitals Voting Shares 5.2(a)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Enbridge Inc), Agreement and Plan of Merger (Enbridge Energy Management L L C)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aASU 1.1(zz) Board Recommendation Section 2.2(bCertificates 2.9(c)(i) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gPrivacy Policy 3.16(h) Company License-Out Agreements Section 4.16(hPlans 6.11(b) Company Financial Advisor Section 4.10 Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStock-Based Award Consideration 2.8(a)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aComparable Plans 6.11(b) Converted Stock-Based Award 2.8(a)(ii) Copyrights 1.1(aaa) Debt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDPA 4.13(a) DTC Payment 2.9(d) Effect 1.1(t) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letters 4.10(a) Financing 4.10(a) Financing Letters 4.10(a) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.18(a) IP Contracts 3.16(e) Xxxx Xxxxxxx Reference Lease 3.14(b) Leased Real Property 3.14(b) Lookback Date Article III Marks 1.1(aaa) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(c) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(ii)(3) Old Plans 6.11(c) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(e) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(aaa) Payment Agent 2.9(a) Payoff Letter 6.18 Per Share Price 2.7(a)(iii) Proxy Statement 6.3(a) SEC Reports Article III Reimbursement Obligations 6.6(f) Required Financing Information 6.6(a)(v) Requisite Stockholder Approval 3.4 Surviving Corporation 2.1 Tail Policy 6.10(c)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Forescout Technologies, Inc), Agreement and Plan of Merger (Forescout Technologies, Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 102 Amounts Section 2.8(d)(i) Alternative Acquisition Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iSection 5.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiApplicable Vesting Period Section 2.7(c)(ii) Antiboycott Rules Section 4.22(aApproval Section 3.5 Assignee Section 10.3 Assumed Consideration Section 2.7(c)(ii) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date Section 3.6(a) Certificate of Merger Section 3.2 Section 2.3 Certificates Section 3.8(cSection 2.8(c) Change Section 1.1 Changes Section Section 1.1 Charter Documents Section 3.1 Closing Section 3.3 Section 2.2 Closing Date Section 3.3 COBRA Section 4.11(dSection 2.2 Code Section 2.8(f) Collective Bargaining Agreement Section 3.18(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals Board Recommendation Section 5.3(a) Company Board Recommendation Change Section 5.3(b) Company Disclosure Letter Article IV Article III Company License-In Agreements Section 4.16(gProducts Section 3.15(b) Company License-Out Agreements Reports Section 3.8 Term Section 4.16(hReference Company Securities Section 3.6(d) Company Financial Advisor Section 4.10 Shareholder Approval Section 3.2 Company SEC Reports Section 4.7(aShareholders Meeting Section 7.3(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Section 7.8 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Due Diligence Review Section 4.13 Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bSection 2.3 Employee Plans Section 3.17(a) Exchange Fund Section 2.8(b) FCPA Section 3.8(b3.20(b) Expiration Time Section 2.1(d)(iFDA Section 3.20(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bSection 3.9(a) Recitals Funded International Employee Plan Section 3.17(i) Good Clinical Practices Section 3.20(e) Good Laboratory Practices Section 3.20(f) ICL Recitals Indemnified Persons Section 7.8(aSection 6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) Israeli Employees Section 3.18(d) ITA Section 2.8(f) Inventions Section Section 1.1 Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(aSection 3.12(a) Material Employee Plans Section 3.17(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cSection 6.1(c)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Lumenis LTD), Agreement and Plan of Merger (Lumenis LTD)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning described in the respective sections corresponding section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Definition: Section: Acquired Person 1.14 Active Immunotherapeutic Approaches 4.2.1 Agreement Preamble Alternative Acquisition Celgene Preamble Celgene Acquired Competing Antibody 4.5.2 Celgene Exclusivity Term 4.5.1 Celgene Indemnitees 9.2 Celgene Proposed Terms 4.2.2 Celgene Share 6.8.4 Celgene Third Party Payments 5.3.4 Combination Product 1.52 Competing Antibody 4.5.1 [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Definition: Section: Competing Compound 4.1 Cure Period 10.2.1 Disclosing Party 7.1 Dispute 11.7.2 Electronic Delivery 11.11 Effective Date Preamble EMA 1.68 Excluded Claim 11.7.3(d) Existing Regulatory Materials 2.2.1 FDA 1.68 [***] [***] Force Majeure 11.3 GAAP 1.1 Grant 4.2.2 Grant Notice 4.2.2 HIPAA 1.5 IFRS 1.1 Indemnitee 9.3 Indemnitor 9.3 Indirect Taxes 5.6.2(b) Insolvency Event 10.4 Joint IP 6.6.4 Joint Know-How 6.6.4 Joint Patent 6.6.4 Licensed Program Assets 2.4 Licensed Program Confidential Information 7.11 Licensed Program Inventory 2.3.4 Licensed Program Know-How 1.46(a) Licensed Program Non-Specific IP 7.2 Licensed Program Patents 1.46(b) Licensed Program Specific IP 7.2 Licensed Program U.S. License Agreement Section 6.2(c)(iiRecitals Master Collaboration Agreement Recitals MHLW 1.68 Negotiation Period 4.2.2 [***] [***] Notice Period 4.2.2 Ongoing Clinical Trial 2.1.3(a) Antiboycott Rules Section 4.22(aOngoing Prothena Development Activities 2.1.3(c) Board Recommendation Section 2.2(bParty or Parties Preamble Patent Liaison 6.7 Payee Party 5.6.2(b) Cancelled Company Shares Section 3.7(a)(iiPaying Party 5.6.2(b) Certificate Per Licensed Product Annual Net Sales 5.3.1 Program Recitals [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Definition: Section: Prothena Preamble Prothena Acquired Competing Compound 4.4 Prothena Indemnitees 9.1 Prothena Licensor 8.3.3 Prothena Ongoing Program Activities 2.1.3(d) Prothena Reversion Antibodies 10.8.1 Publishing Party 7.8.1 Receiving Party 7.1 Regulatory Milestone Payment 5.4.1 Right of Merger Section 3.2 Certificates Section 3.8(cFirst Negotiation 4.2.2 Sales Milestone Payment 5.5.1 SEC 7.4.1(a) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dSecurities Regulators 7.6 Tax Benefit 5.6.2(c) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Term 10.1.1 Transition Plan Section 4.11(c)2.3.6
Appears in 2 contracts
Samples: Master Collaboration Agreement, Master Collaboration Agreement (Prothena Corp PLC)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning specified in the respective sections Section of this Agreement set forth opposite each of the capitalized terms belowsuch term: Term Section Reference Acceptable Confidentiality Agreement Adjusted Option Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i3.2(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 Certificates 2.2 Bank Merger Recitals Bank Merger Surviving Bank Section 3.8(c2.6 Burdensome Condition Section 6.3(c) Changes Cash Consideration Section 1.1 3.1(a)(1) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Code Recitals Company Preamble Company Common Stock 401(k) Plan Section 6.12(b)(1) Company Articles Section 2.5 Company Bank Sub Recitals Company Disclosure Letter Article IV Company License-In Agreements FA Section 4.16(g) Company License-Out Agreements Section 4.16(h5.2(i) Company Financial Advisor Statements Section 4.10 Company SEC Reports Section 4.7(a5.2(j)(1) Company Securities Indemnified Parties Section 4.2(a6.11(b) Company Shares Meeting Section 6.2(a) Term Section Company Restricted Stock Award Section 3.1(a)(1) Company Shareholder Matters Section 5.2(e) Company Stock Option Section 3.2(a) Company Voting Agreements Recitals Confidentiality Agreement Conversion Project Manager Section 10.4 Current Company D&O Insurance 6.13 Covered Employees Section 7.8(c6.12(b) Customs Laws Determination Date Section 4.22(a8.1(h) Debt Financing Dispute Disclosure Schedule Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 5.1 Effective Time Section 3.2 Enforceability Exceptions 2.2 Environmental Condition Section 4.4 6.15(a) Environmental Permits Survey Section 4.15(b6.15(a) Equity Award Exchange Ratio Section 3.2(a) Exchange Agent Section 3.3(a) Exchange Fund Section 3.8(b3.3(a) Expiration Time Exchange Ratio Section 2.1(d)(i3.1 FDICIA Reporting Requirements Section 5.2(j)(2) Financial Statements Incipio Incipio Merger Agreement Fee Section 4.7(b8.3(a) Fee Triggering Event Section 8.3(a) Final Parent Market Price Section 8.1(h) Final Index Price Section 8.1(h) Index Section 8.1(h) Index Ratio Section 8.1(h) Initial Index Price Section 8.1(h) Initial Parent Market Price Section 8.1(h) Intended Tax Treatment Recitals Recitals Indemnified Persons Interest Rate Instruments Section 7.8(a5.2(aa) Inventions Joint Proxy Statement Section 1.1 6.5(a) Loans Section 5.2(z)(1) Material Contract Contracts Section 4.18(a) Maximum Annual Premium Section 7.8(c5.2(v)(1) Merger Recitals Merger Sub Preamble New Certificates Section 3.3(a) Old Certificates Section 3.3(a) OREO Section 6.14(a) Outside Date Section 8.1(e) Parent Preamble Parent 401(k) Plan Section 6.12(b)(3) Parent Audited Financial Statements Section 5.3(i)(1) Parent Bank Sub Recitals Parent Closing Price Section 3.2(a) Parent Common Stock Issuance Section 5.3(e) Parent Determination Stock Price Section 8.1(g) Parent Meeting Section 6.2(b) Term Section Parent Merger Recitals Parent Merger Surviving Company Section 2.6 Parent SEC Filings Section 5.3(i)(1) Pension Plan Section 5.3(r), Section 5.2(t)(2) Per Common Share Consideration Section 3.7(a)(i3.1(a)(1) Minimum Condition Phase II Survey Section 2.1(a)(i6.15(b) Multiemployer Plan Real Property Section 4.11(c5.2(u)(2) Registration Statement Section 6.5(a) Required Third Party Consents Section 6.3(a) Requisite Regulatory Approvals Section 6.3(a) Scheduled Intellectual Property Section 5.2(p)(1) Subsequent Mergers Recitals Supplemental Disclosure Schedule Section 6.1(c) Survey Section 6.14(a) Surviving Corporation Recitals Tail Coverage Period Section 6.11(a)(2) Tail Policy Section 6.11(a)(1) Takeover Laws Section 5.2(h) Title Commitment Section 6.14(a) Title Company Section 6.14(a) Title Notice Section 6.14(b) Title Review Period Section 6.14(b) Trust or Agency Accounts Section 5.2(y)(1) Trust or Agency Agreements Section 5.2(y)(1) Trust or Agency Records Section 5.2(y)(6) Xxxxxx Section 7.3(c)
Appears in 2 contracts
Samples: Agreement and Plan of Merger, Agreement and Plan of Merger (Byline Bancorp, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.3(a) Acquisition Sub Preamble Adverse Recommendation Change Term Section 6.2(c)(i) Reference Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(n) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Change 1.1 Change of Recommendation Notice 7.5(b) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Common Stock Recitals Company Compensation Committee 4.17(n) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.11(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) 4.8 Company Shares Recitals Company Stockholder Meeting 7.4(a) Competing Acquisition Transaction 9.4(b)(i) Confidential Information 1.1 Confidentiality Agreement Section 10.4 Consent 4.5 Continuing Directors 2.3(a) Copyright Rights 1.1 Covered Securityholders 4.17(n) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aXXXXX 4.8(a) Effective Time Section 3.2 Employee Plan / Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(n) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iGrant Date 4.6(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons 7.10(a) Institutions 4.15(h) International Employee Plans 4.17(a) Term Section 7.8(aReference Inventions 1.1 Leased Real Property 4.13(b) Inventions Section 1.1 Leases 4.13(b) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.5(b) New Plans 7.11(c)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Otsuka Holdings Co., Ltd.), Agreement and Plan of Merger (Astex Pharmaceuticals, Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiBook-Entry Shares 2.8(c)(ii) Antiboycott Rules Section 4.22(aBurdensome Condition 6.2(a) Board Recommendation Section 2.2(bCanceled Shares 2.7(a)(ii) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Change of Recommendation Notice 5.3(b) Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.13(d) Company Preamble Company Common Stock Board Recitals Company Board Recommendation 3.5 Company Board Recommendation Change 5.3(a) Company Disclosure Letter Article IV Company License-In Agreements III Term Section 4.16(g) Company License-Out Agreements Section 4.16(h) Reference Company Financial Advisor Section 4.10 3.12 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Termination Fee 8.3(c) Confidentiality Agreement Section 10.4 Current Company 9.4 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.8(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(a) Domain Names 1.1 Effect 1.1 Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 3.4 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFDA Permits 3.22(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 2.7(f) Recitals Recitals Final Offering Periods 2.7(f) Foreign Antitrust Laws 3.7 Indemnified Persons Section 7.8(a6.8(a) Indemnified Proceeding 6.8(b) Intercompany Indebtedness 1.1 Inventions Section 1.1 Letter of Transmittal 2.8(c)(i) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) 3.21 Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Plans 6.9(c) Multiemployer Plan Section 4.11(cOld Plans 6.9(c) Option Consideration 2.7(d) Parent Preamble Parent Termination Fee 8.3(d) Paying Agent 2.8(a) Payor 2.8(e) Plans 3.13(a) Proxy Statement 6.1(a) Real Property Leases 3.20(b) RSU Consideration 2.7(e) Solvent 4.10 Stockholder Approval 3.6 Stockholders Meeting 6.1(c) Surviving Corporation 2.1 Termination Date 8.1(b)(i)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Biogen Inc.), Agreement and Plan of Merger (Reata Pharmaceuticals Inc)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(D) Additional Study Section 3.4 Additional Study Approval Section 3.4(c) Affiliate Master Agreement Agreement Preamble Allocable Overhead Exhibit D Allowable Expenses Exhibit D Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.9(a) Audit Rights Holder Section 9.9(e) Auditee Section 9.9(e) Bankruptcy Code Section 8.8 Barred Indication Section 8.6(b)(vii) Business Day Master Agreement CCB Program MTA Master Agreement Celgene Preamble Celgene Indemnified Parties Section 13.1(b) Celgene Independent Product Master Agreement Challenge Section 14.2(d) Challenging Party Section 14.2(d) Change of Control Master Agreement Clinically Develop Section 8.6(a) Co-Co Buy-In Section 3.5 DEFINITION SECTION Combination Product Section 1.39 Commercialization/Commercialize Master Agreement Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGs Exhibit D Cover/Covering/Covered Master Agreement CPI Section 1.29 Cure Period Section 14.2(b)(i) Damages Master Agreement Deemed Buy-In Section 3.4(c) Develop/Development Master Agreement Development Budget Section 3.2(a)(i) Development Cost Share Section 9.1(a) Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 [Distinct Product Master Agreement] [Distinct Product Catch-Up Payments Section 9.2(a)(iv)] Distribution Costs Exhibit D Earlier Patent Section 10.7 Electronic Delivery Section 15.16 Enabling Manufacturing Section 8.6(a) Execution Date Preamble FDA Master Agreement FDCA Master Agreement Finance Working Group Section 2.2(f) force majeure event Section 15.7 Functional Phenotypic Assay Similarity Criteria Master Agreement Global Safety Database Section 5.3 Gross Profit Exhibit D Incentive Compensation Section 6.5(b)(v) IND Master Agreement Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.10(b)(i) Indication Master Agreement Information Request Section 6.5(b)(vii) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement DEFINITION SECTION Licensed Branding Section 6.6(c) Licensing Party Section 8.5(c) Lump Sum Section 3.4(c) Manufacture/Manufacturing Master Agreement Manufacturing Costs Exhibit D Marketing Costs Exhibit D Master Agreement Introduction Material Breach Section 14.2(b)(i) Operating Profits or Losses Exhibit D Opt-In Right Master Agreement Other Operating Income/Expense Exhibit D Party or Parties Preamble Patent Officers Master Agreement Patent Prosecution Expenses Section 10.2(c) Patent Master Agreement Payee Party Section 9.10(b)(i) Paying Party Section 9.10(b)(i) Permitted Indication Section 8.6(b)(vii) Person Master Agreement Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit D Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Pivotal Clinical Trial Master Agreement Product Recall Expenses Exhibit D Product Trademarks Section 6.6(a) Profit & Loss Share Section 9.6(a) Program Assets Section 12.4(a) Program Compound Master Agreement Program Product Master Agreement Program Target Master Agreement Prosecuting Party Section 10.2(d)(ii) Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 14.2(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.1(b) Regulatory Expenses Exhibit D Report Exhibit D Requesting Party Section 11.3(b)(iii) ROW Development Costs Section 9.1(a) DEFINITION SECTION Royalty Term Section Reference Acceptable Confidentiality 9.3(b) Sales Costs Exhibit D Sales Milestone Condition Section 9.2(b) SEC Section 11.3(b)(i) Selected Target Master Agreement Selling Party Section 1.39 Separate Program Master Agreement Separate Program Product Section 8.6(b)(vii) Sublicense Revenues Exhibit D Subsequent Third Party Agreement Section 6.2(e)(iii9.7(b) Acquisition Proposal Term Section 6.2(e)(i14.1(a) Acquisition Sub Third Party Contractors Section 8.2(a)(ii) Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4 Third Party Products Liability Action Section 13.5(a) U.S. Commercialization Budget Section 6.2(c) U.S. Commercialization Costs Section 6.5(c) U.S. Commercialization Plan Section 6.2(a) Vividion Preamble Adverse Recommendation Change Vividion Indemnified Parties Section 6.2(c)(i13.1(a) Agreement Preamble Alternative Acquisition Agreement Vividion Opt-Out Notice Section 6.2(c)(ii2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Vividion Opt-Out Date Section 3.3 COBRA 2.3(b) Worldwide Development Costs Section 4.11(d9.1(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)II
Appears in 2 contracts
Samples: License Agreement (Vividion Therapeutics, Inc.), License Agreement (Vividion Therapeutics, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAction SECTION 6.11(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) INTRODUCTION Cancelled Company Shares Section 3.7(a)(iiSECTION 3.1(b) Certificate of Merger Section 3.2 Certificates Section 3.8(cSECTION 2.3 Chapter 78 SECTION 5.3(b) Changes Section 1.1 Charter Restrictions SECTION 4.3(d) Closing Section 3.3 SECTION 2.2 Closing Date Section 3.3 COBRA Section 4.11(dSECTION 2.2 Code RECITAL (g) Company Preamble INTRODUCTION Company Approvals SECTION 4.3(b) Company Benefit Plans SECTION 4.9(a) Company Change of Recommendation SECTION 6.4(d) Company Common Stock Recitals SECTION 3.1(a) Company Disclosure Letter Article Schedule ARTICLE IV Company License-In Agreements Section 4.16(gEmployees SECTION 4.14(a) Company License-Out Agreements Section 4.16(h) Fairness Opinion SECTION 4.18 Company Financial Advisor Section 4.10 SECTION 4.18 Company Intellectual Property SECTION 4.15(a) Company Leased Real Property SECTION 4.16(b) Company Material Adverse Effect SECTION 7.3(a) Company Material Contracts SECTION 4.19 Company Organizational Documents SECTION 4.1(c) Company Permits SECTION 4.7(b) Company Preferred Stock SECTION 3.1(a) Company Real Property Lease SECTION 4.16(b) Company Recommendation SECTION 4.3(d) Company Related Parties SECTION 8.3(c) Company SEC Reports Section 4.7(aDocuments SECTION 4.4(a) Company Securities Section Stockholder Approval SECTION 4.17 Company Stockholders’ Meeting SECTION 6.6(c) Company Warrants SECTION 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cSECTION 6.3(b) Customs Laws Section 4.22(aConverted Option 0 DGCL SECTION 2.1 DGCL 203 Restrictions SECTION 4.3(d) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) SECTION 3.3 Effective Time Section 3.2 SECTION 2.3 End Date SECTION 8.1(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bSECTION 4.3(a) Exchange Act SECTION 4.3(b) Exchange Agent SECTION 3.2(a) Exchange Fund Section 3.8(bSECTION 3.2(a) Expiration Time Section 2.1(d)(iExchange Ratio SECTION 3.1(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Form S-4 SECTION 4.12 Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(cParty SECTION 6.11(c) Merger Recitals RECITAL (a) Merger Consideration Section 3.7(a)(iSECTION 3.1(a) Minimum Condition Section 2.1(a)(iMerger Sub INTRODUCTION Other Proxy Materials SECTION 6.6(a) Multiemployer Plan Section 4.11(cParent INTRODUCTION Parent Approvals SECTION 5.3(b) Parent Benefit Plans SECTION 5.9(a) Parent Change of Recommendation SECTION 6.5(d) Parent Disclosure Schedule ARTICLE V Parent Employees SECTION 5.14(a) Parent Intellectual Property SECTION 5.15(a) Parent Leased Real Property SECTION 5.16(b) Parent Material Adverse Effect SECTION 7.2(a) Parent Material Contracts SECTION 5.17 Parent Organizational Documents SECTION 5.1(c) Parent Permits SECTION 5.7(b) Parent Preferred Stock SECTION 5.2(a) Parent Real Property Leases SECTION 5.16(b) Parent Recommendation SECTION 5.3(a) Parent Related Parties SECTION 8.3(d) Parent SEC Documents SECTION 5.4(a) Parent Warrants SECTION 5.2(a) Proxy Statement SECTION 4.12 Representatives SECTION 6.3(a) Sxxxxxxx-Xxxxx Act SECTION 4.5 SEC SECTION 4.4(a) Securities Act SECTION 4.3(b) Shares SECTION 3.2(A) Stock Issuance RECITAL (c) Surviving Corporation SECTION 2.1 Termination Date SECTION 6.1(a) Voting Agreement RECITAL (e) WARN Act SECTION 4.14(b)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.1(e) Acquisition Sub Preamble Adverse Recommendation Change Term Section 6.2(c)(i) Reference Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Arrangements 7.10 Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Catch-Up Opportunity 3.7(e) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section Change 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Commitment Letters 5.10(a) Company Preamble Company Common Stock Board Committee 2.2(a) Company Board Recommendation Recitals Company Board Recommendation Change 7.3(b) Company Compensation Committee 7.10(a) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(d) Company Shares Recitals Comparable Plans 7.9(b) Competing Acquisition Transaction 9.4(b)(i) Confidential Information 1.1 Insight Confidentiality Agreement Section Agreements 10.4 Current Company Consent 4.5 Copyright Rights 1.1 Covered Securityholders 7.10(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Expenses 9.4(a) Xxxxxxx Confidentiality Agreement 10.4 Employee Plans 4.17(a) Employment Compensation Arrangement 7.10(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 Equity Award 4.6(b) ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Expenses 9.4(a) Financing 5.10(a) Fraud and Bribery Laws 4.20(c) Term Section 2.1(d)(iReference Grant Date 4.6(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGuarantors Recitals Inbound IP Contract 4.15(b) Recitals Recitals Indemnified Persons Section 7.8(a) Insight Confidentiality Agreement 10.4 International Employee Plans 4.17(a) Intervening Event Notice 7.3(c)(ii) Inventions Section 1.1 IT Systems 4.15(j) Leased Real Property 4.13(b) Leases 4.13(b) Limited Guaranty Recitals Major Stockholders Recitals Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.4(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a)(ii)(E) Antiboycott Rules Section 4.22(aBylaws 3.1(b) Board Recommendation Section 2.2(bCapitalization Date 3.8(a) Cancelled Cash Replacement Company Shares Section 3.7(a)(iiOption Amounts 2.8(b)(ii) Cash Replacement Company RSU Amounts 2.8(a)(ii) Cash Replacement Company SAR Amounts 2.8(c)(ii) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c)(i) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Clean Team Agreement 6.7 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.17(a) Company Preamble Company Common Stock 401(k) Plan 6.10(c) Company Board Recitals Company Board Recommendation 3.4(a) 14 Term Section Reference Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gFinancial Statements 3.11(a) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(e)(ii) Company Financial Advisor Section 4.10 Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.10 Company Stockholder Meeting 6.4(a) Company Securities Section 4.2(aTermination Fee 8.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 9.4 Continuation Period 6.10(a) Copyrights 1.1(uu) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.9(c) Debt Financing Dispute Section 10.9(a6.5(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(s) Effective Time Section 3.2 2.2 Electronic Delivery 9.13 Employee Plan 3.16(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.3 Excluded Benefits 6.10(a) Exchange Fund Section 3.8(bExport Approvals 3.14(c) Expiration Time Section 2.1(d)(iGeneral Catalyst 1.1(d) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGovernmental Approval 3.7 In-the-Money Warrant 2.8(f)(ii) Recitals Recitals Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Intervening Event 5.3(d)(i) Intervening Event Notice Period 5.3(d)(i)(A) Latest Company Balance Sheet 3.26 Lease 3.22(b) Leased Real Property 3.22(b) Material Contract Section 4.18(aContracts 3.15(a) Maximum Annual Premium Section 7.8(c6.9(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Sub Preamble Merger Transactions Recitals Multiemployer Plan 3.16(c) New Plans 6.10(b) Non-Recourse Party 8.3(g) Old Plans 6.10(b) Other Required Company Filing 6.3(b) Term Section 4.11(c)Reference Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Liability Limitation 8.3(e)(i) Parent Related Parties 8.3(e)(i) Party Preamble Patents 1.1(uu) Payment Agent 2.9(a) Payment Fund 2.9(b) Payoff Amount 1.1(ddd) Per Share Price 2.7(a)(ii) Permits 3.21 Personal Information Laws and Policies 3.24(a) Privacy Policies 3.24(a) Processed 3.24(a) Processing 3.24(a) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.5(f) Representatives 5.3(a)(i) Requisite Stockholder Approval 3.5 Securities 3.8(d) Sublease 3.22(c) Superior Proposal Notice Period 5.3(d)(ii)(C) Surviving Corporation 2.1 Termination Date 8.1(c) Terminated Warrant 2.8(f)(i) Title IV Plan 3.16(c) Top Vendors 3.28 Trademarks 1.1(uu) Uncertificated Shares 2.9(c)(i) Unexercised Warrant 2.8(f)(iii) Unvested Company Options 2.8(b)(ii) Unvested Company RSUs 2.8(a)(ii) Unvested Company SARs 2.8(c)(ii) Vested Option Consideration 2.8(b)(i) Vested RSU Consideration 2.8(a)(i) Vested SAR Consideration 2.8(c)(i) Voting Agreements Recitals
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference 102 Amounts Section 2.8(d)(i) Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.2(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Approval Section 4.22(a3.5 Assignee Section 10.3 Capitalization Date Section 3.6(a) Board Recommendation Cash Bonus Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii2.7(c)(i) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.8(f) Collective Bargaining Agreement Section 3.18(b) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Shares Section 2.8(b) Company 102 Options Section 2.8(d)(i) Company Board Recommendation Section 5.3(a) Company Disclosure Letter Article IV III Company License-In Agreements Products Section 4.16(g3.15(b) Company License-Out Agreements Registered Intellectual Property Section 4.16(h3.15(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.6(b) Company Shares Recitals Section 2.7(a)(i) Company Shareholders Meeting Section 7.3(a) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 7.8 Contractors Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.18(g) Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits 3.17(a) Term Section 4.15(bReference ERISA Affiliate Section 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time FCPA Section 2.1(d)(i3.22(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.9(a) Recitals Recitals Indemnified Persons Funded Employee Plan Section 7.8(a3.17(i) ICL Preamble IPL Section 3.15(g) Information Agent Section 2.8(a) Inventions Section 1.1 Israeli Employees Section 3.18(i) Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.12(a) Merger Recitals Preamble Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Notice Section 2.1(a)(i2.3 Merger Proposal Section 7.4(a) Multiemployer Plan Merger Sub Preamble OECD Convention Section 4.11(c3.22(a) Option Consideration Section 2.7(c) Outside Date Section 9.1(c) Panoptes Section 3.7(g) Parent Preamble Paying Agent Section 2.8(a) Paying Agent Agreement Section 2.8(a) Payor Section 2.8(f) Permits Section 3.19 Principal Company Shareholders Preamble Prohibited Payment Section 3.22(a) Proxy Statement Section 7.3(a) R&D Sponsor Section 3.15(i) Related Party Section 3.26 Representatives Section 1.1 Requisite Shareholder Approval Section 3.3(b) Section 000 Xxxx Xxxxxxx 3.16(ee) Section 14 Arrangement Section 3.18(a) Subsidiary Securities Section 3.7(d) Surviving Company Section 2.1 Tax Returns Section 3.16(a) Termination Fee Section 9.3(b) Trademarks Section 1.1 Uncertificated Shares Section 2.8(c) Term Section Reference Underwater Option Section 2.7(c)(i) Valid Certificate Section 2.8(f) Voting Agreement Preamble WARN Section 3.18(c) Works of Authorship Section 1.1 Withholding Drop Date Section 2.8(f) Withholding Tax Ruling Section 7.9(a)(i)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Elbit Vision Systems LTD)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 102 Amounts Section 2.8(d)(i) Alternative Acquisition Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iSection 5.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiApproval Section 3.5 Assignee Section 10.3 Capitalization Date Section 3.6(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCERCLA Section 3.21(c) Certificate of Merger Section 3.2 Section 2.3 Certificates Section 3.8(cSection 2.8(c) Change Section 1.1 Changes Section Section 1.1 Charter Documents Section 3.1 Closing Section 3.3 Section 2.2 Closing Date Section 3.3 COBRA Section 4.11(dSection 2.2 Code Section 2.8(f) Collective Bargaining Agreement Section 3.18(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Options Section 2.8(d)(i) Company 000 XXXx Section 2.8(d)(i) Company 102 Securities Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Section 5.3(a) Company Board Recommendation Change Section 5.3(b) Company Disclosure Letter Article IV Preamble Company License-In Agreements Section 4.16(gPlans Section 6.2(c) Company License-Out Agreements Section 4.16(hProducts Section 3.15(b) Company Financial Advisor Reports Section 3.8 Term Section 4.10 Company SEC Reports Section 4.7(a) Reference Company Securities Section 4.2(aSection 3.6(b) Company Shares Recitals Section 2.7(a)(i) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Confidentiality Agreement Section 10.4 Current Company Section 7.8 Certificates Section 2.8(c) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aSection 6.1(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bSection 2.2 Employee Plans Section 3.17(a) ERISA Affiliate Section 3.17(a) Exchange Fund Section 3.8(bSection 2.8(b) Expiration Time Section 2.1(d)(iFCPA Section 3.20(b) FDA Section 3.20(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bSection 3.9(a) Recitals Funded International Employee Plan Section 3.17(i) Good Clinical Practices Section 3.20(f) Good Laboratory Practices Section 3.20(f) IAA Section 7.2(a) ICL Recitals Indemnified Persons Section 7.8(aSection 6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) IPL Section 3.15(h) Israeli Employees Section 3.18(d) ITA Section 2.8(f) Inventions Section Section 1.1 Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(aSection 3.12(a) Material Employee Plans Section 3.17(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cSection 6.1(b)
Appears in 1 contract
Additional Definitions. The For purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto specified in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Adjournment Proposal Section 6.2(e)(i5.2(e) Acquisition Sub Preamble Adverse Recommendation Change Advance Section 6.2(c)(i) 5.15 Agreement Preamble Alternative Acquisition Agreement Antitrust Laws Section 6.2(c)(ii5.5(a) Antiboycott Rules Antitrust Matters Section 4.22(a5.5(b) Board Recommendation Assets Section 2.2(b3.18 Book-Entry Shares Section 2.9(d) Cancelled Company Shares RSU Section 3.7(a)(ii2.11(d) Cancelled Stock Option Section 2.11(b) Certificate Section 2.9(d) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(c) Company Disclosure Letter Schedule Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.19(c) Company License-Out Agreements Products Section 4.16(h3.19(a) Company Financial Advisor Term Section 4.10 Reference Company SEC Reports Section 4.7(a) 3.6 Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholders Meeting Section 5.2(e) Company Stockholder Meeting Proposals Section 5.2(a) Company Subsidiary Securities Section 3.2(c) Confidentiality Agreement Section 10.4 5.4(d) Consent Section 3.5(b) Consideration Fund Section 2.10(a) Current Company D&O Insurance Option Section 7.8(c2.11(b) Customs Laws Current Policy Coverage Section 4.22(a5.9(b) Debt Financing Dispute Current Restricted Share Section 10.9(a2.11(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 2.12 Effective Time Section 3.2 Enforceability Exceptions 2.2 Employee Plans Section 4.4 Environmental Permits 3.15(a) Equity Commitment Section 4.15(b4.6 Equity Funding Section 4.6 Equity Investor Recitals ERISA Affiliate Section 3.15(a) Exchange Fund ESPP Section 3.8(b3.4(c) Expiration Time Expense Cap Section 2.1(d)(i7.3(c) Financial Statements Incipio Incipio Merger Agreement Identified Company Representations Section 4.7(b6.2(a)(i) Recitals Recitals Indemnified Persons Section 7.8(a5.9(a) Inventions International Employee Plans Section 1.1 3.15(a) Intervening Event Section 5.3(e) Leased Real Property Section 3.17(b) Leases Section 3.17(b) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.10(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.9(a) Minimum Condition Merger Proposal Section 2.1(a)(i5.2(e) Multiemployer Plan Merger-Related Proposals Section 4.11(c)5.2(e) Merger Sub Preamble Open source Section 3.19(j) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.17(a) Parent Preamble Parent Disclosure Schedule Article IV Parent Plans Section 5.7(b) Permits Section 3.11(a) Paying Agent Section 2.10(a) Prior Agreement Recitals Proxy Statement Section 5.2(a) Qualifying Amendment Section 5.2(c) Regulation M-A Filing Section 5.2(d) Requisite Stockholder Approval Section 3.22 Term Section Reference Xxxxxxxx-Xxxxx Act Section 3.6 Surviving Corporation Recitals Transferred Employees Section 5.7(a) ARTICLE II
Appears in 1 contract
Samples: Agreement and Plan of Merger (Conexant Systems Inc)
Additional Definitions. The definition of each of the following capitalized terms shall have the respective meanings ascribed thereto is set forth in the respective sections Section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Section Reference Acceptable Confidentiality 13D Group Section 10.08(a)(ii) 1974 Convention Section 13.01 Agreement Preamble API Supply Section 6.03 Archemix Patent Rights Section 3.01(g) Auditor Section 7.07 Breaching Party Section 11.02(a) Clinical Supply Agreement Section 6.2(e)(iii6.03 Co-Chairs Section 2.05 Co-Formulated Product Option Term Section 3.04(a) Acquisition Proposal Code Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition 3.10 Commercial Supply Agreement Section 6.2(c)(ii6.03 Confidential Information Section 9.01 Controlling Party Section 4.09(f) Antiboycott Rules Effective Date Preamble Genentech Section 4.22(a3.11 Indemnification Claim Notice Section 10.10(c)(i) Board Recommendation Indemnified Party Section 2.2(b10.10(c)(i) Cancelled Company Shares Indemnifying Party Section 3.7(a)(ii10.10(c)(i) Certificate of Merger Initial Development Plan Section 3.2 Certificates 4.02 Initial Marketing Plan Section 3.8(c5.04 Invalidity Claim Section 8.03(g) Changes Issued Valid Claim Section 1.1 Closing 1.90 JCD/RS Section 3.3 Closing Date 2.02(a) JCS Section 3.3 COBRA 2.04(a) JMS Section 4.11(d2.03 JOC Section 2.01(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Joint Collaboration IP Section 4.16(g8.01(b)(iv) Company License-Out Agreements Joint Patent Rights Section 4.16(h8.02(c) Company Financial Advisor Legal Dispute Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality 12.01 Lucentis License Agreement Section 10.4 Current Company D&O Insurance 3.11 Marketing Plan Section 7.8(c5.04 Nektar Patent Rights Section 3.01(h) Customs Laws Non-Breaching Party Section 4.22(a11.02(a) Debt Financing Dispute Non-Casting Vote Matter Section 10.9(a2.08(d) DGCL Recitals Dissenting Company Shares Novartis Preamble Novartis Alternative Anti-PDGF Product Section 3.7(c)(i3.07(a) EAR Novartis Casting Vote Matters Section 4.22(a2.08(c)(ii) Effective Time Novartis Collaboration IP Section 3.2 Enforceability Exceptions 8.01(b)(iii) Novartis Indemnified Parties Section 4.4 Environmental Permits 10.10(a) Novartis Patent Rights Section 4.15(b8.02(a) Exchange Fund Ophthotech Preamble Ophthotech Anti-VEGF Co-Formulated Product Section 3.8(b3.04(f)(iii) Expiration Time Ophthotech Alternative Anti-PDGF Product Section 2.1(d)(i3.06(a) Financial Statements Incipio Incipio Merger Ophthotech Casting Vote Matters Section 2.08(c)(i) Ophthotech Collaboration IP Section 8.01(b)(iii) Ophthotech Indemnified Parties Section 10.10(b) Ophthotech Patent Rights Section 8.02(b) Ophthotech Product Patent Rights Section 1.61 [**] Section [**] OSI IP Section 3.01(i) PEG Section 3.01(h)(i) Pending Valid Claim Section 1.90 Product Positioning and Branding Strategy Section 2.01(c)(ii) Promotional Materials Section 5.05 Requesting Party Section 4.09(f) Restricted Period Section 10.08(b) Severed Clause Section 13.03 Supply Agreement Section 4.7(b6.03 Term Section 11.01 Third Party License Section 7.04(d) Recitals Recitals Indemnified Persons wet AMD Introduction Working Group Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)2.06
Appears in 1 contract
Samples: Licensing and Commercialization Agreement (Ophthotech Corp.)
Additional Definitions. The following Other capitalized terms defined elsewhere in this Agreement and not defined in this Article 1 shall have the respective meanings ascribed thereto assigned to such terms in this Agreement in the respective sections of this Agreement set forth opposite each of the capitalized terms below: . Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDate Preamble Assumed Awards 5.12(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Bear Sxxxxxx 4.16 Certificate of Merger Section 3.2 Amendment Recitals Certificates Section 3.8(c2.7(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dClaim 5.7(a) Code Recitals Company Preamble Company Common Stock Recitals 401(k) Plans 5.12(e) Company Balance Sheet 3.4(b) Term Section Company Benefit Arrangements 3.10 (d) Company Charter Documents 3.1(b) Company Disclosure Letter Article IV 3 Company License-In Agreements Section 4.16(gFinancial Statements 3.4(b) Company License-Out Agreements Section 4.16(hIP Rights 3.9(a) Company Financial Advisor Section 4.10 Material Contract 3.12(a) Company-Owned IP Rights 3.9(a) Company SEC Reports Section 4.7(aDocuments 3.4(a) Company Securities Section 4.2(aSource Code 3.9(g) Company Shares Stockholder Approval 3.3(c) Company Stockholders’ Meeting 3.4(e) Company Voting Agreements Recitals Company Voting Debt 3.2(d) Company Warrants 2.5(b) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c5.2(c)(1) Customs Laws Section 4.22(aContinuing Employees 5.12(d) Debt Financing Dispute Section 10.9(a) DGCL Delaware Law Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.9 Exchange Agent 2.7(a) Exchange Fund Section 3.8(b2.7(b) Expiration Time Section 2.1(d)(iExchange Multiple 2.4(g) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExchange Quotient 2.4(g) Recitals Recitals Exchange Ratio 2.4(a) Expenses 5.7(a) Jxxxxx Xxxxxxxxxx 3.16 Indemnified Persons Section 7.8(aParties 5.7(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Post-Closing Directors 5.13(a) Maximum Annual Premium Section 7.8(c) L-1 2.2 Merger Recitals Merger Consideration 2.4(a) Merger Sub Preamble Outside Date 7.1(b)(1) Parent Preamble Parent Balance Sheet 4.4(b) Parent Benefit Arrangements 4.10(d) Parent Benefit Plans 5.12 (d) Parent Charter Amendment Recitals Parent Charter Documents 4.1(b) Parent Disclosure Letter 4 Parent Financial Statements 4.4(b) Parent IP Rights 4.9(a) Parent Material Contract 4.12(a) Parent-Owned IP Rights 4.9(a) Parent SEC Documents 4.4(a) Parent Source Code 4.9(g) Term Section 3.7(a)(iParent Stock Issuance Recitals Parent Stockholder Approval 4.3(c) Minimum Condition Section 2.1(a)(iParent Stockholders’ Meeting 3.4(e) Multiemployer Plan Section 4.11(cParent Voting Agreements Recitals Parent Voting Debt 4.2(d) Parent Warrants 4.2(b) Restraints 6.1(c) Returns 3.8 Rule 145 Affiliates 5.14 Stock Consideration 2.4(a) Surviving Corporation 2.1 USBX 4.16 Use 3.9(a) and 4.9(a)
Appears in 1 contract
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning specified in the respective sections Section of this the Agreement set forth opposite each of the capitalized terms belowsuch term: Term TERM SECTION 338(h)(10) Allocation Section Reference Acceptable Confidentiality Agreement 7.5(b) Acquiror Preamble Acquiror Capitalization Date Section 6.2(e)(iii4.5(a) Acquisition Proposal Acquiror Evaluation Date Section 6.2(e)(i4.7(d) Acquisition Sub Preamble Adverse Recommendation Change Acquiror Financial Statements Section 6.2(c)(i4.7(b) Acquiror Loans Section 4.10 Acquiror Preferred Stock Section 4.5(a) Agreement Preamble Alternative Acquisition Agreement Allocation Methodology Section 6.2(c)(ii7.5(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 Certificates 1.2(b) Book Entry Section 3.8(c2.5(c) Changes Borrowing Affiliate Section 1.1 5.2(b)(vi) Burdensome Condition Section 7.1 CARES Act Section 3.10(c) CIC Payment Section 7.6(d) Closing Section 3.3 1.2(a) Closing Date Section 3.3 COBRA Section 4.11(d1.2(a) Company Preamble Company Common Stock Recitals Adverse Recommendation Section 5.4 Company Disclosure Letter Article IV Company License-In Agreements Capitalization Date Section 4.16(g3.5(a) Company License-Out Agreements Employees Section 4.16(h5.2(b)(viii) Company Estimated Closing Balance Sheet Section 5.9(a) Company Financial Advisor Statements Section 4.10 Company SEC Reports Section 4.7(a3.7(a) Company Investment Securities Section 4.2(a3.25(a) Company Shares Recitals Confidentiality Agreement Loans Section 10.4 Current 310(a) Company D&O Insurance Material Contract Section 7.8(c3.16 Company Officer/Director Bonuses Section 2.1(e)(i)(D) Customs Laws Company Permitted Exceptions Section 4.22(a3.9(b) Debt Financing Dispute Company Stockholders’ Meeting Section 10.9(a5.4 Company Tangible Common Equity Section 2.1(e) DGCL Recitals Dissenting Company Conversion Fund Section 2.5(b) Covered Employees Section 7.6(a) Dissenters’ Shares Section 3.7(c)(i) EAR Section 4.22(a) 2.6 Effective Time Section 3.2 Enforceability Exceptions 1.2(b) Environmental Condition Section 4.4 7.7(a) Environmental Permits Property Section 4.15(b7.7(a) Exchange Fund Agent Section 3.8(b2.5(a) Expiration Time Final 338(h)(10) Election Section 2.1(d)(i7.5(b) Financial Statements Incipio Incipio Merger Agreement Final Closing Balance Sheet Section 4.7(b5.9(b) Recitals Recitals Forfeited Retention Payment Section 2.1(f) Indemnified Persons Party Section 7.8(a6.5(a) Inventions TERM SECTION Letter of Transmittal Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c2.5(c) Merger Recitals Merger Sub Preamble Net Remediation Costs Section 7.7(c) New Plans Section 7.6(b) Objections Statement Section 7.5(b) Old Plans Section 7.6(c) Owned Environmental Property Section 7.7(c) Per Share Cash Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Per Share Merger Consideration Section 4.11(c)2.1(a)(ii) Per Share Stock Consideration Section 2.1(a)(ii) Phase I Report Section 7.7(a) Phase II Survey Section 7.7(b) Phase II Survey Report Section 7.7(b) Previously Disclosed Section 12.3(b) Q Sub Section 3.11(q) Retention Agreement Section 2.1(f) Retention Payment Recipient Section 2.1(f) S Corp Section 3.11(a) Section 409A Section 3.12(n) Special Dividend Section 2.1(c) Special Dividend Amount Section 2.1(c) Surviving Entity Recitals Termination Date Section 10.1(e) Termination Fee Section 10.3(b) Total Cash Consideration Section 2.1(a)(i) Total Payments Section 7.6(e) Unpaid Aggregate Company Appreciation Bonus Section 2.1(f) 84
Appears in 1 contract
Samples: Agreement and Plan of Merger (First Busey Corp /Nv/)
Additional Definitions. The following Other capitalized terms defined elsewhere in this Agreement and not defined in this Article I shall have the respective meanings ascribed thereto assigned to such terms in this Agreement in the respective sections of this Agreement set forth opposite each of the capitalized terms below: . Term Section Reference Acceptable Confidentiality Agreement Acceptance Time Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.1(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.2(e)(iii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Book-Entry Shares Section 3.7(a)(ii3.6(b)(i) Certificate of Merger Bribery Act Section 3.2 Certificates 4.10(d) Chosen Courts Section 3.8(c) Changes Section 1.1 9.12 Closing Section 3.3 3.4 Closing Date Section 3.3 COBRA 3.4 Company Preamble Company 401(k) Plan Section 4.11(d6.9(c) Company Preamble Adverse Recommendation Change Section 6.2(d) Company Benefit Plans Section 4.11(a) Company Board Recitals Company Board Recommendation Recitals Company Capitalization Date Section 4.2(a) Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Leases Section 4.16(g4.17 Company Permits Section 4.10(b) Company License-Out Agreements SEC Documents Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.6(a) Company Shares Recitals Company Stockholders Recitals Confidentiality Agreement Section 10.4 Current Company 2.3(c) Continuing Employees Section 6.9(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.7(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.9 Divestitures Section 6.5(d) EAR Enforceability Limitations Section 4.22(a4.3(b) Effective Time Excluded Shares Section 3.2 Enforceability Exceptions 3.6(a) Expiration Date Section 4.4 Environmental 2.1(d) ESPP Section 6.9(d) FCPA Section 4.10(d) FDA Section 4.19(a) FDA Permits Section 4.15(b4.19(c) Exchange Fund FDCA Section 3.8(b4.19(a) Final Exercise Date Section 6.9(d) Inclusive Companies Section 4.15 Indemnified Parties Section 6.7(a) Initial Expiration Time Date Section 2.1(d)(i2.1(d) Financial Statements Incipio Incipio Merger Agreement Investments Section 4.7(b4.2(f) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Medical Device Section 7.8(c4.19(a) Merger Recitals Merger Consideration Section 3.7(a)(i3.6(a) Minimum Condition Merger Effective Time Section 2.1(a)(i3.3 Merger Fund Section 3.8(a)(i) Multiemployer Merger Sub Preamble Money Laundering Laws Section 4.10(g) Offer Recitals Offer Commencement Date Section 2.1(a) Offer Conditions Section 2.1(b) Offer Documents Section 2.2(a) Offer Price Recitals Other Anticorruption Laws Section 4.10(d) Outside Date Section 8.1(b)(i) Parent Preamble Parent 401(k) Plan Section 4.11(c)6.9(c) Parent Governing Documents Section 5.1 Paying Agent Section 3.8(a)(i) Registered IP Section 4.16(a) Regulatory Laws Section 4.19(a) Schedule 14D-9 Section 2.3(b) Social Security Act Section 4.19(g) Surviving Corporation Section 3.1 Termination Fee Section 8.3(a) Transactions Recitals
Appears in 1 contract
Samples: Agreement and Plan of Merger (Zimmer Biomet Holdings, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Annex-15 Term Section Reference Acceptable Agreement Preamble Anti-Corruption Laws Section 3.19(b) Articles of Merger Section 1.1 Xxxxx Option Section 4.5(a)(iv) Book-Entry Shares Section 2.3(c) Canaccord Section 4.2(b) Certificates Section 2.3(c) Closing Date Section 2.1 Code Recitals Common Stock Consideration Section 1.4(b)(i) Confidentiality Agreement Section 6.2(e)(iii7.5(h) Acquisition Proposal Continuing Employee Section 6.2(e)(i7.7(a) Acquisition Sub Preamble Adverse Recommendation Change Continuing Employees Section 6.2(c)(i7.7(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Policy Section 7.8(c) Customs Laws DGCL Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) 3.23 EAR Section 4.22(a3.19(c)(i) ECCNs Section 3.19(c)(ii) Effective Time Section 3.2 Enforceability Exceptions 1.1 Employment Agreements Recitals Exchange Agent Section 4.4 Environmental Permits Section 4.15(b2.3(a) Exchange Fund Section 3.8(b2.3(b)(i) Expiration Time Exchange Ratio Section 2.1(d)(i1.4(b)(i) Financial Statements Incipio Incipio Merger Agreement Export Controls Section 4.7(b3.19(c)(i) Recitals Recitals FCPA Section 3.19(b) Import Restrictions Section 3.19(c)(i) Indemnified Persons Parties Section 7.8(a) Inventions ITAR Section 1.1 Material Contract 3.19(c)(i) Joint Proxy Statement/Prospectus Section 4.18(a7.3(a) Malicious Code Section 3.13(m) Maximum Annual Premium Section 7.8(c) MBCA Recitals Merger Recitals Merger Consideration Shareholder Meetings Section 3.7(a)(i7.4(a) Minimum Condition Merger Sub Preamble OFAC Section 2.1(a)(i3.19(c)(i) Multiemployer Plan Qumu Preamble Qumu Board Section 4.11(c)3.2(b) Qumu Board Recommendation Section 7.4(e) Qumu Board Recommendation Change Section 7.4(f) Qumu Capitalization Representations Section 2.2(b)(ii)(B) Qumu Designee Section 8.1(a) Qumu Disclosure Letter Article III Qumu Fundamental Representations Section 2.2(b)(ii)(A) Annex-16
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Synacor, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnnual Report Article III Anti-Bribery Laws 3.20(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 3.14 Cancelled Company Shares 2.7(a)(ii) Cancelled RSUs 2.7(e) Term Section 3.7(a)(iiReference Cancelled RSU Consideration 2.7(e) Capitalization Date 3.6(a) Centre 9.10(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 CFIUS 6.2(a) Citi Loan Agreement 6.18(b) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Commitment Letters 4.10(a) Company Preamble Company Board Recommendation Recitals Company Board Recommendation Change 6.5(a) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gPlans 6.11(b) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(b)(v) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Competing Acquisition Transaction 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.5 Contributor 3.15(b) D&O Insurance Section 7.8(c6.10(b) Customs Laws Section 4.22(aDebt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dispute 9.10(a) Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.2 Employee Plans 3.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) ERISA Affiliate 3.17(a) Exchange Fund 2.8(b) Exclusively Licensed IP 3.15(g) Exon-Xxxxxx 3.5 Extended Termination Date 8.1(b)(i) Financing 4.10(a) Financing Agreements 6.15(c) FSE List 3.20(d) Guarantor Recitals Term Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Reference Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Termination Date 8.1(b)(i) Maximum Annual Premium Section 7.8(cInternational Employee Plans 3.17(a) Merger Recitals Merger Consideration Section 3.7(a)(iInvestor Preamble Investor Parent Option 2.7(d) Minimum Condition Section 2.1(a)(iInvestor Parent RSU 2.7(e) Multiemployer Plan Section 4.11(cInvestor Related Parties 8.3(c)(iii) Joint Notice 3.5 Leased Real Property 3.13(b) Leases 3.13(b) Lenders 4.10(a)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Omnivision Technologies Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiCapitalization Date 3.7(a) Antiboycott Rules Section 4.22(aCertificates 2.8(c) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Change 1.1 Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aShareholders Meeting 7.3(d) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 7.7 Consent 3.6 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(aDissenting Shareholder 2.7(c) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c) Effective Time 2.3 Equity Commitment Letter Section 3.2 Enforceability Exceptions 4.10(a) Equity Financing Section 4.4 Environmental Permits Section 4.15(b4.10(a) Exchange Fund 2.8(b) Guarantee Recitals HKIAC Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals 10.9 Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a6.1(a) Maximum Annual Premium Section 7.8(c6.1(c) Merger Recitals Merger Sub Preamble Option Consideration 2.7(d) Outside Date 9.1(b) Parent Preamble Term Section 3.7(a)(iReference Paying Agent Section 2.8(a) Minimum Condition Section 2.1(a)(iPer ADS Merger Consideration 2.7(a)(ii) Multiemployer Per Share Merger Consideration 2.7(a)(ii) Permits 3.14 Plan Section 4.11(c)of Merger Recitals Preliminary Proxy Statement 7.3(a) Proxy Statement 7.3(a) Recommendation Change Notice 5.3(b) Registrar of Companies 2.3 Requisite Shareholder Approval 3.4 Schedule 13E-3 3.6 Special Committee Recitals Subsidiary Securities 3.8(c) Surviving Corporation 2.1 Tax Returns 3.13(a) Uncertificated Shares 2.8(c) Voting Agreement Recitals
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 102 Amounts Section 2.8(d)(i) Alternative Transaction Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.3(a) Agreement Preamble Alternative Acquisition Agreement Approval Section 6.2(c)(ii3.4 Capitalization Date Section 3.5(a) Antiboycott Rules Cash Award Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii2.7(c)(ii) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.2 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Closing Option Consideration Section 4.11(d2.7(c)(i) Closing RSUs Consideration Section 2.7(c)(i) Closing Warrant Consideration Section 2.7(c)(i) Code Section 2.13(a) - 9 - Term Section Reference Collective Bargaining Agreement Section 3.16(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock 102 Options Section 2.8(d)(i) Company 000 XXXx Section 2.8(d)(i) Company 102 Securities Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(a) Company Cure Period Section 9.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Nominee Section 4.16(g7.3(a) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.5(b) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current 2.7(a)(i) Company Subsidiaries Section 3.6(a) Continuing Employees Section 6.2(a) control Section 1.1 controlled by Section 1.1 under common control with Section 1.1 D&O Insurance Section 7.8(c6.1(c) Customs Laws Divestiture Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a7.2(d)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.3 Exchange Fund Section 3.8(b2.8(b) Expiration Time Excluded Employee Plan Section 2.1(d)(i6.2(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.7(c) Recitals ICL Recitals Indemnified Persons Section 7.8(a6.1(a) Inventions Information Agent Section 1.1 2.8(a) Interim Option Tax Ruling Section 7.7(a) Investments Law Section 3.14(p) ITA Section 2.13(a) Lease Section 3.11(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.10(a) Material Contracts Section 3.10(a) Maximum Annual Premium Section 7.8(c6.1(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Notification Section 2.1(a)(i7.2(a) Multiemployer Merger Proposal Section 7.4(a) Merger Sub Preamble Options Tax Ruling Section 7.7(a) Outside Date Section 9.1(c) Parent Preamble Parent Cure Period Section 9.1(g) Parent Retention Plan Section 4.11(c6.4 Payor Section 2.13(a) Permits Section 3.17(a) Proxy Statement Section 7.3(a) - 10 - Term Section Reference R&D Sponsor Section 3.13(g) Recommendation Change Notice Section 5.3(b) Restricted Actions Section 7.3(b) Rothschild Section 3.22 Subsequent Option Consideration Section 2.7(c)(ii) Subsequent RSU Consideration Section 2.7(c)(ii) Surviving Company Section 2.1 Tax Returns Section 3.14(a) Termination Fee Section 9.3(b) Transaction Expenses Amount Section 3.26 Uncertificated Shares Section 2.8(c) VAT Section 3.14(q) Vesting Date Section 2.7(c)(ii) willful breach Section 9.2 Withholding Drop Date Section 2.13(b) Withholding Tax Ruling Section 7.7(b)
Appears in 1 contract
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Acquiror Definition of ‘Change of Control’ in ARTICLE I Act Section Reference Acceptable 5.6.1 Agreement Preamble Auditor Section 4.7.2 Bankruptcy Code Section 3.3.1 BPCIA Section 5.6.2 Change of Control ARTICLE I Claims Section 8.1 Competing Infringing Activities Section 5.5 [*] Section [*] Confidential Information Section 6.1 Development and Regulatory Milestone Payment Section 4.2 Development and Regulatory Milestone Payments Section 4.2 Disclosing Party Section 6.1 [*] Section [*] Effective Date Preamble Existing Confidentiality Agreement Section 6.2(e)(iii6.1(e) Acquisition Proposal Future IP Section 6.2(e)(i5.1.2 Indemnified Party Section 8.3.1 Indemnifying Party Section 8.3.1 Inventory Section 7.2(m) Acquisition Sub Losses Section 8.1 Novartis Preamble Adverse Recommendation Change Novartis Indemnitees Section 6.2(c)(i8.2 Novartis Patents Section 5.1.2 Novartis Product Section 9.4.4(b) Parties Preamble Party Preamble Payment Breach Section 9.2 Phase I/II Definition of ‘Phase II Clinical Trial’ in ARTICLE I Phase II Definition of ‘Phase II Clinical Trial’ in ARTICLE I [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Phase III Definition of ‘Phase III Clinical Trial’ in ARTICLE I pivotal Definition of ‘Phase III Clinical Trial’ in ARTICLE I Process Section 2.5.2 Product Marks Section 5.8 [*] Section [*] Receiving party Section 6.1 [*] Section [*] Rights Definition of ‘Control’ in ARTICLE I Royalty Term Section 4.3.2(a) Sales & Royalty Report Section 4.4.2 Selling Party Definition of ‘Net Sales’ in ARTICLE I Servier Definition of ‘Servier Loan’ in ARTICLE I Servier Liens Section 4.1.1(a) Servier Loan Agreement Preamble Alternative Acquisition Agreement Definition of ‘Servier Loan’ in ARTICLE I Servier Loan Repayment Section 6.2(c)(ii4.1.1(a) Antiboycott Rules Servier Payoff Estimated Amount Section 4.22(a4.1.1(a) Board Recommendation [*] Section 2.2(b) Cancelled Company Shares [*] Term Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs 9.1 Trade Control Laws Section 4.22(a) Debt Financing Dispute 11.7 XOMA Preamble XOMA Indemnitees Section 10.9(a) DGCL Recitals Dissenting Company Shares 8.1 [*] Section 3.7(c)(i) EAR [*] [*] Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)[*]
Appears in 1 contract
Samples: License Agreement (XOMA Corp)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections Section of this Agreement set forth opposite each indicated below: Definition: Section: Acceptance Milestone Section 6.3(a)(iii) Acquirer Section 1.20 [ * ] Section 2.5 [ * ] Section 1.62 Adamas Preamble [ * ] Section 6.4(d)(iv) Adamas FDC and ER Patent Rights Schedule 11.6 Adamas FDC Patent Rights Schedule 11.6 Adamas IP Infringement Claim Section 7.4(a) Adamas Manufacturing Know-How Section 3.1(c) Adamas Paragraph IV Claim Section 7.11(a) Adamas Patent Challenge Section 7.3(d)(ii) [ * ] Section 6.4(d)(iv) Agents Section 8.1 Alliance Manager Section 4.2(c) Antitrust Action Section 11.2(c) Antitrust Law Section 11.2(c) Approval Milestone Section 6.3(a)(iv) Arbitrators Section 12.2(b)(i) Assignment and Assumption Agreement Section 2.7 Xxxx-Xxxx Act Section 9.1(l) Bioequivalence Milestone Section 6.3(a)(i) Cessation Notice Section 11.2(a) Claim Section 12.2(b)(i) Confidential Information Section 8.2 Confidentiality Agreement Section 8.2 Courts Section 12.1 [ * ] Section 3.3 Effective Date Preamble ER Royalty Term Section 6.4(c)(iii) Existing Supply Agreement Section 3.3 FDC Launch Assumptions Section 5.4 FDC Royalty Term Section 6.4(c)(i) First Sales Year Section 1.81 Forest Preamble Forest Blocking Patent Section 6.4(c)(vii) [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the capitalized terms belowSecurities Act of 1933, as amended. Definition: Section: [ * ] Section 9.2(e) Forest Parent Preamble Forest Parties Section 10.2 Forest Patent Challenge Section 7.3(b) Forest Reversion Intellectual Property Schedule 11.6 Forest Third Party Patent Licenses Section 6.4(c)(vii) Indemnified Party Section 10.3(a) Indemnifying Party Section 10.3(a) Initial Development Plan Section 1.25 Invalidity Claim Section 7.5 JAMS Section 12.2(b)(i) JDC Section 4.1 Joint IP Working Group; JIPWG Section 7.1 Joint Know-How Section 7.2 Joint Manufacture Committee; JMC Section 3.3 Joint Patent Rights Section 7.2 Late Payment Notice Section 6.9 [ * ] Section 5.4 Letter Agreement Section 4.2(a) [ * ] Section 6.4(d)(iii) Milestone Event Section 6.3(a) Milestone Payment Section 6.3(a) [ * ] Section 1.62 Outside Milestone Date Section 6.3(b) Paragraph IV Claim Section 7.11(a) Payment Date Section 2.1(b) Pre-Change of Control Rights Section 1.20 [ * ] Section 2.5 Primary Detail Section 1.23 Product Category Section 1.81 Proprietary Non-Donepezil FDC Product Section 6.4(c)(ii) Proprietary Non-Donepezil FDC Royalty Term Section 6.4(c)(ii) Regulatory Filings Section 2.6 Regulatory Plan Section 1.80 Regulatory Plan Change Section 4.2(d)(ii) Related Adamas Patent Rights Section 1.8 Reverted FDC Products Schedule 11.6 Royalty Commencement Date Section 6.4(c)(iv) Rules Section 12.2(b)(i) Secondary Detail Section 1.23 Stability Milestone Section 6.3(a)(ii) Technology Transfer Plan Section 3.1(a) [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Definition: Section: Term Section Reference Acceptable Confidentiality Agreement 11.1 Termination Effective Date Schedule 11.6 Third Party Claims Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)10.1
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Stockholder Approval 3.4 Advisor 3.3(a) Agreement Preamble Alternative Acquisition Agreement 5.3(a) Anti-Corruption Laws 3.26(b) Buyer Parties Preamble Bylaws 3.1 Capitalization Date 3.7(a) Cash Replacement Company PSU Amounts 2.8(b)(ii) Cash Replacement Company RSU Amounts 2.8(a)(ii) Cash Replacement Holdings Incentive Unit Amounts 2.8(e)(ii) Cash Replacement Holdings RSU Amounts 2.8(d)(ii) Cash Replacement Option Amounts 2.8(c)(i) Term Section 6.2(c)(iiReference Certificates 2.9(c) Antiboycott Rules Section 4.22(aCharter 2.5(a) Board Recommendation Section 2.2(bChosen Courts 9.10(a) Cancelled Company Shares Section 3.7(a)(iiClass B Per Share Price 2.7(b)(iii) Certificate of Merger Section 3.2 Certificates Section 3.8(cClass C Per Share Price 2.7(b)(iv) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Certificate of Merger 2.2(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 3.7(b) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(e)(ii) Company Financial Advisor Section 4.10 Merger Recitals Company Merger Effective Time 2.2(b) Company Parties Preamble Company Plans 6.11(c) Company Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Continuation Period 6.11(c) Copyrights 1.1(eee) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDLLCA Recitals DPA 3.26(g) Effective Time Section DTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(v) Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bePrivacy Directive 1.1(hh) Equity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(a) ESPP 2.8(h) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cGDPR 1.1(hh)
Appears in 1 contract
Additional Definitions. The For purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto specified in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Term Section 6.2(c)(iiReference Antitrust Laws Section 5.5(a) Antiboycott Rules Antitrust Matters Section 4.22(a5.5(b) Board Recommendation Assets Section 2.2(b3.18 Assumed RSU Section 2.11(d) Book-Entry Shares Section 2.9(d) Cancelled Company Shares RSU Section 3.7(a)(ii2.11(d) Cancelled Stock Option Section 2.11(b) Cash Consideration Section 2.9(a) Certificate Section 2.9(d) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(c) Company Disclosure Letter Schedule Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.19(c) Company License-Out Agreements Products Section 4.16(h3.19(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.6 Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholders Meeting Section 5.2(e) Company Stockholder Meeting Proposals Section 5.2(a) Company Subsidiary Securities Section 3.2(c) Confidentiality Agreement Section 10.4 5.4(d) Consent Section 3.5(b) Consent Solicitation Section 5.16(a) Current Company D&O Insurance Option Section 7.8(c2.11(b) Customs Laws Current Policy Coverage Section 4.22(a5.9(b) Current Restricted Share Section 2.11(c) Current RSU Section 2.11(d) Debt Financing Dispute Offer Section 10.9(a5.16(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 2.12 Effective Time Section 3.2 Enforceability Exceptions 2.2 Employee Plans Section 4.4 Environmental Permits 3.15(a) ERISA Affiliate Section 4.15(b3.15(a) ESPP Section 2.11(h) Exchange Agent Section 2.10(a) Exchange Fund Section 3.8(b2.10(a) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a5.9(a) Inventions International Employee Plans Section 1.1 3.15(a) Intervening Event Section 5.3(e) Leased Real Property Section 3.17(b). Leases Section 3.17(b) Lenders Section 8.9(b) Term Section Reference Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.10(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.9(a) Minimum Condition Merger Proposal Section 2.1(a)(i5.2(e) Multiemployer Plan Merger-Related Proposals Section 4.11(c5.2(e) Merger Sub Preamble Open source Section 3.19(j) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.17(a) Parent Preamble Parent Disclosure Schedule Article IV Parent Plans Section 5.7(b) Parent Form 10-K Article IV Parent SEC Reports Section 4.6 Parent Securities Section 4.4(c) Parent Subsidiary Securities Section 4.2(c) Permits Section 3.11(a) Potential Financing Section 5.16(b) Potential Financing Sources Section 5.16(b) Proxy Statement/Prospectus Section 5.2(a) Qualifying Amendment Section 5.2(c) Registration Statement Section 5.2(a) Regulation M-A Filing Section 5.2(d) Requisite Stockholder Approval Section 3.22 Xxxxxxxx-Xxxxx Act Section 3.6 Stock Consideration Section 2.9(a)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Standard Microsystems Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement 102 Amounts Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.8(d)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Approval Section 4.22(a) Board Recommendation 3.5 Assignee Section 2.2(b) Cancelled Company 10.3 Book-Entry Shares Section 3.7(a)(ii2.8(c)(ii) Buyer Recitals Capitalization Date Section 3.6(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Changes Charter Documents Section 1.1 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.8(f) Collective Bargaining Agreement Section 3.17(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Options Section 2.8(d)(i) Company 102 PSUs Section 2.8(d)(i) Company 100 XXXx Section 2.8(d)(i) Company 102 Securities Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Section 7.3(a) Company Board Recommendation Change Section 5.3(b) Company Designated Directors Section 6.5 Company Disclosure Letter Article IV III Company License-In Agreements Plans Section 4.16(g6.2(c) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.6(b) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Company Shares Recitals Section 2.7(a) Confidentiality Agreement Section 10.4 Current Company 7.8 consolidated financial statements Section 3.9(a) Copyrights Section 1.1 D&O Insurance Section 7.8(c6.1(c) Customs Laws Designs Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 1.1 Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits Section 4.15(b3.16(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time FCPA Section 2.1(d)(i3.19(b) Financial Statements Incipio Incipio Merger Agreement FDA Section 4.7(b3.19(c) Recitals IAA Section 7.2(a) ICL Recitals Indemnified Persons Section 7.8(a6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) Intervening Event Recommendation Change Notice Section 5.3(d) Inventions Section 1.1 Israeli Employee Section 3.17(d) Israeli Employees Section 3.17(d) IT Systems Section 3.14(i) ITA Section 2.8(f) Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.12 Material Employee Plans Section 3.16(a) Maximum Annual Premium Section 7.8(c6.1(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a) Minimum Condition Merger Proposal Section 2.1(a)(i7.4(a) Multiemployer Merger Sub Preamble Notice Date Section 7.3(a) OECD Convention Section 3.19(b) Option Consideration Section 2.7(c) Options Tax Ruling Section 7.9(a) Outside Date Section 9.1(c) Parent Preamble Parent Plans Section 6.2(c) Patents Section 1.1 Paying Agent Section 2.8(a) Permits Section 3.18(a) Prohibited Payment Section 3.19(b) Proxy Statement Section 7.3(a) PSUs Consideration Section 2.7(d) Recommendation Change Notice Section 5.3(d) Registered Intellectual Property Section 3.14(a) Related Party Section 3.23 Reporting Tail Endorsement Section 6.1(c) RSUs Consideration Section 2.7(d)(i) Section 102 Plan Section 4.11(c)3.16(g) Subsidiary Securities Section 3.7(d) Surviving Company Section 2.1 Tax Returns Section 3.15(a) Termination Fee Section 9.3(b)(i) Trade Control Laws Section 3.19(d) Trade Secrets Section 1.1 Trademarks Section 1.1 Transition Period SEC Report Section 7.10(b) Uncertificated Shares Section 2.8(c)(ii) Withholding Drop Date Section 2.8(f) Withholding Tax Ruling Section 7.9(b) Works of Authorship Section 1.1
Appears in 1 contract
Samples: Agreement and Plan of Merger (SodaStream International Ltd.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto set forth in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Definition Location Acquired Company; Acquired Companies RECITALS Aggregate Share Purchase Price Section Reference Acceptable Confidentiality 2.02(c) Agreement PREAMBLE Alternative Acquisition Agreement Section 6.2(e)(iii5.08(c)(ii) Acquisition Proposal Arbitration Notice Section 6.2(e)(i8.13(a) Acquisition Sub Preamble ATA BVI PREAMBLE ATA Learning PREAMBLE ATA Learning Share Purchase Price Section 2.02(c) ATA Learning Shares Section 2.01 ATA Learning SPA RECITALS ATA Online RECITALS ATA Online Share Purchase Price Section 2.02(b) ATA Online Shares Section 2.01 Bankruptcy and Equity Exception Section 4.08(b) Beijing AIC Section 2.04(a)(i) Business RECITALS Buyer; Buyers PREAMBLE Buyer 1 PREAMBLE Buyer 2 PREAMBLE Buyer 3 PREAMBLE Buyer 4 PREAMBLE Buyer 5 PREAMBLE Buyer 6 PREAMBLE Buyer 7 PREAMBLE Contracting Parties Section 8.16(a) Debt Commitment Letters Section 4.08(a) Debt Financing Section 4.08(a) Debt Financing Agreement Section 5.06(a) Deposit RECITALS Deposit Account Section 5.01 Deposit Date Section 3.07(b) Dispute Section 8.13(a) Dividend and Distribution Section 5.10 Dividend and Distribution Amount Section 5.10 Equity Commitment Letter Section 4.08(a) Equity Financing Section 4.08(a) First Closing Section 2.03(a) First Closing Date Section 2.03(a) Financing Section 4.08(a) Financing Documents Section 4.08(a) Foreign Exchange Approvals Section 5.10 Guarantor PREAMBLE HKIAC Section 8.13(b) HKIAC Rules Section 8.13(b) Long-stop Date Section 7.01(b) Non-Party Affiliates Section 8.16(a) Party; Parties PREAMBLE Pledge of Sponsor Acquired Shares Section 5.11 PRC; China PREAMBLE Proposing Person Section 5.08(b)(ii) Second Closing Section 2.03(b) Second Closing Date Section 2.03(b) Seller PREAMBLE Seller Board RECITALS Seller Adverse Recommendation Change Section 6.2(c)(i5.08(c)(i) Agreement Preamble Alternative Acquisition Agreement Seller Termination Fee Section 6.2(c)(ii7.03 Special Committee RECITALS Superior Proposal Notice Period Section 5.08(d)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Third Closing Section 3.3 2.03(c) Third Closing Date Section 3.3 COBRA Section 4.11(d2.03(c) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Xing Wei RECITALS Zhongxiao RECITALS Zhongxiao Shares Section 3.7(c)(i2.01 Zhongxiao Share Purchase Price Section 2.02(a) EAR Zhongxiao SPA RECITALS 31.5% ATA Online Shares Section 4.22(a2.01(b) Effective Time 7.5% ATA Online Shares Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.01(a)(ii)
Appears in 1 contract
Samples: Share Purchase Agreement (ATA Inc.)
Additional Definitions. The following Other capitalized terms defined elsewhere in this Agreement and not defined in this Article I shall have the respective meanings ascribed thereto assigned to such terms in this Agreement in the respective sections of this Agreement set forth opposite each of the capitalized terms below: . Term Section Reference Acceptable Confidentiality Agreement Acceptance Time Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.4(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.2(e)(iii) Antiboycott Rules Appraisal Shares Section 4.22(a3.9 Book-Entry Shares Section 3.6(b)(i) Bribery Act Section 4.10(d) Capitalization Time Section 4.2(a) Certificate Section 3.6(b)(i) Chosen Courts Section 9.14 Closing Section 3.4 Closing Date Section 3.4 Code Recitals Company Preamble Company 401(k) Plan Section 6.9(c) Company Adverse Recommendation Change Section 6.2(d) Company Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h2.3(a) Company Financial Advisor Statements Section 4.10 4.6(b) Company Joint Venture Agreement Section 4.3(c) Company Joint Venture Entity Section 4.3(c) Company Joint Venture Securities Section 4.3(c) Company Material Contract Section 4.17(a) Company Owned Real Property Section 4.11(a) Company Plans Section 4.15(a) Company SEC Reports Documents Section 4.7(a4.6(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 6.2(b)(i) Continuing Directors Section 2.4(a) Continuing Employees Section 6.9(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.7(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.6(a) EAR Divestitures Section 4.22(a6.5(c) Effective Time Equity Commitment Section 3.2 Enforceability Exceptions 5.4(b) Equity Interests Section 4.4 Environmental Permits 4.2(b) ERISA Affiliate Section 4.15(b4.15(a) Exchange Fund Excluded Shares Section 3.8(b3.6(a) Expenses Section 8.3(c) FCPA Section 4.10(d) Indemnified Parties Section 6.7(a) Independent Directors Section 2.4(b) Initial Expiration Time Date Section 2.1(d)(i2.1(d) Financial Statements Incipio Incipio Merger Agreement Leased Property Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.11(b) Merger Recitals Merger Consideration Section 3.7(a)(i3.6(a) Minimum Condition Merger Effective Time Section 2.1(a)(i3.3 Merger Fund Section 3.8(a) Multiemployer Plan Merger Sub Preamble Money Laundering Laws Section 4.11(c4.10(b) Offer Recitals Offer Commencement Date Section 2.1(a) Offer Conditions Section 2.1(b) Offer Documents Section 2.2(a) Offer Price Recitals Other Anticorruption Laws Section 4.10(d) Outside Date Section 8.1(b)(i) Parent Preamble Paying Agent Section 3.8(a)(i) Real Property Leases Section 4.11(b) Schedule 14D-9 Section 2.3(b) Stockholder List Date Section 2.3(c) Surviving Corporation Section 3.1 Tender and Support Agreement Recitals Termination Fee Section 8.3(a) Voting Company Debt Section 4.2(b)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.2(b) Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(d) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.3(a) Capitalization Date 3.5(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.2(b) Term Section Reference Company Board Recommendation Change 5.3(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Plan 3.5(b) Company License-Out Agreements Section 4.16(hIn License 3.13(e) Company Financial Advisor Section 4.10 IP Contract 5.2(n) Company IP License 3.13(f) Company Material Real Property Lease 3.11 Company Out Licenses 3.13(f) Company Real Property Lease 3.11 Company Related Parties 8.3(f)(i) Company SEC Reports Section 4.7(a3.7 Company Subsidiary Documents 3.4 Company Termination Fee 8.3(b)(i) Company Securities Section 4.2(aCopyrights 1.1(eee) Company Shares Recitals Confidentiality Covered Persons 6.10(a) COVID-19 1.1(t)(vi) COVID-19 Measures 1.1(t)(xi) Credit Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cTermination 6.20 Cut-Off Time 5.3(a) Customs Laws Section 4.22(aDebt Commitment Letter 4.11(b) Debt Financing Dispute Section 10.9(a4.11(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.10(d) DTC Payment 2.10(d) Early ESPP Exercise Date 2.9 Effect 1.1(t) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.13 Equity Commitment Letters 4.11(a) Equity Financing 4.11(a) ESPP 2.9 Event Notice Period 5.3(e)(i)(1) Exchange Fund 2.10(b) Excluded Benefits 6.11(a) Export Controls 3.19(c)(i) Financing 4.11(b) Financing Conditions 4.11(c) Financing Letters 4.11(b) Go-Shop Period 5.3(a) Guaranties Recitals Guarantor Recitals Import Restrictions 3.19(c)(i) Interim Period 5.1 Intervening Event 5.3(e)(i) IRS 1.1(eee) Labor Agreement 3.14(a)(viii) Legal Restraint 7.1(c) Malicious Code 3.13(n) Marks 1.1(eee) Term Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Reference Material Contract Section 4.18(a3.14(a) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble No-Shop Period Start Date 5.3(a) Option Consideration Section 3.7(a)(i2.8(a) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Disclosure Letter Article IV Parent Reimbursement Obligations 6.21 Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party Preamble Patents 1.1(eee) Pay-Off Letter 6.20 Payment Agent 2.10(a) Per Share Price 2.7(a)(ii) Permits 3.20 Prohibited Financing Modifications 6.5(b) Proposal Notice Period 5.3(e)(ii)(3) Proxy Statement 6.3(a) Qualified Plan Section 4.11(c)3.16(d) Reimbursement Obligations 6.6(a) Representatives 5.3(a) Required Amounts 4.11(f) Required Approvals 7.1(b) Required Investment Screening Laws 3.3(b) Requisite Stockholder Approval 3.2(c) RSU Consideration 2.8(b)(i) Sale Reimbursement Obligations 6.21 SEC Clearance Date 6.3(g) Surviving Corporation 2.1 Takeover Statute 3.23 Termination Date 8.1(c) Uncertificated Shares 2.10(c) Voting and Support Agreement Recitals
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAccelerated Vesting Date 2.8(a)(ii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.2(b) Agreement Preamble Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.4(d) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Company Shares Section 3.7(a)(iiArticles 3.3(a) Capitalization Date 3.5(a) CBA 3.14(a)(vii) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Chosen Courts 9.10(a) Circular 2.12(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Companies Registrar 2.2 Company Preamble Company Common Stock Recitals Board Recommendation 3.2(b) Company Board Recommendation Change 5.3(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEnvironmental Permits 3.18(c) Company License-Out Agreements Section 4.16(hIn Licenses 3.13(e) Company Financial Advisor Section 4.10 IP Licenses 3.13(f) Company Out Licenses 3.13(f) Company Real Property Leases 3.11 Company Related Parties 8.3(g) Company SEC Reports Section 4.7(a3.7 Company Shareholders Meeting 6.3 Company Subsidiary Documents 3.4 Company Termination Fee 8.3(b)(i) Company Securities Section 4.2(aand 8.3(b)(iii) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cContingent Cash Award 2.8(a)(ii) Customs Laws Section 4.22(aCovered Persons 6.9(a) COVID-19 Measures 1.1(r)(xi) Cut-Off Time 5.3(a) Debt Commitment Letter 4.9(b) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a4.9(b) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.13 Equity Commitment Letter 4.9(a) Equity Financing 4.9(a) Event Notice Period 5.3(e)(i)(1) Exchange Fund 2.9(b) Financing 4.9(b) Financing Conditions 4.9(c) Term Section 3.8(bReference Financing Letters 4.9(b) Expiration Time Go-Shop Period 5.3(a) Government Grants 3.25 Guarantee Recitals Guarantors Recitals ICL Recitals Import Restrictions 3.19(c)(i) Interim Period 5.1 Interim Section 2.1(d)(i102 Tax Ruling 6.6(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIntervening Event 5.3(e)(i) Recitals Recitals Indemnified Persons Section 7.8(aIsraeli Employees 3.17(i) Inventions Section 1.1 Known Allegation 3.17(g) Malicious Code 3.13(m) Marks 1.1(yy) Material Contract Section 4.18(a3.14(a) Maximum Annual Premium Section 7.8(c6.9(c) Merger Recitals Merger Proposal 6.19(a) Merger Sub Preamble No-Shop Period Start Date 5.3(a) Notice Date 6.3 Option Consideration 2.8(a)(i) Owned Company Shares 2.7(a)(iv) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Plan 6.10(b) Parent Related Parties 8.3(g) Parent Termination Fee 8.3(c) Party Preamble Patents 1.1(yy) Payment Agent 2.9(a) Payor 2.12(a) Per Share Price 2.7(a)(iii) Permits 3.20 Prohibited Financing Modifications 6.4(b) Proposal Notice Period 5.3(e)(ii)(3) Proxy Statement 6.3 Qualified Plan 3.16(d) Reimbursement Obligations 6.5(a)(x)(J) Representatives 5.3(a) Required Amounts 4.9(f) Requisite Shareholder Approval 3.2(c) RSU Consideration 2.8(b)(i) Sanctioned Countries 3.19(c)(i) Sanctioned Person 3.19(c)(i) Term Section 3.7(a)(iReference Section 102 Tax Ruling 6.6(a) Minimum Condition Section 2.1(a)(i14 Arrangement 3.17(i) Multiemployer Plan Section 4.11(cSeverance Pay Law 3.17(i) Surviving Company 2.1 Takeover Statutes 3.23 Termination Date 8.1(c) Trade Controls 3.19(c)(i) Transactions Recitals Uncertificated Shares 2.9(c) Voting and Support Agreements Recitals Withholding Agent 2.9(a) Withholding Drop Date 2.12(a) Withholding Tax Ruling 6.6(b)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Tufin Software Technologies Ltd.)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning specified in the respective sections Section of this Agreement set forth opposite each of the capitalized terms belowsuch term: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 Certificates 2.2 Bank Merger Recitals Bank Merger Surviving Bank Section 3.8(c2.6 Blue Sky Section 6.5(a) Changes Burdensome Condition Section 1.1 6.3(c)(2) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Recitals Company 401(k) Plan Section 4.11(d6.12(a)(1) Company Preamble Company Common Stock Bank Sub Recitals Company Disclosure Letter Article IV Company License-In Agreements FA Section 4.16(g) Company License-Out Agreements Section 4.16(h5.2(i) Company Financial Advisor Statements Section 4.10 Company SEC Reports Section 4.7(a5.2(j)(1) Company Securities Meeting Section 4.2(a6.2 Company Preferred Stock Section 5.2(b)(1) Company Shares Recitals Confidentiality Agreement Shareholder Matters Section 10.4 Current Company D&O Insurance 5.2(e) Conversion Project Manager Section 7.8(c6.13 Covered Employees Section 6.12(e) Customs Laws Determination Date Section 4.22(a8.1(h) Debt Financing Dispute Disclosure Schedule Section 10.9(a) DGCL Recitals Dissenting Company Shares 5.1 Doubtful Section 3.7(c)(i) EAR Section 4.22(a5.2(y)(6) Effective Time Section 3.2 Enforceability Exceptions 2.2 Exchange Agent Section 4.4 Environmental Permits 3.3(a) Xxxxxx Xxx Section 4.15(b5.2(y)(4) Exchange Fund FBCA Section 3.8(b2.2 Fee Section 8.3(a) Expiration Time Fee Termination Date Section 2.1(d)(i8.3(a) Fee Triggering Event Section 8.3(a) Final Index Price Section 8.1(h) Xxxxxxx Mac Section 5.2(y)(4) Historical Financial Statements Incipio Incipio Merger Agreement Section 4.7(b5.2(j)(1) Indemnified Party Section 6.11(a) Index Group Section 8.1(h) Index Price Section 8.1(h) Initial Index Price Section 8.1(h) Initial Parent Market Price Section 8.1(h) Intended Tax Treatment Recitals Recitals Indemnified Persons Loans Section 7.8(a5.2(y)(1) Inventions Loss Section 1.1 5.2(y)(6) Material Contract Contracts Section 4.18(a) Maximum Annual Premium Section 7.8(c5.2(w)(1) Merger Recitals Merger Consideration Value Per Share Section 3.7(a)(i3.2(a)(1) Minimum Condition Merger Sub Preamble New Certificates Section 2.1(a)(i3.3(a) Multiemployer Obligor Section 5.2(y)(1) OCC Section 5.2(f) OFR Section 5.2(f) Old Certificates Section 3.3(a) Outside Date Section 8.1(e) Parent Preamble Parent 401(k) Plan Section 4.11(c6.12(a)(2) Parent Arrangements Section 5.2(u)(8) Parent Average Stock Price Section 8.1(h) Parent Bank Sub Recitals Parent Merger Recitals Parent Merger Surviving Company Section 2.6 Parent SEC Filings Section 5.3(i)(1) Pension Plan Section 5.2(u)(2) Per Common Share Consideration Section 3.1(a)(1) Pool Section 5.2(y)(5) Privacy Policies Section 5.2(dd) Proxy Statement Section 6.5(a) Real Property Section 5.2(v) Registration Statement Section 6.5(a) Regulatory Agreement Section 5.2(o) Required Third-Party Consents Section 5.2(f) Requisite Regulatory Approvals Section 6.3(a) Satisfactory Section 5.2(n)(2) Scheduled Intellectual Property Section 5.2(q)(1) Securitization Agreement Section 5.2(j)(2) SERPs Section 6.12(b) Starting Date Section 8.1(h) Subsequent Mergers Recitals Substandard Section 5.2(y)(6) Supplemental Disclosure Schedule Section 6.1(c) Surviving Corporation Recitals Takeover Laws Section 5.2(h) Trading Day Section 8.1(h)
Appears in 1 contract
Samples: Agreement and Plan of Merger (FCB Financial Holdings, Inc.)
Additional Definitions. The In addition to those terms defined in Section 1.1, the following capitalized terms shall have the respective meanings ascribed thereto meaning set forth in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Period 3.4(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Division 7.5(b) Antiboycott Rules Section 4.22(aArbitrator 3.4(d) Board Recommendation Section 2.2(bAtom Minority Shareholder Preamble Atom Minority Shares Recitals Certificates 3.3(a) Cancelled Company Shares Section 3.7(a)(iiClosing 2.2 Closing Cash 3.4(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Closing Indebtedness 3.4(a) Closing Net Working Capital 3.4(a) Company Preamble Company Common Stock Recitals Benefit Plan 4.19(a) Company Disclosure Letter Schedule Article IV 4 Company License-In IP Agreements Section 4.16(g4.14(a)(ix) Company License-Out Agreements Section 4.16(hPersonnel 4.19(a) Company Financial Advisor Section 4.10 Shareholders Preamble Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Transaction Expense Direction Notice 6.3 Copyrights 1.1 D&O Insurance Section 7.8(c7.6(e) Customs Disputed Items 3.4(d) Disqualified Individual 7.9 Environment 4.20(f) Environmental Laws Section 4.22(a4.20(f) Debt Financing Dispute Section 10.9(aEnvironmental Permit 4.20(f) DGCL ERISA Recitals Dissenting ERISA Affiliate 4.19(c) Estimated Closing Cash 3.1 Estimated Closing Indebtedness 3.1 Estimated Closing Net Working Capital 3.1 Estimated Company Shares Section 3.7(c)(iTransaction Expenses 3.1 Fairness Opinion Recitals Forward Looking Statements 5.10 FTC 7.5(b) EAR Section 4.22(aHazardous Material 4.20(f) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bHSR Act 4.5 indemnified party 10.5(a) Exchange Fund Section 3.8(bindemnifying party representative 10.5(a) Expiration Time Section 2.1(d)(iIndemnity Escrow Account 3.5(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIndemnity Escrow Amount 3.5(e) Recitals Recitals Indemnified Persons Section 7.8(aIndemnity Escrow Release Date 3.5(f) Inventions Section Interim Indemnity Escrow Release Date 3.5(f) Interim Outstanding Claims 3.5(f) ISRA 4.20(f) IT System 4.13(g) Leased Real Property 4.12(a) Leases 4.12(a) Legal Proceeding 4.17 Licensed Intellectual Property 4.13(b) Marks 1.1 Material Contract Section 4.18(a4.14(a) Maximum Annual Premium Section 7.8(cMaterial Customers 4.24 Material Distributors 4.24 Material Suppliers 4.24 NJDEP 7.5(c) Merger Recitals Merger Consideration Section 3.7(a)(iNotice of Objection 3.4(c) Minimum Condition Section 2.1(a)(iOutside Date 9.1(c) Multiemployer Plan Section 4.11(cOutstanding Claims 3.5(f) Outstanding Tax Claims 3.5(d) Outstanding Tax Return Claims 3.5(b) Owned Intellectual Property 4.13(a) Owned Real Property 4.12(b) Parent Preamble Parent Indemnified Parties 7.2(b) Parent Indemnitees 10.1(a) Patents 1.1 Permits 4.16 Personal Data 4.13(g) Post-Closing Statement 3.4(a) Pre-Closing Statement 3.1 Pre-Closing Straddle Period 7.2(b) Pre-Closing Tax Period 7.2(b) Pre-Closing Tax Return 3.5(b) Purchase Price Escrow Account 3.5(a) Purchase Price Escrow Amount 3.5(a) Registered Intellectual Property 4.13(a) Release 4.20(f) Released Parties 7.6(b) Releasing Parties 7.6(b) Remedial Action 4.20(f) Reserve 11.10(b) Shareholder Group 11.16 Shareholder Indemnitees 10.2(a) Shareholder Released Parties 7.7(a) Shareholder Releasing Parties 7.7(a) Shareholders’ Representative Preamble Software 4.13(g) Straddle Period 7.2(b) Tax Escrow Account 3.5(c) Tax Escrow Amount 3.5(c) Tax Escrow Release Date 3.5(d) Tax Return Escrow Account 3.5(b) Tax Return Escrow Amount 3.5(b) Tax Return Escrow Release Date 3.5(b) Tax Return Excess 3.5(c) Third Party Claim 10.5(a) Transaction Tax Deductions 7.2(b) Transfer Taxes 7.2(a)
Appears in 1 contract
Samples: Stock Purchase Agreement (Ashland Global Holdings Inc)
Additional Definitions. The following capitalized terms shall have table identifies the respective meanings ascribed thereto location of definitions set forth in the respective sections various Sections of this Agreement set forth opposite each of the capitalized terms belowAgreement: Term Section Reference Acceptable Agreement Introduction Alliance Manager Section 3.1 Anti-Corruption Laws Section 11.7(a)(i) Arbitration Notice Section 15.3(a) Arbitrators Section 15.3(b) Business Combination Transaction Section 1.12(b) Buyers Section 1.36 Claims Section 12.1 Clinical Supply Agreement Section 7.1 Commercial Supply Agreement Section 7.2 Competing Product Section 2.4(a) Competing Program Section 2.6 Confidentiality Agreement Section 6.2(e)(iii16.6 Continuing Technology Transfer Section 4.1 Development Target Section 5.2 Development Target Deadline Section 5.2 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Disclosing Party Section 10.1(a) Acquisition Proposal Disclosure Schedule Article 11 Dispute Section 6.2(e)(i15.1 Divestiture Section 2.5 Effective Date Introduction Ex-Territory Infringement Section 13.3 Examined Party Section 9.7 Executive Officers Section 3.2(f) Acquisition Sub Preamble Adverse Recommendation Change Global Brand Elements Section 6.2(c)(i8.4(b) Agreement Preamble Alternative Acquisition Global Development Plan Section 5.3(a) Indemnified Party Section 12.3 Indemnifying Party Section 12.3 Initial Technology Transfer Section 4.1 JDC Section 3.2(f)(ii) JSC Section 3.2(a) License Section 2.1 Losses Section 12.1 New IP Section 13.1(a) NMPA Submission Timeline Section 5.1(c) NVCR Introduction NVCR Indemnitees Section 12.1 Outstanding Voting Securities Section 1.12(a) Party/Parties Introduction Paying Party Section 9.8(c) Product Infringement Section 13.3 Product Marks Section 13.5 Publication Section 10.4 Receiving Party Section 10.1(a) Recipient Section 9.8(c) Representatives Section 10.1(c) Review Period Section 10.4(a) Royalty Term Section 9.3(b) Rules Section 15.3(a) Safety Agreement Section 6.2(c)(ii6.5(a) Antiboycott Rules Seller Section 4.22(a) Board Recommendation 1.36 Supply Agreement Term Sheet Section 2.2(b) Cancelled Company Shares 7.3 Technology Transfer Section 3.7(a)(ii) Certificate of Merger 4.1 Term Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer 14.1 Territory Development Plan Section 4.11(c)5.4 VAT Section 1.57 Zai Introduction Zai Indemnitees Section 12.2 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have table identifies the respective meanings ascribed thereto location of definitions set forth in the respective sections various Sections of this Agreement set forth opposite each of the capitalized terms belowAgreement: Term Section Reference Acceptable Agreement Introduction Alliance Manager Section 3.1 Anti-Corruption Laws Section 11.7(a)(i) Arbitration Notice Section 15.3(a) Arbitrators Section 15.3(b) Business Combination Transaction Section 1.12(b) Buyers Section 1.35 Claims Section 12.1 Clinical Supply Agreement Section 7.1 Commercial Supply Agreement Section 7.2 Competing Product Section 2.4(a) Competing Program Section 2.6 Confidentiality Agreement Section 6.2(e)(iii16.6 Continuing Technology Transfer Section 4.1 Development Target Section 5.2 Development Target Deadline Section 5.2 Disclosing Party Section 10.1(a) Acquisition Proposal Disclosure Schedule Article 11 Dispute Section 6.2(e)(i15.1 Divestiture Section 2.5 Effective Date Introduction Ex-Territory Infringement Section 13.3 Examined Party Section 9.7 Executive Officers Section 3.2(f) Acquisition Sub Preamble Adverse Recommendation Change Global Brand Elements Section 6.2(c)(i8.4(b) Agreement Preamble Alternative Acquisition Global Development Plan Section 5.3(a) Indemnified Party Section 12.3 Indemnifying Party Section 12.3 Initial Technology Transfer Section 4.1 JDC Section 3.2(f)(ii) JSC Section 3.2(a) License Section 2.1 Losses Section 12.1 New IP Section 13.1(a) NMPA Submission Timeline Section 5.1(c) NVCR Introduction NVCR Indemnitees Section 12.1 Outstanding Voting Securities Section 1.12(a) Party/Parties Introduction CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED WITH [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 11 EXHIBIT 10.15 CONFIDENTIAL Paying Party Section 9.8(c) Product Infringement Section 13.3 Product Marks Section 13.5 Publication Section 10.4 Receiving Party Section 10.1(a) Recipient Section 9.8(c) Representatives Section 10.1(c) Review Period Section 10.4(a) Royalty Term Section 9.3(b) Rules Section 15.3(a) Safety Agreement Section 6.2(c)(ii6.5(a) Antiboycott Rules Seller Section 4.22(a) Board Recommendation 1.35 Supply Agreement Term Sheet Section 2.2(b) Cancelled Company Shares 7.3 Technology Transfer Section 3.7(a)(ii) Certificate of Merger 4.1 Term Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer 14.1 Territory Development Plan Section 4.11(c)5.4 VAT Section 1.56 Zai Introduction Zai Indemnitees Section 12.2
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAssumed Company Option 2.8(c)(i) Board Recommendation Section 2.2(bAssumed Company Stock-Based Award 2.8(c)(ii) Base Indenture 1.1(ppp) Book-Entry Shares 2.9(b) Burdensome Condition 6.2(b) Bylaws 3.1 Cancelled Owned Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(b) Changes Section 1.1 Charter 3.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g1.4(a) Company License-Out Agreements Section 4.16(hEmployee 3.18(i) Company Financial Advisor Section 4.10 Plans 6.9(b) Company Recent SEC Reports Article III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.9(b) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.8(c) DGCL Recitals Term Section Reference Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.7(b)(i)1.1(o)2.2 Electronic Delivery Employee Plans ERISA Affiliate Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals FinCEN First Supplemental Indenture Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Indenture Initial Termination Date Injunction International Employee Plan Lease Leased Real Property Maximum Annual Premium Merger Merger Sub New Plans Notice Period OFAC Old PlansOwned Real Property Parent Parent Disclosure Letter Parent Qualified Plan Parent Recent SEC Reports Parent Termination Fee Party Paying Agent Payoff Letter Permits Proxy Statement Representatives Repurchase Transaction Repurchase Transaction Notice Requisite Stockholder Approval Revolving Credit Facility Termination Sanctioned Countries Sanctioned Person Sanctions Second Supplemental Indenture 9.123.18(a)3.18(a)2.9(a)3.21(d)1.1(ooo)6.8(a)1.1(ppp)8.1(c)8.1(b)3.18(a)3.14(b)3.14(b)6.8(c)Recitals Preamble 6.9(c) 5.3(d)(ii)(3)3.21(c)6.9(c)3.14(a)Preamble 1.4(b) 6.9(d)Article IV 8.3(c)(i) Preamble 2.9(a) 6.16(d)3.206.3(a)5.3(a)6.16(c)6.16(c)3.46.16(d)3.21(c)3.21(c)3.21(c)1.1(ppp) -17- Term Section 7.8(cReference Sublease 3.14(c) Merger Recitals Merger Consideration Section 3.7(a)(iSurrendered Company Stock-Based Award 2.8(a) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cSurviving Corporation 2.1 Tax Returns 3.17(a)(i)
Appears in 1 contract
Samples: Agreement and Plan of Merger
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement 102 Amounts Section 6.2(e)(iii2.9(d)(i) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Agreement Preamble APM House Section 4.22(a2.3 Approval Section 3.5 Assignee Section 10.3 BLR Section 3.20(f) Board Recommendation Capitalization Date Section 2.2(b3.6(a) Cancelled Company Shares CERCLA Section 3.7(a)(ii3.20(c) Certificate of Merger Section 3.2 2.4 Certificates Section 3.8(c2.9(c)(i) Change Section 1.1 Changes Section 1.1 Term Section Reference Charter Documents Section 3.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA 2.3 Code Section 4.11(d2.9(c)(i) Collective Bargaining Agreement Section 3.17(a) Companies Registrar Section 2.4 Company Preamble Company Common Stock Recitals 102 Options Section 2.9(d)(i) Company 102 Securities Section 2.9(d)(i) Company 102 Shares Section 2.9(b) Company Board Recommendation Section 5.3(a) Company Board Recommendation Change Section 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Plans Section 4.16(g6.2(b) Company License-Out Agreements Products Section 4.16(h3.14(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.6(b) Company Shares Recitals Section 2.8(a)(i) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Confidentiality Agreement Section 10.4 Current Company 7.8 Contractors Section 3.17(h) Copyrights Section 1.1 Certificates Section 2.8(c)(i) D&O Insurance Section 7.8(c6.1(b) Customs Laws Disclosed Open Source Software Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.14(k) Effective Time Section 3.2 Enforceability Exceptions 2.4 Employee Plans Section 4.4 Environmental Permits 3.16(a) ERISA Affiliate Section 4.15(b3.16(a) Exalenz US Section 2.1 Exchange Fund Section 3.8(b2.9(b) Expiration Time FCPA Section 2.1(d)(i3.19(b) FDA Section 3.19(g) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.8(c) Recitals Funded International Employee Plan Section 3.16(i) Good Clinical Practices Section 3.19(j) Good Laboratory Practices Section 3.19(j) Healthcare Laws Section 3.19(c) ICA Section 7.2(a) ICL Recitals Indemnified Persons Section 7.8(a6.1(a) Information Agent Section 2.9(a) IPL Section 3.14(g) Israeli Employees Section 3.17(e) Inventions Section 1.1 Term Section Reference Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.12(b) Leases Section 3.12(b) Letter of Transmittal Section 2.9(c)(i) Material Contract Section 4.18(a3.11(a) Material Employee Plans Section 3.16(a) Maximum Annual Premium Section 7.8(c6.1(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.8(a)(i) Minimum Condition Merger Proposal Section 2.1(a)(i7.4(a) Multiemployer Merger Sub Preamble OECD Convention Section 3.19(b) Open Source Software Section 3.14(k) Option Consideration Section 2.8(c)(i) Ordinary Share Section 2.8(a)(i) Outside Date Section 9.1(c) Ordinary Shares Section 2.8(a)(i) Parent Preamble Parent Plans Section 6.2(b) Patents Section 1.1 Paying Agent Section 2.9(a) Paying Agent Agreement Section 2.9(a) Payor Section 2.9(f) Permits Section 3.18(a) Pharmaceutical Product Section 3.19(m) Primary Company Executives Section 3.16(h) Prohibited Payment Section 3.19(b) R&D Sponsor Section 3.14(i) Recommendation Change Notice Section 5.3(c) Related Party Section 3.23 Reporting Tail Endorsement Section 6.1(b) Sales Taxes Section 3.15(aa) Section 102 Plan Section 4.11(c3.16(i) Section 14 Arrangement Section 3.17(g) Service Inventions Section 3.14(g) Subsidiary Securities Section 3.7(d) Surviving Company Section 2.2 Tax Returns Section 3.15(a) Termination Fee Section 9.3(b)(i) Trademarks Section 1.1 Trade Secrets Section 1.1 Transaction Report Section 7.3(a) Transition Period Report Section 7.10(b) Uncertificated Shares Section 2.9(c)(i) US Subsidiary Purchase Section 2.1 Term Section Reference Valid Certificate Section 2.9(f) VAT Section 3.15(z) Voting Agreement Recitals WARN Section 3.17(b) Works of Authorship Section 1.1 Withholding Drop Date Section 2.9(f) Withholding Tax Ruling Section 7.9(a)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Meridian Bioscience Inc)
Additional Definitions. The following capitalized Each of the terms shall have set forth below has the respective meanings ascribed thereto meaning set forth in the respective sections of this Agreement provision set forth opposite each of such term in the capitalized terms belowfollowing table: Term Provision Accounting Firm Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii1.3(d) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Additional HM Purchaser Recitals Agreement Preamble Alternative Acquisition Agreement Expiration Date Section 6.2(c)(ii9.1(c) Antiboycott Rules Books and Records Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 6.5 Closing Section 3.3 2.1 Closing Date Section 3.3 COBRA 2.1 Closing Debt Amount Section 4.11(d1.2(a)(i)(B) Company Confidential Information Section 6.4(a) Disputed Item Section 1.3(b) Eagle Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Eagle Parties Preamble Effective Time Section 3.2 Enforceability Exceptions 2.5 Estimated Partnership Cash Section 4.4 Environmental Permits 1.2(a)(i)(A) Estimated Working Capital Section 4.15(b1.2(a)(i)(C) Exchange Fund Final Adjustment Amount Section 3.8(b1.3(a) Final CFO Certificate Section 1.3(a) Final Payment Section 1.3(e) HM Preamble HM Parties Preamble HMSC Put Option Recitals Initial Adjustment Amount Section 1.2(b) Initial Adjustment Statement Section 1.2(a)(i) Initial Purchase Price Section 1.2(b) Losses Section 10.2 Negotiation Period Section 1.3(c) Objection Date Section 1.3(b) Objection Notice Section 1.3(b) Other Tax Proceeding Section 6.7(f) Parent Companies Preamble Parties Preamble Partnership Recitals Partnership Agreement Recitals Purchase Price Section 1.3(g) Purchasers Preamble Purchaser Indemnified Parties Section 10.2 Purchaser Party Release Section 2.3(d) Put Option Agreement Recitals Record Retention Period Section 6.5 -34- Term Provision Seller[s] Preamble Seller Indemnified Parties Section 10.3 Seller Party Release Section 2.2(c) Subject Partnership Interests Recitals Survival Expiration Time Date Section 2.1(d)(i10.1 Surviving Indemnification Rights Section 6.2 Tax Proceeding Section 6.7(e) Financial Statements Incipio Incipio Merger Agreement Third-Party Claims Section 4.7(b) 10.4 TLCC Partners Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)TLCC Put Option Recitals
Appears in 1 contract
Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections section of the Agreement indicated below: Definition Section Agreement Recitals Alliance Managers 3.1(a) Applicant 7.5(b) Applicant Response 7.5(c)(ii) Baseline Net Sales 1.41 Biosimilar Application 7.5(a) BPCIA 7.5(a) Challenge Jurisdiction 5.3(e) Challenged Patent Rights 5.3(e) Challenge-Related Royalty Increase 5.3(e) Clawback Amount 5.3(e) Combination 1.48 Covered Results 6.3 Covers 5.3(c)(iii) [***] [***] Disclosing Party 1.12 Disclosure Letter 9.1(c) Dispute 11.12 Effective Date Recitals Immediate Patent Infringement Action 7.5(c)(v) ImmunoGen Recitals Portions of this Agreement set forth opposite each Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the capitalized terms below: Securities Exchange Act of 1934, as amended. CONFIDENTIAL TREATMENT REQUESTED ImmunoGen Indemnitees 10.1(a) ImmunoGen Proprietary Antibody 1.25 Indemnified Party 10.2 Indemnifying Party 10.2 Infringed Patent List 7.5(c)(v) Infringement 7.4(a) Infringement Notice 7.4(a) JDC 3.2(a) Lilly Recitals Lilly Indemnitees 10.1(b) Lilly Response 7.5(c)(iii) Losses 10.1(a) Material Breach 8.2(b) Monies 7.4(g) Negotiation Period 7.5(c)(v) Patent Committee 7.2(c)(i) Patent List 1.33 Party/Parties Recitals Permitted Third Party Service Providers 2.1(a) Post-Royalty Term Section Reference Acceptable Confidentiality Issued Patents 5.5(b) Pre-Market Notice 7.5(d)(ii) Proposed Biosimilar Product 7.5(a) Proposed Patent List 7.5(c)(i) Receiving Party 1.12 Reinstated License 5.5(b) Reinstated Royalty Term 5.5(b) Representatives 1.12 Royalty Restoration Date 5.5(b) Royalty Term 5.5 18 Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. CONFIDENTIAL TREATMENT REQUESTED Safety Data Exchange Agreement Section 6.2(e)(iii3.4 [***] [***] Term 8.1(a) Acquisition Proposal Section 6.2(e)(iThird Party Claims 10.1(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iThird Party Payments 5.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiUpfront Fee 5.1 Wind-Down Period 8.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)2. GRANT OF RIGHTS
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Jurisdiction Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 6.21 Agreement Preamble Alternative Acquisition Agreement Anti-Bribery Laws Section 6.2(c)(ii3.25 Assumed Option Section 6.11(b) Antiboycott Rules Assumed RSU Section 4.22(a) Board Recommendation Section 2.2(b6.11(a) Cancelled Company Shares Option Section 3.7(a)(ii6.11(b)(ii) Capitalization Reference Date Section 3.04(a) Certificate of Merger Section 3.2 2.02(a) Certificates Section 3.8(c2.06(a) Changes Clarification Request Section 1.1 6.01(b) Closing Section 3.3 2.03 Closing Date Section 3.3 COBRA 2.03 Collective Bargaining Agreements Section 4.11(d3.19(a) Company Preamble Company Balance Sheet Section 3.09 Company Board Recitals Company Board Recommendation Section 6.02(a) Company Board Recommendation Change Section 6.02(b) Company Capitalization Representation Section 7.02(a)(iii) Company Common Stock Recitals Company Disclosure Letter Article IV ARTICLE III Company License-In Inbound License Section 3.21(c) Company IP Agreements Section 4.16(g3.21(c) Term Section Reference Company Leased Real Property Section 3.20(b) Company License-Out Agreements Outbound License Section 4.16(h3.21(c) Company Financial Advisor Owned Real Property Section 4.10 3.20(a) Company Real Property Leases Section 3.20(b) Company Registered IP Section 3.21(a) Company Regulatory Agency Section 3.26(a) Company Regulatory Permits Section 3.26(a) Company SEC Reports Section 4.7(a3.06(a) Company Securities Section 4.2(a3.04(c) Company Shares Stockholders’ Meeting Section 6.03(a) Company Specified Representations Section 7.02(a)(ii) Company Support Agreement Recitals Company Termination Fee Amount Section 8.03(b) Confidentiality Agreement Section 10.4 Current Company 6.09 Consent Section 3.05(b) Copyrights Section 1.01 D&O Insurance Section 7.8(c6.13(b) Customs Laws Delaware Secretary of State Section 4.22(a2.02(a) Debt Financing Dispute DOJ Section 10.9(a6.05(a) DGCL Recitals Dissenting Company Shares Dollars or $ Section 3.7(c)(i1.03(d) EAR Domain Names Section 4.22(a) 1.01 Effect Section 1.01 Effective Time Section 3.2 2.02(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.03(a) EPA Section 4.15(b3.26(a) EU Section 1.01 Exchange Agent Section 2.06(a) Term Section Reference Exchange Fund Section 3.8(b2.06(b) Expiration Time Excluded Shares Section 2.1(d)(i2.05(a)(i) Financial Statements Incipio Incipio Merger Agreement Export and Import Approvals Section 4.7(b3.22 Export Controls Section 3.22 FDA Section 3.26(a) Recitals Recitals FDCA Section 3.26(a) FIFRA Section 3.26(a) FQPA Section 3.26(a) FTC Section 6.05(a) Form F-4 Section 6.04(a) Fractional Share Cash Amount Section 2.05(c) Import Restrictions Section 3.22 Indemnified Persons Parties Section 7.8(a6.13(a) Inventions Issuance Section 1.1 6.04 Labor Organization Section 3.19(a) Linklaters Section 6.04(e) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Sub Preamble MoFo Section 6.04(e) Notice Period Section 6.02(d)(ii) Option Consideration Section 3.7(a)(i6.11(b)(ii) Minimum Condition Parent Preamble Parent Board Recitals Parent Capitalization Date Section 2.1(a)(i4.03(a) Multiemployer Plan Parent Capitalization Representation Section 4.11(c7.03(a)(iii) Term Section Reference Parent Disclosure Letter ARTICLE IV Parent Regulatory Agency Section 4.16(a) Parent Regulatory Permits Section 4.16(a) Parent SEC Reports Section 4.05(a) Parent Securities Section 4.03(d) Parent Subsidiary Securities Section 4.01(e) Parent Specified Representations Section 7.03(a)(ii) Permits Section 3.13 Patents Section 1.01 Proxy Statement/Prospectus Section 6.04(a) Requisite Stockholder Approval Section 3.03(c) Restrictive Contracts Section 3.11(a)(vi) R&W Policy Section 6.14 Significant Customer Section 3.15(a) Significant Supplier Section 3.15(b) Specified Jurisdictions Section 7.01(b) Share Consideration Section 2.05(a)(i) Subsidiary Securities Section 3.02(d) Surviving Company Section 2.01 Tail Policy Section 6.13(b) Takeover Law Section 3.29(b) Targeted Amount Section 6.21 Tax Incentive Section 3.16(l) Termination Date Section 8.01(c) Trademarks Section 1.01 Trade Secrets Section 1.01 Triggering Event Section 8.01(e)(ii) Uncertificated Shares Section 2.06(a) USDA Section 3.26(a)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Marrone Bio Innovations Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement 401(k) Termination Date Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.12(a) Agreement Preamble Alternative Acquisition Agreement Alternate Debt Financing Section 6.2(c)(ii6.16(c) Antiboycott Rules Anti-Bribery Laws Section 4.22(a3.25 Antitrust Termination Date Section 8.1(d) Board Recommendation Assets Section 2.2(b3.21 Assumed Option Section 6.11(c)(i) Assumed RSU Section 6.11(a) Cancelled Company Shares Option Section 3.7(a)(ii6.11(c)(ii) Capitalization Reference Date Section 3.4(a) Cash Consideration Section 2.7(a)(i) Certificate of Merger Section 3.2 2.2(a) Certificates Section 3.8(c2.8(a) Changes Clarification Request Section 1.1 6.1(b) Closing Section 3.3 2.3(a) Closing Date Section 3.3 COBRA 2.3(a) Collective Bargaining Agreements Section 4.11(d3.19(a) Company Preamble Company Board Recitals Company Board Recommendation Section 6.2(a) Company Board Recommendation Change Section 6.2(b) Company Capitalization Representation Section 7.2(a)(iii) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Inbound License Section 3.22(e) Company IP Agreements Section 4.16(g3.22(e) Company License-Out Agreements Leased Real Property Section 4.16(h3.20(b) Company Financial Advisor Outbound License Section 4.10 3.22(e) Company Real Property Leases Section 3.20(b) Company Registered IP Section 3.22(a) Company Related Party Section 9.5 Company SEC Reports Section 4.7(a) 3.6 Company Securities Section 4.2(a3.4(c) Company Shares Recitals Shareholders’ Meeting Section 6.3 Term Section Reference Company Specified Representations Section 7.2(a)(ii) Company Termination Fee Amount Section 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 6.9 Consent Section 3.5(b) Copyrights Section 1.1 D&O Insurance Section 7.8(c6.13(b) Customs Laws Debt Commitment Letters Section 4.22(a4.16(a) Debt Financing Dispute Section 10.9(a4.16(a) DGCL Recitals Delaware Secretary of State Section 2.2(a) Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Dollars or $ Section 4.22(a1.3(d) Domain Names Section 1.1 Effect Section 1.1 Effective Time Section 3.2 2.2(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.3(a) EU Section 4.15(b1.1 Exchange Agent Section 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Export and Import Approvals Section 2.1(d)(i3.23 Export Controls Section 3.23 First Step Merger Recitals Form S-4 Section 6.4(a) Financial Statements Incipio Incipio Merger Agreement Fractional Share Cash Amount Section 4.7(b2.7(c) Recitals Recitals Import Restrictions Section 3.23 Indemnified Persons Parties Section 7.8(a6.13(a) Inventions Interim Surviving Corporation Section 1.1 2.1(a) Xxxxx Day Section 6.4(e) Labor Organization Section 3.19(a) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Sub Preamble Merger Sub LLC Preamble New Debt Commitment Letters Section 2.1(a)(i6.16(c) Multiemployer Plan Notice Period Section 4.11(c6.2(c)(i) Option Consideration Section 6.11(c)(ii) Parent Preamble Parent Board Recitals Parent Capitalization Date Section 4.7(a) Parent Capitalization Representation Section 7.3(a)(iii) Parent Disclosure Letter Article IV Parent SEC Reports Section 4.8(a) Term Section Reference Parent Securities Section 4.7(c) Parent Specified Representations Section 7.3(a)(ii) Parent Subsidiary Preferred Stock Section 5.4(b) Parent Subsidiary Securities Section 4.2(c) Parent Termination Fee Section 8.3(c) Patents Section 1.1 Proxy Statement/Prospectus Section 6.4(a) Regulation M-A Filing Section 6.4(d) Required Financial Information Section 6.17(a)(iv) Requisite Shareholder Approval Section 3.3(c) Revenue Cap Section 6.5(e) SAR Consideration Section 6.11(d) Second Step Merger Recitals Significant Customer Section 3.15(a) Significant Supplier Section 3.15(b) Specified Jurisdictions Section 7.1(b) Stock Consideration Section 2.7(a)(i) Subsidiary Securities Section 3.2(d) Surviving Company Section 2.1(b) Tail Policy Section 6.13(b) Takeover Law Section 3.29(b) Tax Incentive Section 3.16(l) Termination Date Section 8.1(d) Trademarks Section 1.1 Trade Secrets Section 1.1 Transition Period Section 6.12(b) Triggering Event Section 8.1(f)(ii) Uncertificated Shares Section 2.8(a) WSGR Section 6.4(e)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement 102 Amounts Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.8(d) Agreement Preamble Alternative Acquisition Agreement Approval Section 6.2(c)(ii3.6 Assignee Section 10.3 Capitalization Date Section 3.7(a) Antiboycott Rules CERCLA Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii3.26(d) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.2 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.8(g) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals Board Recommendation Section 5.3(a) Company Disclosure Letter Article IV Company License-In Agreements Products Section 4.16(g3.14(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.9 Company Securities Section 4.2(a3.7(b) Company Shares Recitals Confidentiality Agreement Shareholder Approval Section 10.4 Current 3.3 Company D&O Insurance Shareholders Meeting Section 7.8(c5.7(a) Customs Laws Copyrights Section 4.22(a) Debt Financing Dispute 1.1 Customer Transferred IP Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.14(b) Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits 3.22(a) ERISA Affiliate Section 4.15(b3.22(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time FCPA Section 2.1(d)(i3.25(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.10(a) Recitals Recitals Funded International Employee Plan Section 3.22(i) Indemnified Persons Section 7.8(a6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 5.8(b) Inventions Section 1.1 IPL Section 3.14(b) ITA Section 2.8(g) Joint Venture Interests Section 1.1 Leased Real Property Section 3.14(b) Leases Section 3.14(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.13(a) Material Customer Section 1.1 Material Employee Plans Section 3.22(a) Material Supplier Section 1.1 Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c3.14(b)
Appears in 1 contract
Samples: Agreement and Plan of Merger
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(iii) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(iii) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Copyrights 1.1(rr) Covered Severance Plan Employees 6.11(b) Cut-Off Date 5.3(b) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDSPP Participation Schedule 3.73.7(b) DTC 2.10(d) Effect 1.1(q) Effective Time 2.2 Electronic Delivery 9.13 Term Section Reference Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iGo-Shop Period 5.3(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(j) Intervening Event 5.3(e)(i) IP Contracts 3.16(d) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(rr) Material Contract Section 4.18(aCustomer 1.1(vv)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble No-Shop Period Start Date 5.3(a) Minimum Condition Section 2.1(a)(iNotice Period 5.3(e)(ii)(3) Multiemployer Plan Section 4.11(c)Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(rr) Payment Agent 2.10(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Financing Information 6.6(a)(iv) Requisite Stockholder Approval 3.4 Surviving Corporation Article II
Appears in 1 contract
Samples: Agreement and Plan of Merger (Nutraceutical International Corp)
Additional Definitions. The For purposes of this Agreement, the following capitalized terms terms, when used in this Agreement, shall have the respective meanings ascribed thereto assigned to them in the respective sections of this Agreement set forth opposite each of the capitalized terms belowidentified Section: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.3(d) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAggregated Adjusted Options 3.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAggregate Share Merger Consideration 3.1(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3 Claim 6.7(b) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Code 3.2(f) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gContracts 4.12(a) Company License-Out Agreements Section 4.16(hInsiders 3.3(g) Company Financial Advisor Leases 4.4(b) 7 Term Section 4.10 Company SEC Reports Section 4.7(aMultiemployer Plans 4.10(a)(ii) Company Securities Section 4.2(aOwned Real Property 4.4(a) Company Real Property 4.4(c) Company Restricted Stock 3.3(c) Company Stock Option 3.3(a)(i) Company Stockholder Approval 4.2(a)(ii) Company Stockholders Meeting 6.4(a) Company Tenant Lease 4.4(b) Company Voting Agreements Recitals Continuing Employees 6.12(a) Deposit 8.2 DGCL 2.1 DGCL Modifications 6.3 D&O Indemnitees 6.7(a) Dissenting Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c3.1(d) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aDissenters’ Rights Statute 3.1(d) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 Escrow Agent 8.2 Escrow Agreement 8.2 Exchange Agent 3.2(a) Exchange Fund Section 3.8(bForm S-4 6.10 IRS 5.10(a)(iii) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Joint Proxy Statement 6.10 License Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) 6.24 Merger Recitals Merger Sub Preamble New Board 2.6 Notice of Adverse Change 6.3(e) Notice of Proposal 6.3(c) Notice of Superior Proposal 6.3(e) Outside Date 8.1(b)(i) Parent Preamble Parent Certificate of Incorporation Amendment 5.2(a)(i) Parent Common Stock Recitals Parent Contracts 5.12(a) Parent Leases 5.4(b) Parent Multiemployer Plans 5.10(a)(ii) Parent Owned Real Property 5.4(a) Parent Real Property 5.4(c) Parent Restricted Stock 3.3(c) Parent Stockholder Approval 5.2(a)(ii) Parent Stockholders Meeting 6.4(b) Term Section Parent Tenant Lease 5.4(b) Parent Voting Agreements Recitals Payoff Letters 6.15 Per Share Merger Consideration Section 3.7(a)(i3.1(c) Minimum Condition Section 2.1(a)(iPermanent Restraint 8.1(b)(v) Multiemployer Plan Section 4.11(c)Principal Company Stockholders Recitals Principal Parent Stockholders Recitals Proxy Statement 6.10 Registration Statement 6.23 REITs 4.26 Reorganization 6.5 Restraints 7.1(d) Surviving Corporation 2.1 TIC Interests 4.26
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Shares 2.7(a)(ii) Agreement Preamble Alternative Acquisition Financing 6.12(a) Alternative Termination Fee 8.2(e) Alternative Transaction Process 5.1 Base Amount 6.2(c) BBGS Agreement Section 6.2(c)(iiRecitals BBGS Buyer Recitals BBGS Sale Recitals BBGS Sale Materials 3.23 BBX Intermediate Preamble Canceled Shares 2.7(a)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCap 8.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 CFIUS 6.1(f) Change of Recommendation 5.2(d) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Commitment Letters 4.11 Company Preamble Company Board 3.2(a) Company Common Stock Recitals 3.4(a) Company Covered Employees 3.12(a) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEmployees 6.5(a) Company Financial Advisor Section 4.10 Statements 3.5(a) Company Intellectual Property 3.14(b) Company Material Contract 3.9(a) Company Non-U.S. Plan 3.12(k) Company Permits 3.8 Company Plan 3.12(a) 91 Company Preferred Stock 3.4(a) Company Recommendation 3.2(b) Company SEC Reports Section 4.7(aDocuments 3.5(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) 3.21 Covered Securityholders 3.22 Debt Financing Dispute Section 10.9(aCommitment Letter 4.11 Debt Documents 6.12(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Equity Commitment Letter 4.11 ERISA 3.12(a) ERISA Affiliate 3.12(i) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i1.1(c)(i) Financial Statements Incipio Incipio Merger Advisor 3.17 Forward Termination Fee 8.2(e) GAAP 3.5(a) General Enforceability Exceptions 3.2(a) Guarantee Recitals Guarantor Recitals Intervening Event 5.2(e) Leases 3.13(b) Material Customer 3.26(a) Material Customer Agreement Section 4.7(b3.26(a) Recitals Recitals Indemnified Persons Section 7.8(aMaterial Supplier 3.26(b) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(cSupplier Agreement 3.26(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i1.1(a)(i) Multiemployer Plan Section 4.11(cNASDAQ 1.1(e)(iii) New Plans 6.5(a) OFAC 3.24(c) Offer Recitals Offer Commencement Date 1.1(a) Offer Documents 1.1(e)(i) Offer Price Recitals Offer to Purchase 1.1(a) Option Cash Payment 2.8(a) Original Expiration Time 1.1(c)(i) Owned Intellectual Property 3.14(a) Parent Preamble Parent Entities Preamble Paying Agent 2.9(a) PBGC 3.12(b) 92 Performance Share Cash Payment 2.8(c) Recovery Costs 72 Related Party Contract 3.25 Representatives 5.2(a) Required Amount 4.11 Required Financial Information 6.12(b) Restraints 7.1(b) Restricted Parties 3.24(d) Rights 3.4(a) RSU Cash Payment 2.8(b) Schedule 14D-9 1.2(a) Schedule TO 1.1(e)(i) Shares Recitals Significant Customer 3.26(a) Significant Customer Agreement 3.26(a) Significant Supplier 3.26(b) Significant Supplier Agreement 3.26(b) Stockholder List Date 1.2(b) Surviving Corporation 2.1 Termination Date 8.1(b) Termination Fee 8.2(e) Top Parent Preamble Transaction Expenses 9.3 Uncertificated Shares 2.9(c) WARN Act 3.18(c)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have table identifies the respective meanings ascribed thereto location of definitions set forth in the respective sections various Sections of this Agreement set forth opposite each of the capitalized terms belowAgreement: Term Section Reference Acceptable Agreement Introduction Alliance Manager Section 3.1 Anti-Corruption Laws Section 11.7(a)(i) Arbitration Notice Section 15.3(a) Arbitrators Section 15.3(b) Business Combination Transaction Section 1.12(b) Buyers Section 1.35 Claims Section 12.1 Clinical Supply Agreement Section 7.1 Commercial Supply Agreement Section 7.2 Competing Product Section 2.4(a) Competing Program Section 2.6 Confidentiality Agreement Section 6.2(e)(iii16.6 Continuing Technology Transfer Section 4.1 Development Target Section 5.2 Development Target Deadline Section 5.2 Disclosing Party Section 10.1(a) Acquisition Proposal Disclosure Schedule Article 11 Dispute Section 6.2(e)(i15.1 Divestiture Section 2.5 Effective Date Introduction Ex-Territory Infringement Section 13.3 Examined Party Section 9.7 Executive Officers Section 3.2(f) Acquisition Sub Preamble Adverse Recommendation Change Global Brand Elements Section 6.2(c)(i8.4(b) Agreement Preamble Alternative Acquisition Global Development Plan Section 5.3(a) Indemnified Party Section 12.3 Indemnifying Party Section 12.3 Initial Technology Transfer Section 4.1 JDC Section 3.2(f)(ii) JSC Section 3.2(a) License Section 2.1 Losses Section 12.1 New IP Section 13.1(a) NMPA Submission Timeline Section 5.1(c) NVCR Introduction NVCR Indemnitees Section 12.1 Outstanding Voting Securities Section 1.12(a) Party/Parties Introduction THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 11 EXHIBIT 10.15 Execution Version CONFIDENTIAL Paying Party Section 9.8(c) Product Infringement Section 13.3 Product Marks Section 13.5 Publication Section 10.4 Receiving Party Section 10.1(a) Recipient Section 9.8(c) Representatives Section 10.1(c) Review Period Section 10.4(a) Royalty Term Section 9.3(b) Rules Section 15.3(a) Safety Agreement Section 6.2(c)(ii6.5(a) Antiboycott Rules Seller Section 4.22(a) Board Recommendation 1.35 Supply Agreement Term Sheet Section 2.2(b) Cancelled Company Shares 7.3 Technology Transfer Section 3.7(a)(ii) Certificate of Merger 4.1 Term Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer 14.1 Territory Development Plan Section 4.11(c)5.4 VAT Section 1.56 Zai Introduction Zai Indemnitees Section 12.2
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement 102 Amounts Section 6.2(e)(iii2.8(d)(i) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.2(b)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.2(b)(ii) Antiboycott Rules Approval Section 4.22(a3.5 Benchmark Section 3.26 Capitalization Date Section 3.6(a) Board Recommendation CERCLA Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) 1.1 Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Changes Charter Documents Section 1.1 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Closing Net Cash Section 4.11(d6.2(f) Code Section 2.12(a) Collective Bargaining Agreement Section 3.18(b) Companies Registrar Section 2.3 Company Preamble Company Common Stock 102 Options Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recitals Company Disclosure Letter Article IV III Company License-In Agreements Ground Stations Section 4.16(g3.24 Company Reports Section 3.8(a) Company License-Out Agreements Shareholder Approval Section 4.16(h) 3.2 Company Financial Advisor Shareholders Meeting Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a5.9(a) Company Shares Recitals Section 2.7(a)(i) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 5.3 control Section 7.8(c) Customs Laws 1.1 Copyrights Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 1.1 Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits 3.17(a) Encouragement Law Section 4.15(b3.16(s) Estimated Closing Certificate Section 5.17(a) Excess Earnout Certificate Section 5.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Expense Reimbursement Section 2.1(d)(i7.3(b) FCC Section 3.5 FCPA Section 3.20(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.9(a) Recitals Funded International Employee Plan Section 3.17(e) Term Section Reference Guarantor Preamble ICL Recitals Indemnified Persons Person Section 7.8(a5.6(a) Independent Accountant Section 5.17(b) Interim Option Tax Ruling Section 5.14(a) Inventions Section 1.1 Israeli Employees Section 3.18(e) IT Systems Section 3.15(i) ITA Section 2.12(a) Joint Venture Interests Section 3.7(b) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Major Stations Section 3.24 Material Contract Section 4.18(a3.12(a) Maximum Annual Premium Material Customer Section 7.8(c3.12(a) Material Employee Plans Section 3.17(a) Material Permits Section 3.19(a) Material Supplier Section 3.12(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Proposal Section 2.1(a)(i5.10(a) Multiemployer Plan Merger Sub Preamble MOC Section 4.11(c)3.5 Objection Notice Section 5.17(b) OECD Convention Section 3.20(b) Option Consideration Section 2.7(c)(i) Option Tax Ruling Section 5.14(a) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.13(a) Parent Preamble Patents Section 1.1 Paying Agent Section 2.8(a) Permits Section 3.19(a) Prohibited Payment Section 3.20(b) Proxy Statement Section 5.9(a) Registered Intellectual Property Section 3.15(a) RSUs Consideration Section 2.7(d)(i) Section 14 Arrangement Section 3.18(a) Special Enterprise Section 3.16(s) Surviving Company Section 2.1 Tax Returns Section 3.16(a) Temporary Order Section 3.16(t) Termination Fee Section 7.3(c) Trade Secrets Section 1.1
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAnti-Corruption Laws 3.26(b) Buyer Parties Preamble Bylaws 3.1 Capitalization Date 3.7(a) Cash Replacement Company PSU Amounts 2.11(b)(ii) Cash Replacement Company RSU Amounts 2.11(a)(ii) Cash Replacement Holdings Incentive Unit Amounts 2.11(e)(ii) Cash Replacement Holdings RSU Amounts 2.11(d)(ii) Cash Replacement Option Amounts 2.11(c)(i) Certificates 2.12(c) Charter 2.8(a) Chosen Courts 9.10(a) Class B Per Share Price 2.10(b)(iii) Class C Per Share Price 2.10(b)(iv) Closing 2.6 Closing Date 2.6 Collective Bargaining Agreement 3.19(a) Company Preamble Company Board Recommendation Section 2.2(b3.3(a) Cancelled Company Shares Section 3.7(a)(iiBoard Recommendation Change 5.3(c)(i) Company Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d2.5(b) Company Preamble Class B Stock Recitals Company Class C Stock Recitals Term Section Reference Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 3.7(b) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(e)(ii) Company Financial Advisor Section 4.10 Merger Recitals Company Merger Effective Time 2.5(b) Company Parties Preamble Company Plans 6.11(c) Company Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aTermination Fee 8.3(b)(i) Company Shares Recitals Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Continuation Period 6.11(c) Copyrights 1.1(bbb) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.10(d)(i) EAR Section 4.22(aDLLCA Recitals DPA 3.26(g) Effective Time Section DTC 2.12(d) DTC Payment 2.12(d) Effect 1.1(s) Electronic Delivery 9.13 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bePrivacy Directive 1.1(ee) Equity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(a) ESPP 2.11(h) Exchange Fund Section 3.8(b2.12(b) Expiration Date 2.1(c) Extension Deadline 2.1(d)(iii) GDPR 1.1(ee) Guarantor Recitals Guaranty Recitals Holdings Preamble Holdings Certificate of Merger 2.5(a) Holdings LLCA 3.1 Holdings Merger Recitals Holdings Merger Effective Time Section 2.1(d)(i2.5(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons 6.10(a) Initial Expiration Date 2.1(c) International Employee Plans 3.18(a) Term Section 7.8(aReference Intervening Event 5.3(d)(i) Inventions Section 1.1 IP Contracts 3.16(f) Lease 3.14(b) Leased Real Property 3.14(b) LLC Agreement 2.8(d) Marks 1.1(bbb) Material Contract Section 4.18(aRelationships 1.1(fff)(v) Maximum Annual Premium Section 7.8(c6.10(c) Merger Mergers Recitals Merger Consideration Section 3.7(a)(i) Sub I Preamble Merger Sub II Preamble Minimum Condition ANNEX I New Plans 6.11(d) Notice Period 5.3(d)(ii)(3) Offer Recitals Offer Acceptance Consideration 2.2(a)(iii) Offer Acceptance Time 2.2(a)(iii) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)(i) Offer Documents 2.1(f)(i) Offer Prices Recitals Offer to Purchase 2.1(f)(i) Offering Period 2.11(h) Old Plans 6.11(d) Original Agreement Recitals Other Required Company Filing 6.3(a) Other Required Parent Filing 6.3(b) Owned Company Share 2.10(b)(v) Owned Holdings Unit 2.10(a)(iii) Parent Disclosure Letter Article IV Parent Entities Preamble Parent Liability Limitation 8.3(e)(i) Parent Related Parties 8.3(e)(i) Party Preamble Patents 1.1(bbb) Payment Agent 2.12(a) Per Share Price 2.10(b)(ii) Per Unit Price 2.10(a)(ii) Permits 3.20 Recent SEC Reports Article III Reimbursement Obligations 6.6(g) Representatives 5.3(a) Schedule 14D-9 2.2(b)(i) Schedule TO 2.1(f)(i) Special Majority Condition ANNEX I Stockholder List Date 2.3 Sublease 3.14(c) Surviving Corporation 2.4(b) Term Section 2.1(a)(iReference Surviving Entities 2.4(b) Multiemployer Plan Section 4.11(cSurviving LLC 2.4(a) Tax Returns 3.17(a) Tender Agreements Recitals Termination Date 8.1(c) Trade Control Laws 3.26(a) Uncertificated Shares 2.12(c) Uncertificated Units 2.12(c) Unvested Company Option 2.11(c)(i) Unvested Company PSUs 2.11(b)(ii) Unvested Company RSU 2.11(a)(ii) Unvested Holdings Incentive Unit 2.11(e)(ii) Unvested Holdings RSU 2.11(d)(ii) Vested Company PSU Consideration 2.11(b)(i) Vested Company RSU Consideration 2.11(a)(i) Vested Company Option Consideration 2.11(c)(i) Vested Holdings Incentive Unit Consideration 2.11(e)(i) Vested Holdings RSU Consideration 2.11(d)(i)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 6.12(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAffected Employee 6.12(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAlternate Debt Financing 6.15(c) Antiboycott Rules Section 4.22(aAssumed Option 2.7(d)(iv) Board Recommendation Section 2.2(bAssumed RSU 2.7(d)(i) Assumed SAR 2.7(d)(iv) Cancelled Company Shares 2.7(a)(ii) Term Section 3.7(a)(iiReference Capitalization Representations 7.2(a) Capitalization Time 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.7(a)(i) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Closing Date Indebtedness 6.15(e)(i)f) Collective Bargaining Agreements 3.20(a) Company Preamble Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In IP Agreements Section 4.16(g3.22(d) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRegistered IP 3.22(a) Company Securities Section 4.2(a3.4(d) Company Shares Recitals Stockholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c6.10 Consent 3.5(b) Customs Laws Section 4.22(aDebt Commitment Letters 4.8(a) Debt Financing Dispute Section 10.9(a4.8(a) DGCL Recitals Debt Financing Conditions 4.8(b) Debt Financing Sources 4.8(a) Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.13(b) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.3(a) Escrowed Compensatory Payments 2.8(c) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExport Controls 3.23(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 6.15(e)(i) Recitals Recitals Financing Sources 6.15(e)(i) Import Restrictions 3.23(a) Indemnified Persons Section 7.8(aParties 6.13(a) Inventions Section 1.1 Intervening Event 6.2(c)(ii) Labor Organization 3.20(a) Leased Real Property 3.21(b) Leases 3.21(b) Loan Documents 6.17 Material Contract Section 4.18(a3.11(a) Maximum Annual Premium 6.13(b) Term Section 7.8(c) Reference Merger Recitals Merger Consideration Section 3.7(a)(iRecitals Merger Sub Preamble New Debt Commitment Letters 6.15(c) Minimum Condition Section 2.1(a)(iNoteholders 6.18(c) Multiemployer Plan Section 4.11(cNotes Consents 6.18(a) Notes Offer to Purchase 6.18(a) Notes Tender Offer 6.18(a) Notes Tender Offer Documents 6.18(c) Notice Period 6.2(c)(i) Optional Redemption 6.18(e) Optional Redemption Notice 6.18(e) Owned Real Property 3.21(a) Parent Preamble Parent Expenses 8.3(b)(iv) Parent Specified Representations 7.3(a) Payment Agent 2.8(a) Permits 3.14 Pre-Closing Director 6.15(e)(ii) Proxy Statement 3.8 PSU Consideration 2.7(d)(iii) Real Property 3.21(b) Required Financial Information 6.15(e) Requisite Stockholder Approval 3.3(c) Senior Notes 6.18(a) Significant Customer 3.16(a) Significant Supplier 3.16(b) Special Shares 2.7(e) Specified Representations 7.2(a) Subsidiary Securities 3.2(d) Supplemental Indenture 6.18(d) Surviving Corporation 2.1 Tail Policy 6.13(b) Tax Incentive 3.17(k) Termination Date 8.1(d) Termination Fee Amount 8.3(b)(i) TIA 6.18(b) Transition Period 6.12(b) Uncertificated Shares 2.7(a)(i) Unvested Restricted Stock 2.7(d)(v)
Appears in 1 contract
Additional Definitions. The For purposes of this Agreement, the following capitalized terms terms, when used in this Agreement, shall have the respective meanings ascribed thereto assigned to them in the respective sections of this Agreement set forth opposite each of the capitalized terms belowidentified Section: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.3(d) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAggregated Adjusted Options 3.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAggregate Share Merger Consideration 3.1(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3 Claim 6.7(b) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Code 3.2(f) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gContracts 4.12(a) Company License-Out Agreements Section 4.16(hInsiders 3.3(g) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aLeases 4.4(b) Company Securities Section 4.2(aMultiemployer Plans 4.10(a)(ii) Company Owned Real Property 4.4(a) Company Real Property 4.4(c) Company Restricted Stock 3.3(c) Company Stock Option 3.3(a)(i) Company Stockholder Approval 4.2(a)(ii) Company Stockholders Meeting 6.4(a) Company Tenant Lease 4.4(b) Company Voting Agreements Recitals Continuing Employees 6.12(a) Deposit 8.2 DGCL 2.1 DGCL Modifications 6.3 D&O Indemnitees 6.7(a) Dissenting Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c3.1(d) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aDissenters’ Rights Statute 3.1(d) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 Escrow Agent 8.2 Escrow Agreement 8.2 Exchange Agent 3.2(a) Exchange Fund Section 3.8(bForm S-4 6.10 IRS 5.10(a)(iii) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Joint Proxy Statement 6.10 License Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) 6.24 Merger Recitals Merger Sub Preamble New Board 2.6 Notice of Adverse Change 6.3(e) Notice of Proposal 6.3(c) Notice of Superior Proposal 6.3(e) Outside Date 8.1(b)(i) Parent Preamble Parent Certificate of Incorporation Amendment 5.2(a)(i) Parent Common Stock Recitals Parent Contracts 5.12(a) Parent Leases 5.4(b) Parent Multiemployer Plans 5.10(a)(ii) Term Section Parent Owned Real Property 5.4(a) Parent Real Property 5.4(c) Parent Restricted Stock 3.3(c) Parent Stockholder Approval 5.2(a)(ii) Parent Stockholders Meeting 6.4(b) Parent Tenant Lease 5.4(b) Parent Voting Agreements Recitals Payoff Letters 6.15 Per Share Merger Consideration Section 3.7(a)(i3.1(c) Minimum Condition Section 2.1(a)(iPermanent Restraint 8.1(b)(v) Multiemployer Plan Section 4.11(c)Principal Company Stockholders Recitals Principal Parent Stockholders Recitals Proxy Statement 6.10 Registration Statement 6.23 REITs 4.26 Reorganization 6.5 Restraints 7.1(d) Surviving Corporation 2.1 TIC Interests 4.26
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Accel Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iRecitals Accel Breakup Fee 1.1(ss) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(e)(ii) Antiboycott Rules Section 4.22(aAssets 3.14 Bylaws 2.5(b) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Charter 2.5(a) Closing Section 3.3 2.3 Closing Date 2.3 Collective Bargaining Agreement 3.19(a) Commitment Letter 4.10(a) Term Section 3.3 COBRA Section 4.11(d) Reference Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 6.5(a) Company Disclosure Letter Article IV III Company License-In Intellectual Property Agreements Section 4.16(g3.16(c) Company License-Out Agreements Section 4.16(hProducts 3.16(b) Company Financial Advisor Section 4.10 Registered Intellectual Property 3.16(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStock-Based Award Consideration 2.7(d) Company Shares Recitals Stockholder Meeting 6.4 Confidentiality Agreement Section 10.4 Current 9.4 Consent 3.6 Continuing Discussion Period 5.3(c) Dissenting Company Shares 2.7(c)(i) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a) 6.6 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aEffect 1.1(m) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) ESPP 2.7(g) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinal Offering 2.7.(g) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 In-Licenses 3.16(c) International Employee Plans 3.18(a) Investor 4.10(a) Leased Real Property 3.15(b) Lease 3.15(b) Material Contract Section 4.18(a3.13(a) Material Customer Agreements 3.13(a)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Newco Preamble Newco Expenses 8.3 Newco Representatives 5.3(f) No-Shop Period Start Date 5.3(a) Notice Period 5.3(f) Option Consideration 2.7(e) Other Required Company Filing or Other Required Company Filings 3.27(a) Other Required Newco Filing or Other Required Newco Filings 4.6(b) Out-Licenses 3.16(c) Owned Company Shares 2.7(a)(iii) Term Section 3.7(a)(iReference Payment Agent 2.8(a) Minimum Condition Section 2.1(a)(iProxy Statement 3.27(a) Multiemployer Plan Section 4.11(c)Recent SEC Reports Article III Representatives 5.3(a) Requisite Stockholder Approval 3.4 Sublease 3.15(c) Subsidiary Securities 3.8(c) Surviving Corporation 2.1
Appears in 1 contract
Samples: Agreement and Plan of Merger (Sumtotal Systems Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2020 Bonus Plan 7.9(d) Acquisition Proposal Section 6.2(e)(i2020 Bonuses 7.9(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i401(k) Plan 7.9(e) 401(k) Plan Termination Date 7.9(e) Accepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bBalance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) CARES Act 1.1 Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d4.12(d) Collaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 3.7(g) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 4.2(b) Company Financial Advisor Section 4.10 Advisors 4.11 Company Program Requirements 4.20(d) Company Programs 4.20(d) Company Regulatory Agency 4.20(b) Company Regulatory Permits 4.20(b) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section Tail Policy 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) Data 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Domain Names 1.1 Effect 1.1 Effective Time Section 3.2 Effects 1.1 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFFCRA 1.1 FFDCA 1.1 Final Exercise Date 3.7(g) Recitals Recitals Final Offering Period 3.7(g) Foreign Antitrust Laws 1.1 Indemnified Persons Section 7.8(a) Indemnified Proceeding 7.8(b) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.19(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Parent Preamble Parent 401(k) Plans 7.9(e) Participant 4.12(e) Paying Agent 3.8(a) Plans 4.12(a) Proprietary Information 1.1 Real Property Leases 4.18(b) Remedy Actions 7.2(a) Retention Agreements Recitals RSU Consideration 3.7(e) Schedule 14D-9 2.2(a) Schedule TO 2.1(f)(i) Subsidiary Securities 4.2(e) Surviving Corporation 3.1 Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c) Works of Authorship 1.1
Appears in 1 contract
Samples: Agreement and Plan of Merger (Momenta Pharmaceuticals Inc)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto described in the respective sections corresponding section of this Agreement set forth opposite each of the capitalized terms indicated below: Certain confidential information contained in this document, marked by [***], has been omitted because Roivant Sciences, Ltd. (the “Company”) has determined that the information (i) is not material and (ii) would likely cause competitive harm to the Company if publicly disclosed. Agreement Preamble Commercialization Milestone Event Section 5.2.3(a) Commercialization Milestone Payment Section5.2.3(a) [***] [***] Cure Period Section 10.2.1 Developing Section 1.23 Development Section 1.24 Development Milestone Event Section 5.2.1(a) Development Milestone Event Notice Section 5.2.1(a) Development Milestone Payment Section 5.2.1(a) Development Plan Section 3.1.2 Disclosing Party Section 7.1 Dispute Section 11.6.2(a) EEA Section 8.4.1(b) Effective Date Preamble Eisai Preamble Eisai Indemnitees Section 9.1 Eisai Transition Plan Section 10.6.1(d) Electronic Delivery Section 11.17 EMA Section 1.94 Executive Officer Section 3.4.3 Existing Drug Substance Inventory Section 4.3.1(a) Existing Raw Materials Inventory Section 4.3.1(b) Existing Transferred Inventory Section 4.3.1(a) Existing Regulatory Materials Section 3.2.3(a) FDA Section 1.94 GAAP Section 1.1 [***] [***] IAS/IFRS Section 1.1 ICC Section 11.6.2(b) ICD10 Section 1.51 ICH Guidelines Section 1.42 Indemnification Claim Notice Section 9.3.1 Indemnitee Section 9.3.1 Indemnitor Section 9.3.1 Infringement Section 6.3.1 Insolvency Event Section 10.4.1 [***] [***] Manufacturing Know-How and Materials Section 4.4.1 Manufacturing Technology Transfer Section 4.4.1 Manufacturing Technology Transfer Plan Section 4.4.1 MHLW Section 1.94 MHRA Section 1.94 Parties Preamble Party Preamble Patent Term Restoration Section 6.3.10 Receiving Party Section 7.1 Regulatory Milestone Event Section 5.2.2 Regulatory Milestone Payment Section 5.2.2 Regulatory Transition Activities Section 3.2.3(b) Royalty Reduction Trigger Section 1.61 Pharmavant Preamble Pharmavant Indemnitees Section 9.2 Pharmavant Manufacturing Know-How Section 10.6.1(d)(ix) Roivant Sciences Recitals Pharmavant Trademarks Section 6.6 Securities Regulators Section 7.3.1(a) Share Purchase Agreement Section 5.1(b) Tactical Plan Section 1.16 Term Section Reference Acceptable Confidentiality 10.1.1 Third Party Infringement Section 6.5.1 Transferred Regulatory Materials Section 3.2.3(b) Transitional Supply Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)4.3.2
Appears in 1 contract
Samples: Exclusive License Agreement (Roivant Sciences Ltd.)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning described in the respective sections corresponding section of this Agreement set forth opposite each indicated below: Definition: Section: Acquired Person 1.15 4[***] For the purposes of the capitalized terms below“Target” definition, “[***]” means [***] [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Definition: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Section: Active Immunotherapeutic Approaches 4.2.1 Agreement Preamble Alternative Acquisition Celgene Preamble Celgene Acquired Competing Antibody 4.4.2 Celgene Exclusivity Term 4.4.1 Celgene Indemnitees 9.2 Celgene Proposed Terms 4.2.2 Celgene Share 6.8.2(d) Celgene Third Party Payments 5.2.4 Clinical Trial Preliminary Activities Outside Date 10.5 Combination Product 1.52 Competing Antibody 4.4.1 Competing Compound 4.1 Cure Period 11.2.1 Disclosing Party 7.1 Dispute 11.7.2 Electronic Delivery 12.11 Effective Date Preamble EMA 1.69 Excluded Claim 11.7.3(d) FDA 1.69 [***] [***] Force Majeure 11.3 GAAP 1.1 Grant 4.2.2 Grant Notice 4.2.2 HIPAA 1.5 IFRS 1.1 Indemnitee 9.3 Indemnitor 9.3 Indirect Taxes 5.5.2(b) Insolvency Event 10.4 Joint IP 6.6.4 Joint Know-How 6.6.4 Joint Patents 6.6.4 Licensed Program Assets 2.5 Licensed Program Confidential Information 7.11 Licensed Program Know-How 1.46(a) Licensed Program Non-Specific IP 7.2 Licensed Program Patents 1.46(b) Licensed Program Specific IP 7.2 [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Definition: Section: Master Collaboration Agreement Section 6.2(c)(iiRecitals MHLW Negotiation Period 4.2.2 [***] [***] Notice Period 4.2.2 Ongoing Prothena Development Activities 2.3.3 Party or Parties Preamble Patent Liaison 6.7 Payee Party 5.5.2(b) Antiboycott Rules Section 4.22(aPaying Party 5.5.2(b) Board Recommendation Section 2.2(bPer Licensed Product Annual Net Sales 5.2.1 Program Recitals Prothena Preamble Prothena Indemnitees 9.1 Prothena Licensor 8.3.3 Prothena Ongoing Program Activities 2.3 Prothena Reversion Antibodies 10.10.1 Publishing Party 8.8.1 Receiving Party 7.1 Regulatory Milestone Payment 5.3.1 Right of First Negotiation 4.2.2 Sales Milestone Payment 5.4.1 SEC 8.4.1(a) Cancelled Company Shares Section 3.7(a)(iiSecurities Regulators 7.6 Tax Benefit 5.5.2(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Term 10.1.1 Transfer Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.2.1(a)
Appears in 1 contract
Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections section of the Agreement indicated below: Definition Section Agreement Recitals Alliance Managers 3.1(a) Applicant 7.5(b) Applicant Response 7.5(c)(ii) Baseline Net Sales 1.41 Biosimilar Application 7.5(a) BPCIA 7.5(a) Challenge Jurisdiction 5.3(e) Challenged Patent Rights 5.3(e) Challenge-Related Royalty Increase 5.3(e) Clawback Amount 5.3(e) Combination 1.48 Covered Results 6.3 Covers 5.3(c)(iii) [***] [***] Disclosing Party 1.12 Disclosure Letter 9.1(c) Dispute 11.12 Effective Date Recitals Immediate Patent Infringement Action 7.5(c)(v) Portions of this Agreement set forth opposite each Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the capitalized terms below: Securities Exchange Act of 1934, as amended. ImmunoGen Recitals ImmunoGen Indemnitees 10.1(a) ImmunoGen Proprietary Antibody 1.25 Indemnified Party 10.2 Indemnifying Party 10.2 Infringed Patent List 7.5(c)(v) Infringement 7.4(a) Infringement Notice 7.4(a) JDC 3.2(a) Lilly Recitals Lilly Indemnitees 10.1(b) Lilly Response 7.5(c)(iii) Losses 10.1(a) Material Breach 8.2(b) Monies 7.4(g) Negotiation Period 7.5(c)(v) Patent Committee 7.2(c)(i) Patent List 1.33 Party/Parties Recitals Permitted Third Party Service Providers 2.1(a) Post-Royalty Term Section Reference Acceptable Confidentiality Issued Patents 5.5(b) Pre-Market Notice 7.5(d)(ii) Proposed Biosimilar Product 7.5(a) Proposed Patent List 7.5(c)(i) Receiving Party 1.12 Reinstated License 5.5(b) Reinstated Royalty Term 5.5(b) Representatives 1.12 Royalty Restoration Date 5.5(b) Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Royalty Term 5.5 Safety Data Exchange Agreement Section 6.2(e)(iii3.4 [***] [***] Term 8.1(a) Acquisition Proposal Section 6.2(e)(iThird Party Claims 10.1(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iThird Party Payments 5.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseUpfront Fee 5.1 Wind-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cDown Period 8.3(a)
Appears in 1 contract
Samples: License Agreement (Immunogen Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i102 Amounts Section 2.8(d)(i) Agreement Preamble Alternative Acquisition Agreement Term Section 6.2(c)(iiReference Approval Section 3.5 Assignee Section 10.3 Capitalization Date Section 3.6(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCERCLA Section 3.20(c) Certificate of Merger Section 3.2 Section 2.3 Certificates Section 3.8(cSection 2.8(c) Change Section 1.1 Changes Section Section 1.1 Charter Documents Section 3.1 Closing Section 3.3 Section 2.2 Closing Date Section 3.3 COBRA Section 4.11(dSection 2.2 Code Section 2.8(f) Collective Bargaining Agreement Section 3.17(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Options Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Section 3.8 Company Securities Section 4.2(aSection 3.6(b) Company Shares Recitals Section 2.7(a)(i) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Compensation Schedule Section 5.1(b)(vii) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aSection 7.8 Certificates Section 2.8(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Section 2.2 Exchange Fund Section 3.8(bSection 2.8(b) Expiration Time Section 2.1(d)(iFCPA Section 3.19(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bSection 3.8(b) Recitals ICL Recitals Indemnified Persons Section 7.8(aSection 6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) IPL Section 3.14(g) ITA Section 2.8(f) Inventions Section Section 1.1 Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.12(b) Leases Section 3.12(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(cSection 3.11(a) Merger Recitals Term Section Reference Merger Consideration Section 3.7(a)(iSection 2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Proposal Section 7.4(a) Multiemployer Plan Section 4.11(c)Merger Sub Preamble OECD Convention Section 3.19(b) Option Consideration Section 2.7(c) Options Tax Ruling Section 7.9(a) Ordinary Share Section 2.7(a)(iii) Outside Date Section 9.1(c) Ordinary Shares Section 2.7(a)(i) Parent Preamble Patent Rights Section 1.1 Paying Agent Section 2.8(a) Payor Section 2.8(f) Permits Section 3.18 Primary Company Executives Section 3.16(h) Prohibited Payment Section 3.19(b) R&D Sponsor Section 3.14(i) Record ADS Holders Section 7.3(a) Registered Intellectual Property Section 3.14(a) Related Party Section 3.23 Reporting Tail Endorsement Section 6.1(b) Subsidiary Securities Section 3.7(d) Surviving Company Section 2.1
Appears in 1 contract
Samples: Agreement and Plan of Merger (Ultra Clean Holdings, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2016 Warrant 2.7(f)(ii) Acquisition Proposal Section 6.2(e)(i2016 Warrant Consideration 2.7(f)(ii) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 2.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Chosen Courts 9.9(b) Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.16(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 3.2(b) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 6.1(b) Company Financial Advisor Section 4.10 Advisors 3.21 Company Plans 6.9(c) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a3.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Competing Acquisition Transaction 8.3(b) Covered Securityholders 3.24 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.4(c) DGCL Recitals Disclosure Schedule Article III Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b)(i) Effective Time Section 3.2 2.2 Employment Compensation Arrangement 3.24 Enforceability Exceptions Section 4.4 3.2 Environmental Permits Section 4.15(b3.12(b) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i1.1(c)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFCPA 3.19 FDA Permits 3.17(b) Recitals Recitals Healthcare Laws 3.17(a) Indemnified Persons Section 7.8(a6.4(b) Indemnified Proceeding 6.4(b) Inventions Section 1.1 10.1 Know-How 10.1 Leased Real Property 3.13(b) Material Contract 3.15(a) Term Section 4.18(a) Reference Maximum Annual Premium Section 7.8(c6.4(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i1.1(a)(i) Multiemployer Plan Section 4.11(c)3.16(c) New Plans 6.9(c) Notice of Intended Recommendation Change 6.1(c) Offer Recitals Offer Documents 1.1(e)(i) Offer Price Recitals Offer to Purchase 1.1(a) Old Plans 6.9(c) Option Consideration 2.7(c) Parent Preamble Parent Common Stock 2.7(c) Payment Agent 2.8(a) Plans 3.16(a) Real Property Leases 3.13(b) Representatives 5.3(a) Restraint 7.1(b) Restricted Share Wage Consideration 2.7(g) RSU Consideration 2.7(d) Schedule 14D-9 1.2(a) Schedule TO 1.1(e)(i) Software 10.1 Solvent 4.10 Stock Award Exchange Ratio 2.7(c) Stockholder List Date 1.2(b) Surviving Corporation 2.1 Termination Date 8.1(b) Termination Fee 8.3(b) Trademarks 10.1 Uncertificated Shares 2.8(c) Works of Authorship 10.1
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 102 Amounts Section 2.8(d)(i) Alternative Transaction Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.3(a) Agreement Preamble Alternative Acquisition Agreement Anti-Kickback Statute Section 6.2(c)(ii3.20(h) Antiboycott Rules Approval Section 4.22(a3.4 BLA Section 3.20(b) Board Recommendation Capitalization Date Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii3.5(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.2 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.13(a) Collective Bargaining Agreement Section 3.16(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock 102 Options Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(a) Company Cure Period Section 9.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current 2.7(a)(i) Term Section Reference Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Company Subsidiary Section 3.6(a) Continuing Employees Section 6.2(a) D&O Insurance Section 7.8(c6.1(c) Customs Laws Divestiture Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a7.2(e)(i) Effective Time Section 3.2 Enforceability Exceptions 2.3 Electronic Data Room Section 4.4 Environmental Permits Section 4.15(b) 3.26 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i2.8(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.7(c) IAA Section 7.2(a) ICL Recitals Recitals IND Section 3.20(b) Indemnified Persons Section 7.8(a6.1(a) Inventions Information Agent Section 1.1 2.8(a) Interim Option Tax Ruling Section 7.9(a) ITA Section 2.13(a) Lease Section 3.11(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.10(a) Maximum Annual Premium Section 7.8(c6.1(c) Medicine Section 3.20(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Notification Section 2.1(a)(i7.2(a) Multiemployer Plan Merger Proposal Section 4.11(c7.4(a) Merger Sub Preamble NDA Section 3.20(b) Option Consideration Section 2.7(c) Option Tax Ruling Section 7.9(a) Outside Date Section 9.1(c) Parent Preamble Parent Cure Period Section 9.1(h) Paying Agent Agreement Section 2.8(a) Payor Section 2.13(a) Permits Section 3.17(a) Proxy Statement Section 7.3(a) R&D Sponsor Section 3.13(g) Recommendation Change Notice Section 5.3(b) Surviving Company Section 2.1 Tax Returns Section 3.14(a) Termination Fee Section 9.3(b) Uncertificated Shares Section 2.8(c) Voting Agreements Recitals Withholding Drop Date Section 2.13(b) Withholding Tax Ruling Section 7.9(b)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 6.12(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Restraint 6.5(d) Antiboycott Rules Section 4.22(aAntitrust Termination Date 8.1(d) Board Recommendation Section 2.2(bAssets 3.21 Assumed Option 6.11(d)(ii) Assumed RSA 6.11(c) Assumed RSU 6.11(b) Assumed Stock Appreciation Right 6.11(a)(ii) Cancelled Company Shares Section 3.7(a)(iiOption 6.11(d)(i) Cancelled SAR 6.11(a)(i) Cancelled RSU 6.11(b) Capitalization Representation 7.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.7(a)(i) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.19(a) Company Preamble Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Common Stock Recitals Company Disclosure Letter Article IV III Preamble Company LicenseForm 10-In K Article III Preamble Company IP Agreements Section 4.16(g3.22(e) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRegistered IP 3.22(b) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) D&O Insurance Section 7.8(c6.13(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.2 Exchange Fund 2.8(b) Export Controls 3.23(a) Import Restrictions 3.23(a) Incentive Plan 6.12(d) Indemnified Parties 6.13(a) Term Section 3.8(bReference Intervening Event 6.2(c)(ii) Expiration Time Section 2.1(d)(iLabor Organization 3.19(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bLeases 3.20(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Section 3.7(a)(iRecitals Merger Sub Preamble Normal Closing Due Date 2.3 Notice Period 6.2(c)(i) Minimum Condition Section 2.1(a)(iOption Consideration 6.11(d)(i) Multiemployer Plan Section 4.11(c)Parent Preamble Parent Specified Representations 7.3(a) Payment Agent 2.8(a) Permits 3.13 Proxy Statement 3.8 Real Property 3.20(b) Requisite Stockholder Approval 3.3(c) SEC Reports 3.6(a) Significant Customer 3.15(a) Significant Supplier 3.15(b) Specified Representations 7.2(a) Stock Appreciation Right Consideration 6.11(a)(i) Stub Bonus 6.12(d) Subsidiary Securities 3.2(d) Surviving Corporation 2.1 Tail Policy 6.13(b) Takeover Law 3.29(a) Tax Incentive 3.16(k) Termination Date 8.1(d) Termination Fee Amount 8.3(b)(i) Triggering Event 8.1(f)(ii) Uncertificated Shares 2.7(a)(i) Voting Agreement Recitals
Appears in 1 contract
Samples: Agreement and Plan of Merger (Microchip Technology Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term 2020 Indenture Section Reference Acceptable Confidentiality Agreement 6.12(a) 2020 Notes Section 6.2(e)(iii6.12(a) Acquisition Proposal 2021 Indenture Section 6.2(e)(i6.12(a) Acquisition Sub Preamble 2021 Notes Section 6.12(a) Adverse Recommendation Change Section 6.2(c)(i5.03(d)(i) Agreement Preamble Alternative Acquisition Agreement Anti-Bribery and Anti-Corruption Laws Section 6.2(c)(ii4.26 Available Cash Amount Section 2.02(k) Antiboycott Rules Bankruptcy and Equity Exception Section 4.22(a3.02 Book-Entry Shares Section 2.01(c) Board Recommendation Section 2.2(b) Cancelled BR Guarantor Recitals Canceled Company Shares Section 3.7(a)(ii2.01(b) Capital Stock Section 4.03(a) Capitalization Date Section 4.03(a) Certificate Section 2.01(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 1.02 Closing Section 3.3 1.03 Closing Date Section 3.3 COBRA Section 4.11(d) 1.03 76 Company Preamble Company Common Stock Recitals Benefit Plan Section 4.10(a) Company Board Recommendation Section 4.04 Company Disclosure Documents Section 4.07 Company Disclosure Letter Article ARTICLE IV Company License-In Agreements Financial Advisors Section 4.16(g4.23 Company Owned Property Section 4.17(a) Company License-Out Agreements Related Parties Section 4.16(h8.03(f) Company Financial Advisor SEC Documents Section 4.10 Company SEC Reports Section 4.7(a4.06(a) Company Securities Section 4.2(a4.03(a) Company Shares Recitals Stockholder Approval Section 4.04 Company Stockholder Meeting Section 4.04 Company Termination Fee Section 8.03(b) Confidentiality Agreement Agreements Section 10.4 Current Company D&O Insurance 6.02 Copyrights Section 7.8(c) Customs Laws 10.01 Debt Commitment Letters Section 4.22(a3.09(a) Debt Financing Dispute Section 10.9(a3.09(a) DGCL Recitals Discharge Section 6.12(c) Dissenting Company Shares Section 3.7(c)(i2.03(a) EAR DTC Section 4.22(a2.02(j) DTC Payment Section 2.02(j) Effective Time Section 3.2 Enforceability Exceptions 1.02 End Date Section 4.4 8.01(b)(i) Environmental Permits Law Section 4.15(b4.13 Equity Commitment Letter Section 3.09(a) Equity Financing Section 3.09(a) Exchange Fund Section 3.8(b2.02(b) Expiration Time Excluded Contract Section 2.1(d)(i4.14(b) Financial Statements Incipio Incipio Merger Agreement Filed Company Contract Section 4.7(b4.14(a) Filed Company SEC Documents ARTICLE IV Financing Section 3.09(a) Financing Commitments Section 3.09(a) GAAP Section 4.06(c) Governmental Approvals Section 6.18(a) Grant Date Section 4.03(c) Guarantee Recitals Guarantor Recitals Indemnified Persons Guarantors Recitals Indentures Section 7.8(a6.12(a) Inventions Inquiry Section 1.1 5.03(a)(i) International Benefit Plan Section 4.10(a) Investors Recitals IRS Section 4.10(b) Key Vendor Contracts Section 4.16(a) Key Vendors Section 4.16(a) 77 Lease Section 4.17(a) Leased Real Property Section 4.17(a) Legal Restraints Section 7.01(c) Letter of Transmittal Section 2.02(c) Material Contract Section 4.18(a4.14(b) Maximum Annual Premium Amount Section 7.8(c6.05(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.01(c) Minimum Condition Merger Sub Preamble Merger Sub Common Stock Section 2.1(a)(i2.01(a) Multiemployer Plan Non-Recourse Company Party Section 4.11(c9.10 Notes Section 6.12(a) Notice Period Section 5.03(d)(ii) Optional Redemption Section 6.12(b) Optional Redemption Notices Section 6.12(b) Parent Preamble Parent Disclosure Letter Article III Parent Related Parties Section 8.03(f) Parent Termination Fee Section 8.03(c) Patents Section 10.01 Paying Agent Section 2.02(a) Personal Information Section 4.20(a) Preferred Stock Section 4.03(a) Primary Debt Commitment Letter Section 3.09(a) Privacy Obligations Section 4.20(a) Proxy Statement Section 6.01(a) Real Property Section 4.17(a) Registered Intellectual Property Rights Section 4.18(a) Rental Contract Section 4.15(a) Representatives Section 5.03(a) Secondary Debt Commitment Letter Section 3.09(a) Solvent Section 3.10 Surviving Company Section 1.01 Systems Section 4.21(b) Trademarks Section 10.01 VRTO Guarantor Recitals WARN Act Section 4.19(d)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Rent a Center Inc De)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning specified in the respective sections Section of this Agreement set forth opposite each of the capitalized terms belowsuch term: Term Section Reference Acceptable Confidentiality Agreement 280G Stockholder Vote Section 6.2(e)(iii6.9(e) Acquisition Proposal Action Section 6.2(e)(i5.1(m) Acquisition Sub Acquirer Preamble Adverse Recommendation Change Acquirer 401(k) Plan Section 6.2(c)(i6.9(c) Acquirer Merger Recitals Acquirer Merger Surviving Company Section 2.7 Acquirer Reserve Percentage Section 3.1(d)(2) Acquirer SEC Filings Section 5.2(h) Aggregate Agreed Option Amount Section 3.2(c) Aggregate Cash Consideration Section 3.1(b)(5) Table of Contents Aggregate Non-Agreed Option Amount Section 3.2(c) Aggregate Option Amount Section 3.2(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Anticipated Closing Date Section 3.3 3.1(c)(1) Benefit Plans Section 5.1(u) Burdensome Condition Section 6.3(c)(2) Cash Per Share Consideration Section 3.1(b)(2) Cause Section 3.2(b) CECL Section 3.1(d)(1) Closing Section 2.3 Closing Date Section 2.3 Closing Tangible Book Value Section 3.1(c)(2) COBRA Section 4.11(d5.1(u)(5) Company Preamble Company Common Stock 401(k) Plan Section 6.9(c) Company Bank Recitals Company Disclosure Letter Article IV Company License-In Agreements FA Section 4.16(g) Company License-Out Agreements Section 4.16(h5.1(i) Company Financial Advisor Statements Section 4.10 Company SEC Reports Section 4.7(a5.1(j)(1) Company Securities Intellectual Property Section 4.2(a5.1(r)(1) Company Shares Recitals Confidentiality Meeting Section 5.1(e)(1) Company Related Person Section 5.1(gg) Company Regulatory Agreement Section 10.4 Current 5.1(o) Company D&O Insurance Reserve Percentage Section 7.8(c3.1(d)(2) Customs Laws Company Restricted Stock Section 4.22(a3.2(e) Debt Financing Dispute Company Stockholder Matters Section 10.9(a5.1(e)(1) Company Stockholder Option Amendment Section 3.2(a)(1) Confidential Information Section 6.8 Continuing Employee Section 6.9(a) Contribution and Business Plan Execution Recitals Conversion Recitals Conversion Price Section 3.2(b) Core Transactions Recitals DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.1 Disability Section 3.2(b) EAR Disclosure Schedule Section 4.22(a) 1.4 Effective Time Section 3.2 Enforceability Exceptions 2.2 ERISA Section 4.4 Environmental Permits 5.1(u) ERISA Affiliate Section 4.15(b5.1(u)(3) Estimated Closing Balance Sheet Section 3.1(c)(1) Evaluation Firm Section 3.1(d)(1) Exchange Fund Agent Section 3.8(b3.3(a) Expiration Time Exchangeable Shares Section 2.1(d)(i3.1(b)(4) Financial Statements Incipio Incipio Merger Agreement Extensions of Credit Section 4.7(b5.1(y)(1) Recitals Recitals Indemnified Persons Extension of Credit Buyer Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c5.1(dd)(2)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAdvisors 3.3(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAggregate Consideration 3.7(e) Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(d) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Articles of Merger 2.2 Audited Financial Statements 3.10(a) Audited Financials Date 3.10(a) Bylaws 3.1 Capitalization Date 3.7(a) Cash Replacement Company Shares Section Restricted Stock Amount 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) OTC Reports 3.9 Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRelated Parties 8.3(f)(i) Company Securities Section 4.2(a3.7(c) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cAgreements 9.4 Consent 3.6 Copyrights 1.1(vv) Customs Laws Section 4.22(aCovered Persons 6.9(a) COVID-19 1.1(x)(xi) COVID-19 Measures 1.1(x)(xi) Debt Commitment Letter 4.11(b) Debt Financing Dispute Section 10.9(a4.11(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(x) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) Event Notice Period 5.4(d)(i)(B)(2)(I) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i) FCC 3.6 FCC Consent 3.6 FCC Filings 3.6 Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.9(a) Financing 4.11(b) Financing Conditions 4.11(c) Financing Letters 4.11(b) Guarantor(s) Recitals Guaranty(ies) Recitals Indemnified Persons Section 7.8(aInjunction 8.1(b) Inventions Section 1.1 Material Contract Section 4.18(aInterim Period 5.1 Intervening Event 5.4(d)(i) KBCA Recitals Kentucky PSC Notification 3.6 Latest Financial Statements 3.10(a) Latest Financials Date 3.10(a) Lease 3.14(b) Leased Real Property 3.14(b) Maximum Annual Premium Section 7.8(c6.9(c) Marks 1.1(vv) Material Customers 1.1(bbb)(ii)(A) Material Vendors 1.1(bbb)(ii)(B) Merger Recitals Merger Sub Preamble Open Source Software 1.1(ccc) Organizational Documents 3.1 OTCQX Disclosure Guidelines 3.9 OTC Market 6.18 OTC Rules 3.9 Owned Company Shares 2.7(a)(iii) Owned Real Property 3.14(a) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party(ies) Preamble Patents 1.1(vv) Payment Agent 2.9(a) Per Share Price 2.7(a)(ii) Permits 3.20 Privacy Requirements 3.16(h) Prohibited Financing Modifications 6.5(b) Proposal Notice Period 5.4(d)(ii)(3) Protected Information 3.16(h) Proxy Statement 6.3(a) Reimbursement Obligations 6.6(b) Relinquishment Applications 3.6 Representatives 5.4(a) Required Amounts 4.11(f) Requisite Shareholder Approval 3.4 RSA Consideration Section 3.7(a)(i2.8(a)(i) Minimum Condition Section 2.1(a)(iSecurity Incident 3.16(h) Multiemployer Plan Section 4.11(cSpecified Acquisition 5.3 Support Agreements Recitals Surviving Corporation. 2.1 Tax Proceeding 3.17(c) Termination Date 8.1(c) Trade Control Laws 3.26(a)(i) Uncertificated Shares 2.9(c) Vested Shares 2.8(a)(i)
Appears in 1 contract
Samples: Agreement and Plan of Merger
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: below Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 2.14 Capitalization Date 2.14(a) Certificate of Incorporation 1.5 Certificate of Merger Section 3.2 1.2 Certificates Section 3.8(c1.8(c) Changes Section 1.1 Closing Section 3.3 1.3 Closing Date Section 3.3 COBRA Section 4.11(d1.3 Collective Bargaining Agreement 2.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 2.3 Company Board Recommendation Change 5.5(a) Company Disclosure Letter Schedule Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 II Company SEC Reports Section 4.7(a2.9 Company Securities 2.7(c) Company Securities Section 4.2(aStockholder Meeting 5.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 8.4 Consent 2.6 D&O Insurance Section 7.8(c5.10(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) Delaware Secretary of State 1.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(ashares 1.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b1.2 Employee Plans 2.18(a) Exchange ERISA Affiliate 2.18(a) Exchance Fund Section 3.8(b1.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Guarantor Reitals Indemnified Persons Section 7.8(a5.10(a) Inventions Section 1.1 Leased Real Property 2.15(b) Leases 2.15(b) Limited Gurantee Recitals Material Contract Section 4.18(a) 2.13 Maximum Annual Premium Section 7.8(c5.10(c) Merger Recitals REcitals Merger Sub Preamble New Plans 5.11(c) Old Plans 5.11(c) Option Consideration Section 3.7(a)(i1.7(d) Minimum Condition Section 2.1(a)(iOther Required Company Filing(s) Multiemployer Plan Section 4.11(c2.27 Owned Company Shares 1.7(a)(ii) Parent Preamble Payment Agent 1.8 Per Share Price 1.7(a)(i) Proxy Statement 2.27 Represenatives 4.3(a) Requisite Stock holder Approval 2.4 RSU Consideration 1.7(d) Surviving Corporation 1.1 Tax Returns 2.17(a) Termination Date 7.1(c) Uncertificated Shares 1.8(c)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Double-Take Software, Inc.)
Additional Definitions. The For purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto specified in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Antitrust Laws Section 6.2(c)(ii5.5(a) Antiboycott Rules 8 Term Section 4.22(aReference Antitrust Matters Section 5.5(b) Board Recommendation Assets Section 2.2(b3.18 Assumed RSU Section 2.11(d) Book-Entry Shares Section 2.9(d) Cancelled Company Shares RSU Section 3.7(a)(ii2.11(d) Cancelled Stock Option Section 2.11(b) Cash Consideration Section 2.9(a) Certificate Section 2.9(d) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(c) Company Disclosure Letter Schedule Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.19(c) Company License-Out Agreements Products Section 4.16(h3.19(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.6 Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholders Meeting Section 5.2(e) Company Stockholder Meeting Proposals Section 5.2(a) Company Subsidiary Securities Section 3.2(c) Confidentiality Agreement Section 10.4 5.4(d) Consent Section 3.5(b) Consent Solicitation Section 5.16(a) Current Company D&O Insurance Option Section 7.8(c2.11(b) Customs Laws Current Policy Coverage Section 4.22(a5.9(b) Current Restricted Share Section 2.11(c) Current RSU Section 2.11(d) Debt Financing Dispute Offer Section 10.9(a5.16(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 2.12 Effective Time Section 3.2 Enforceability Exceptions 2.2 Employee Plans Section 4.4 Environmental Permits 3.15(a) ERISA Affiliate Section 4.15(b3.15(a) ESPP Section 2.11(h) Exchange Agent Section 2.10(a) Exchange Fund Section 3.8(b2.10(a) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a5.9(a) Inventions International Employee Plans Section 1.1 3.15(a) Intervening Event Section 5.3(e) Leased Real Property Section 3.17(b). Leases Section 3.17(b) Lenders Section 8.9(b) Term Section Reference Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.10(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.9(a) Minimum Condition Merger Proposal Section 2.1(a)(i5.2(e) Multiemployer Plan Merger-Related Proposals Section 4.11(c)5.2(e) Merger Sub Preamble Open source Section 3.19(j) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.17(a) Parent Preamble Parent Disclosure Schedule Article IV Parent Plans Section 5.7(b) Parent Form 10-K Article IV Parent SEC Reports Section 4.6 Parent Securities Section 4.4(c) Parent Subsidiary Securities Section 4.2(c) Permits Section 3.11(a) Potential Financing Section 5.16(b) Potential Financing Sources Section 5.16(b) Proxy Statement/Prospectus Section 5.2(a) Qualifying Amendment Section 5.2(c) Registration Statement Section 5.2(a) Regulation M-A Filing Section 5.2(d) Requisite Stockholder Approval Section 3.22
Appears in 1 contract
Samples: Agreement and Plan of Merger (Conexant Systems Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Action 10.9 Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aAlternative Financing 6.2(c) Board Recommendation Section 2.2(bAlternative Financing Documents 6.2(c) Cancelled Available Company Shares Section 3.7(a)(iiCash Financing 6.2(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.8(c) Change 1.1 Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Recitals Benefit Plans 3.14(a) Company Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aShareholders Meeting 7.3(d) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 3.6 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.10(a) Debt Financing 4.10(a) Dispute 10.9 Dissenting Shareholder 2.7(c) Dissenting Shares 2.7(c) Term Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Reference Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 Equity Commitment Letters 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFacility Agreement 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFCPA 1.1 Fee Letter 4.10(a) Recitals Financing 4.10(a) Financing Commitments 4.10(a) HKIAC 10.9 HKIAC Rules 10.9 Holdco Recitals Indemnified Persons Section 7.8(a6.1(a) Inventions Section 1.1 Leased Real Property 3.15(b) Limited Guarantee Recitals Material Contract Section 4.18(aContracts 3.12(a) Maximum Annual Premium Section 7.8(c6.1(c) Measurement Date 3.7(a) Merger Recitals Merger Sub Preamble Negotiation Period 5.3(c) Operating Subsidiary 1.1 Outside Date 9.1(b) Parent Preamble Paying Agent 2.8(a) Per ADS Merger Consideration Section 3.7(a)(i2.7(a)(ii) Minimum Condition Section 2.1(a)(iPer Share Merger Consideration 2.7(a)(ii) Multiemployer Permits 3.15 Plan Section 4.11(cof Merger Recitals Proxy Statement 7.3(a) Real Property Leases 3.15(b) Recommendation Change Notice 5.3(c) Registrar of Companies 2.3 Rollover Shareholders Recitals Rollover Shares Recitals Shareholder Approval 3.4 Schedule 13E-3 3.6 Special Committee Recitals Sponsor 4.10(a) Subsidiary Securities 3.8(c) Support Agreement Recitals Surviving Corporation 2.1 Takeover Statute 3.23 Tax Returns 3.16(b) Trade Secrets 1.1 Uncertificated Shares 2.8(c)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDebt Financing 5.6(b)(ii) Antiboycott Rules Section 4.22(aBreach Cure Period 7.1(g) Board Recommendation Section 2.2(bBreach Termination Date 7.1(g) Cancelled Company Shares Section 3.7(a)(iiCertificate of Incorporation 1.5(a) Certificate of Merger Section 3.2 1.2 Certificates Section 3.8(c1.8(c) Changes Section 1.1 Chancery Court 8.10 Closing Section 3.3 1.3 Closing Date Section 3.3 COBRA Section 4.11(d1.3 Collective Bargaining Agreement 2.18(a) 88 Communications Act 2.6 Company Preamble Company Common Stock Recitals Board Recommendation 2.3 Company Board Recommendation Change 4.3(a) Company Disclosure Letter Schedule Article IV II Company License-In Agreements Section 4.16(gParties 7.3(e)(i) Company License-Out Agreements Section 4.16(hPermits 2.20 Company Restricted Share 1.7(d)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a2.9 Company Securities 2.7(c) Company Securities Section 4.2(aStockholder Meeting 5.4(a) Company Shares Recitals Systems 2.16(c) Confidentiality Agreement Section 10.4 Current Company 8.4 Consent 2.6 Continuation Period 5.11(b) Continuing Plans 5.11(a) D&O Insurance Section 7.8(c5.10(c) Customs Laws Section 4.22(aDebt Commitment Letter 3.10(b) Debt Financing Dispute Section 10.9(a3.10(b) Delaware Secretary of State 1.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a1.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b1.2 Employee Plans 2.18(a) Employment Laws 2.19(b) Equity Financing 3.10(b) Equity Financing Letter 3.10(b) Equity Financing Sources 3.10(b) ERISA Affiliate 2.18(b) Exchange Fund Section 3.8(b1.8(b) Expiration Time Section 2.1(d)(iFCC 2.6 FCC Approvals 2.6 Federal Communications Laws 2.26(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 3.10(b) Financing 3.10(b) Financing Letters 3.10(b) Franchise 2.6 Guarantee Recitals Guarantors Recitals Indemnified Persons Section 7.8(a5.10(a) Inventions Section 1.1 Leased Real Property 2.15(b) Leases 2.15(b) LFA 2.6 LFA Approvals 2.6 Material Contract Section 4.18(a2.13(a) Maximum Annual Premium Section 7.8(c5.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letter 5.6(b)(ii) New Plans 5.11(c) Notice Period 3.4(d)(i) Old Plans 5.11(c) Option Consideration Section 3.7(a)(i1.7(d)(ii) Minimum Condition Section 2.1(a)(iOther Required Company Filing(s) Multiemployer Plan Section 4.11(c2.30 Owned Company Shares 1.7(a)(ii) Parent Preamble Parent Expenses 7.3(b)(ii) Parent Material Adverse Effect 3.1 Parent Parties 7.3(e)(ii) Payment Agent 1.8(a) Per Share Price 1.7(a)(i) Proxy Statement 2.30 Record Date 5.4(b) Required Information 5.6(b)(v)(A) Requisite Stockholder Approval 2.4 Rights 2.31 Rights Agreement 2.31 Rule 13a-15 2.10(b) Second Request 5.2(c) State Communications Laws 2.26(a) State PUC 2.6 State PUC Approvals 2.6 Subscribers 2.32 Subsidiary Securities 2.7(c) Surviving Corporation 1.1 Tax Returns 2.17(a) Termination Date 7.1(c) Transaction Committee Recitals Transaction Litigation 5.16 Uncertificated Shares 1.8(c) Warrant Consideration 1.7(d)(iii)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto defined in the respective sections of this Agreement set forth opposite each of the capitalized terms belowSection indicated: Defined Term Section Reference Acceptable Confidentiality Agreement ------------ ----------------- Accountants' Statement Section 6.2(e)(iii15.2 Accounting Principles Section 15.2(a) Acquisition Cost Section 19.1(b) Acquisition Proposal Section 6.2(e)(i14.2(b) Acquisition Sub Preamble Adverse Recommendation Change Transaction Section 6.2(c)(i19.1(a) Advantaged Party Section 20.3(c) Affected Party Section 23.6(a) Agreement Preamble Alternative Acquisition Agreement Applicable Notice Annex 2 Appraiser Annex 2 Asserted Liability Section 6.2(c)(ii25.6(a) Antiboycott Rules Assumed AT&T Liabilities Section 4.22(a15.1(b)(i) Board Recommendation Assumed BT Liabilities Section 2.2(b15.1(b)(ii) Cancelled Company Assumed Concert Purchase Debt Section 15.5(b) Assumed Liabilities Section 15.1(b)(ii) AT&T Preamble AT&T Assets Section 15.3(a)(i) AT&T GCS Business Financials Section 17.1(h) AT&T GCS Business MAE Section 17.1(e)(ii) AT&T Guarantees Section 15.3(d) AT&T Indemnified Parties Section 25.3 AT&T Initial Valuation Section 15.2(a) AT&T Leases Section 17.1(j)(i) AT&T Minimum Contribution Section 15.4(a) AT&T Parties Preamble AT&T Property Assets Section 17.1(j)(i) AT&T Specified Contracts Section 17.1(n)(i) Bankrupt Parent Section 27.1(a) Breach Notice Section 23.5(b) breaching party Section 23.4(a) BT Preamble BT Assets Section 15.3(a)(ii) BT GCS Business Financials Section 17.2(h) BT GCS Business MAE Section 17.2(e)(ii) BT Guarantees Section 15.3(e) BT Holdings Preamble BT Indemnified Parties Section 25.2 BT Initial Valuation Section 15.2(a) BT Leases Section 17.2(j)(i) BT Minimum Contribution Section 15.4(a) BT Parties Preamble BT Property Assets Section 17.2(j)(i) BT Specified Contracts Section 17.2(n)(i) Burdensome Condition Section 18.4(a) Business Unit Information Section 6.7(a)(i) Call Section 23.4(a) Call Shares Section 3.7(a)(ii23.4(a) Certificate of Merger Cap Section 3.2 Certificates 15.5(b) Capital Call Section 3.8(c16.2(a) Changes Capital Call Date Section 1.1 16.3 Capital Call Notice Section 16.3 Claim Section 24.3(a) Claims Notice Section 25.6(a) Closing Section 3.3 20.1(a) Closing Date Section 3.3 COBRA 20.1(a) College of Wise Counselors Section 4.11(d24.1(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In complying party Section 23.4(a) Concert Financials Section 17.2(h)(ii) Concert Holdings Section 15.5(a) Confidentiality Agreements Section 4.16(g18.10(a) Consumer Price Index Section 11.16 ConsumerCo Section 1.7 Contracts Annex 1 Covered Investor Breach Section 22.3(f) Covered Transaction Section 23.6(a) deadlock Section 6.3(a) Defaulting Shareholder Section 16.4(a) Designated Accountants Section 15.4(b) Disadvantaged Party Section 20.3(c) Distribution of Netco Section 13.2(b) District Court Section 24.3(a) Effective Date Section 23.6(a) Election Notice Section 23.4(a) Employee Matters Agreement Section 18.8(c) engaging party Section 19.3(b) EU Merger Regulations Section 18.3 Event of Default Section 22.3 fair market value Annex 2 Farland Section 11.18(a) Farland Equity Stake Section 11.18(b) Fiduciary Duty Standard Section 11.2(b) Fiscal Year Section 6.5 Funding Breach Section 16.4(a) GBCS Alliance Section 11.5(a) Group Companies Section 11.1 Indemnifying Party Section 25.6(a) Indemnitee Section 25.6(a) Indemnity Payment Section 25.8(c) Independent Auditor Section 6.8 Initial Contributed Assets Section 15.1(a) Initial Valuations Section 15.2(a) Investment Fund Agreement Section 18.8(a) Key Employee Annex 1 Key Governmental Approvals Section 18.4(a) Leverage Ratio Section 6.4(a) Losses Section 25.2 Management Board Valuation Section 15.2 Master Outsourcing Agreement Section 7.3(d) Material Acquisition Transaction Section 19.3(a) MCI-WorldCom Distribution Agreement Section 9.2(b) Minimum Contribution Section 15.4(a) New Assets Section 19.1(a) Newco Subsidiaries Recital B Non-Bankrupt Parent Section 27.1(a) Non-Competition Undertakings Section 11.2(a) Non-Defaulting Shareholder Section 16.4(a) non-engaging party Section 19.3(b) Non-Indemnifying Party Section 25.5(e) non-subject party Section 23.3(b) Other Parent Section 13.2(a) Other Party Annex 2 Peering Arrangements Section 2.1(g) Performance Notice Section 23.2(a) Post-Closing Tax Benefit Section 25.5(a) preferred supplier Section 10.1(b) Preferred Supplier Section 10.1(b) Pro Rata Basis Section 11.4(b) Proposing Party Annex 2 Provisional AOPB Section 6.3(a) Purchased Shares Section 15.5(b) Purchaser Section 10.1(b) Put Section 23.3(b) Put Notice Section 23.3(b) Put Shares Section 23.3(b) Qualified Holding Company License-Out Agreements Section 4.16(h5.5 Recipient Section 18.10(b) Company Financial Advisor Reduction Section 4.10 Company SEC Reports 20.3(b) Retail Price Index Section 4.7(a11.16 Revenue Limitation Section 11.4(b) Company RTP Acts Section 28.1(b) Special Efforts Section 11.2(a) Specified Entity Section 11.2(a) Specified Person Section 11.2(a) subject party Section 23.3(b) target parent Section 14.2(a) Tax Distribution Schedule 6.9 Tax Indemnifying Party Section 25.5(e) Tax Proceeding Section 25.5(e) Term Sheet Section 17.1(r)(vi) Third Party Supplier Section 10.1(b) Thistle BV Preamble Transfer Section 12.1(a) Transition Period Section 23.2(b) Transition Plan Section 18.8(e) Triggering Person Section 13.1 Triggering Transaction Section 13.1 Venture Business Material Adverse Effect Section 17.1(a) VLT Preamble Voting Securities Section 4.2(a14.1(a) Company Shares Recitals Confidentiality Agreement WIP Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c15.4(a)
Appears in 1 contract
Samples: Framework Agreement (At&t Corp)
Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections section of the Agreement indicated below: Definition Section Agreement Recitals Alliance Managers 3.1(a) Applicant 7.5(b) Applicant Response 7.5(c)(ii) Baseline Net Sales 1.41 Biosimilar Application 7.5(a) BPCIA 7.5(a) Challenge Jurisdiction 5.3(e) Challenged Patent Rights 5.3(e) Challenge-Related Royalty Increase 5.3(e) Clawback Amount 5.3(e) Combination 1.48 Covered Results 6.3 Covers 5.3(c)(iii) [***] [***] Disclosing Party 1.12 Disclosure Letter 9.1(c) Dispute 11.12 Effective Date Recitals Immediate Patent Infringement Action 7.5(c)(v) Portions of this Agreement set forth opposite each Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the capitalized terms below: Securities Exchange Act of 1934, as amended. CONFIDENTIAL TREATMENT REQUESTED ImmunoGen Recitals ImmunoGen Indemnitees 10.1(a) ImmunoGen Proprietary Antibody 1.25 Indemnified Party 10.2 Indemnifying Party 10.2 Infringed Patent List 7.5(c)(v) Infringement 7.4(a) Infringement Notice 7.4(a) JDC 3.2(a) Lilly Recitals Lilly Indemnitees 10.1(b) Lilly Response 7.5(c)(iii) Losses 10.1(a) Material Breach 8.2(b) Monies 7.4(g) Negotiation Period 7.5(c)(v) Patent Committee 7.2(c)(i) Patent List 1.33 Party/Parties Recitals Permitted Third Party Service Providers 2.1(a) Post-Royalty Term Section Reference Acceptable Confidentiality Issued Patents 5.5(b) Pre-Market Notice 7.5(d)(ii) Proposed Biosimilar Product 7.5(a) Proposed Patent List 7.5(c)(i) Receiving Party 1.12 Reinstated License 5.5(b) Reinstated Royalty Term 5.5(b) Representatives 1.12 Royalty Restoration Date 5.5(b) Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. CONFIDENTIAL TREATMENT REQUESTED Royalty Term 5.5 Safety Data Exchange Agreement Section 6.2(e)(iii3.4 [***] [***] Term 8.1(a) Acquisition Proposal Section 6.2(e)(iThird Party Claims 10.1(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iThird Party Payments 5.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseUpfront Fee 5.1 Wind-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cDown Period 8.3(a)
Appears in 1 contract
Additional Definitions. The In addition to those terms defined in Section 1.01, the following capitalized terms shall have the respective meanings ascribed thereto meaning set forth in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Period 3.06(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Division 7.05(b) Antiboycott Rules Section 4.22(aArbitrator 3.06(d) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Balance Sheet Date 4.07 Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.03 Closing Section 3.3 2.02 Closing Date Section 3.3 COBRA Section 4.11(d2.02 Closing Indebtedness 3.06(a) Closing Net Working Capital 3.06(a) Closing Payments 3.03 Company Preamble Company Common Stock 401(k) Plan 7.08 Company Benefit Plans 4.18(b) Company Closing Deliverables 3.04(b) Company Shareholder Agreement Recitals Company Disclosure Letter Article IV Shareholder Consent Recitals Company License-In Agreements Section 4.16(gStock Option 3.01(c) Company License-Out Agreements Section 4.16(hTransaction Expense Direction Notice 6.03 Continuing Employees 6.04(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Copyrights 1.01 Current Company D&O Insurance Section 7.8(c) Customs Laws Section Representation 10.14 Customer 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aDisputed Items 3.06(d) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 2.03 Environmental Laws 4.19(a) Environmental Permits Section 4.15(b4.19(c) Exchange Fund Section 3.8(bERISA Affiliate 4.18(g) Expiration Time Section 2.1(d)(iEstimated Closing Cash Amount 3.02 Estimated Closing Indebtedness 3.02 Estimated Closing Net Working Capital 3.02 Estimated Company Transaction Expenses 3.02 FTC 7.05(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bHazardous Material 4.19(a) Recitals Recitals Indemnified Persons Section 7.8(aHSR Act 4.05(a) Inventions Section 1.1 Insurance Policies 4.21 Law 4.05(b) Leased Real Property 4.10 Table of Contents Leases 4.10 Licensed Intellectual Property 4.11(b) Marks 1.01 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.12(a) Merger Recitals Merger Consideration Sub Preamble Notice of Objection 3.06(c) Outside Date 9.01(c) Owned Intellectual Property 4.11(a) Parent Preamble Continuing Employees 6.04(b) Parent Closing Deliverables 3.04(a) Parent DC Plan 7.08 Patents 1.01 Post-Closing Representation 10.14 Post-Closing Statement 3.06(a) Pre-Closing Statement 3.02 Registered Intellectual Property 4.11(a) Section 3.7(a)(i280G Waived Payments 6.05(a) Minimum Condition Section 2.1(a)(iShareholder Group 10.14 Shareholders’ Representative Preamble Surviving Corporation 2.01 Transfer Taxes 7.02(a) Multiemployer Plan Section 4.11(c)Waiving Parties 10.14
Appears in 1 contract
Samples: Agreement and Plan of Merger (Innophos Holdings, Inc.)
Additional Definitions. The For purposes of this Agreement, the following capitalized terms terms, when used in this Agreement, shall have the respective meanings ascribed thereto assigned to them in the respective sections of this Agreement set forth opposite each of the capitalized terms belowidentified Section: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAggregate Merger Consideration 3.1(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAntitrust Condition 8.1(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.3 Closing Section 3.3 2.2 Closing Date 2.2 Term Section 3.3 COBRA Section 4.11(dCode 3.2(g) Collective Bargaining Agreement 4.9 Company Preamble Company Closing Price 3.3(a)(ii) Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gContracts 4.12(a) Company License-Out Agreements Section 4.16(hIndemnitees 6.7(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aLeases 4.4(b) Company Securities Section 4.2(aMultiemployer Plans 4.10(a)(ii) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stockholder Approval 4.2(a)(ii) Company D&O Insurance Section 7.8(cStockholders Meeting 6.4(a) Customs Laws Section 4.22(aCompany Tenant Lease 4.4(b) Company Title IV Plan 4.10(d) Consent Solicitation 6.11(a) Continuing Employees 6.14(a) Debt Financing Dispute Section 10.9(aTender Offer 6.11(a) DGCL Recitals Dissenting Company 2.1 Discharge 6.11(b) Dissent Shares Section 3.7(c)(i3.1(d) EAR Section 4.22(aDissenters’ Rights Statute 3.1(d) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 ERISA 1.1 Exchange Agent 3.2(a) Exchange Fund Section 3.8(bExtension Termination Fee 8.2(f) Expiration Time Section 2.1(d)(iFinancing 6.5(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Commitments 5.17 Form S-4 6.10(a) Recitals Recitals Indemnified Persons Section 7.8(aIndenture 6.11(a) Inventions Section 1.1 Material Contract Section 4.18(aIRS 4.10(a)(iii) Maximum Annual Premium Section 7.8(cJoint Proxy Statement 6.10(a) Merger Recitals Merger Sub Preamble MGCL 4.20 Nine-Month Termination Fee 8.2(d) Notice of Adverse Change 6.3(c) One-Year Termination Fee 8.2(e) Option Exchange Ratio 3.3(a)(iii) Outside Date 8.1(b)(i) Owned Real Property 4.4(a) Parent Preamble Parent Multiemployer Plans 5.10(b) Parent Stockholder Approval 5.2(a) Parent Stockholders Meeting 6.4(b) Parent Title IV Plan 5.10(c) PBGC 4.10(d) Per Share Cash Consideration 3.1(c) Per Share Merger Consideration 3.1(c) Per Share Stock Consideration 3.1(c) Permanent Restraint 8.1(b)(iv) Term Section 3.7(a)(iPre-Amendment Option 3.3(a)(iii) Minimum Condition Section 2.1(a)(iReal Property 4.4(c) Multiemployer Plan Section 4.11(cRequired Information 6.5(b)(v) Restraints 7.1(c) Share Issuance 5.2(a) Stock Option 3.3(a)(i) Surviving Corporation 2.1 Voting Debt 4.3(a)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Great Atlantic & Pacific Tea Co Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement 102 Amounts Section 6.2(e)(iii2.8(d)(i) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Agreement Preamble Approval Section 4.22(a3.5 Assignee Section 10.3 Capitalization Date Section 3.6(a) Board Recommendation CERCLA Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii3.20(c) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.8(f) Collective Bargaining Agreement Section 3.17(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Options Section 2.8(d)(i) Term Section Reference Company 100 XXXx Section 2.8(d)(i) Company 102 Securities Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Section 5.3(a) Company Board Recommendation Change Section 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Plans Section 4.16(g6.2(c) Company License-Out Agreements Products Section 4.16(h3.14(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.8 Company Securities Section 4.2(a3.6(b) Company Shares Recitals Section 2.7(a)(i) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Company Warrant Section 4.7 Confidentiality Agreement Section 10.4 Current Company 7.8 Certificates Section 2.8(c) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a6.1(c) Effective Time Section 3.2 Enforceability Exceptions 2.2 Employee Plans Section 4.4 Environmental Permits 3.16(a) ERISA Affiliate Section 4.15(b3.16(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time FCPA Section 2.1(d)(i3.19(b) FDA Section 3.19(h) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.8(d) Recitals Funded International Employee Plan Section 3.16(i) Good Clinical Practices Section 3.19(k) Good Laboratory Practices Section 3.19(k) Healthcare Laws Section 3.19(c) IAA Section 7.2(a) ICL Recitals Indemnified Persons Section 7.8(a6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) IPL Section 3.14(h) Israeli Employees Section 3.17(d) ITA Section 2.8(f) Inventions Section 1.1 Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.12(b) Leases Section 3.12(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Material Employee Plans Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c3.16(a)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2023 Bonus Plan 7.9(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bAntitrust Clearance Condition Annex A Balance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) Cash Amount Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c3.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.23 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.2(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Covered Entity 4.20(j) CVR Recitals CVR Agreement Recitals D&O Insurance Section 7.8(cIndemnified Party 7.8(a) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aData 1.1 Depository Agent 3.8(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect 1.1 Effective Time Section 3.2 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Existing Payment Period 3.7(h) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFDCA 4.20(a) Recitals Recitals Indemnified Persons Section 7.8(aForeign Antitrust Laws 4.6 French Tax Code 10.14 GDPR 1.1 Internet Properties 1.1 Inventions 1.1 Leased Real Property 4.18(b) Inventions Section 1.1 Material Contract Section 4.18(a4.19(a) Maximum Annual Premium Section 7.8(cMedical Device 4.20(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Milestone Option Amount 3.7(d)(ii) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) No Antitrust Proceedings Condition Annex A No Legal Restraint Condition Annex A Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Owned Real Property 4.18(a) Parent Preamble Paying Agent 3.8(a) Proprietary Information 1.1 PSU Consideration 3.7(f) Real Property 4.18(a) Real Property Leases 4.18(b) Regulatory Permits 4.20(i) Remedy Action 7.2(a) Rights Agent Recitals RSU Consideration 3.7(e) Schedule TO 2.1(f)(i) Schedule 14D-9 2.2(a) Social Security Act 4.20(e) Subsidiary Securities 4.2(e) Surviving Corporation. 3.1 Termination Condition Annex A Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c)(ii) Works of Authorship 1.1
Appears in 1 contract
Additional Definitions. The following capitalized terms defined elsewhere in this Agreement shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms belowtherein defined: Term Acquisition Recitals Adjusted Closing Cash Consideration Section Reference Acceptable Confidentiality Agreement 2.1(c) Adjusted Closing Stock Consideration Section 6.2(e)(iii2.1(c) Acquisition Proposal Aggregate Consideration Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.1(b) Agreement Preamble Alternative Acquisition Agreement Auditor Section 6.2(c)(ii2.4(b) Antiboycott Rules BD Filings Section 4.22(a5.11(d) Board Recommendation Capitalization Rep Section 2.2(b10.1(a)(iii) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 3.1 Closing Date Section 3.3 3.1 COBRA Section 4.11(d5.14(d) Companies Preamble Companies Closing Certificate Section 9.3(e) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Plan Section 4.16(g5.14(a) Companies Specified Representations Section 10.4(a) Company License401(k) Plan Section 8.6(d) Continuing Employee Section 8.6(b) Continuation Period Section 8.6(b) CP Advisory Revenue Target Section 2.5(a) CP CS Preamble CP LP Preamble CPE Preamble Current Representation Section 8.3(c) D&O Indemnitees Section 8.9(a) De Minimis Amount Section 10.4(c) Deductible Section 10.4(c) Designated Person Section 8.3(c) Earn-Out Agreements Objection Section 4.16(h2.5(b) Earn-Out Payment Section 2.5(a) Earn-Out Statement Section 2.5(b) Escrow Agent Section 2.3 Escrow Agreement Section 2.3 Escrow Amount Section 2.3 Escrow Cash Amount Section 2.3 Escrow Stock Amount Section 2.3 Expense Reserve Section 2.7(f) FCA Condition Section 9.1(e) Final Closing Balance Sheet Section 2.4(c) Final Post-Closing Adjustment Section 2.4(c) Financial Statements Section 5.6(a) First Earn-Out Period Section 2.5(a) HSR Act Section 5.5(b) Indemnitee Section 10.3(a) Indemnitor Section 10.3(a) Indemnity Reserve Amount Section 10.5(b) IRS Section 2.9(a) Late Paid Receivables Section 2.4(g) Licensed Company Financial Advisor Intellectual Property Section 4.10 5.19(b) Limited Recourse Losses Section 10.4(g) Lock-Up Period Section 2.6 Losses Section 10.1(c) Material Contracts Section 5.20(a) Material Permits Section 5.10(c) Notice Section 10.3(a) Objection Notice Section 2.4(b) Outside Pool Amount Section 10.4(g) Owned Company Intellectual Property Section 5.19(a) Parties Recitals Party Recitals Pending Claim Section 10.5(a) Policies Section 5.21(a) Post-Closing Representation Section 8.3(c) Proposed Closing Balance Sheet Section 2.4(a) Proposed Net Working Capital Adjustment Amount Section 2.4(a) Purchaser Preamble Purchaser 401(k) Plan Section 8.6(d) Purchaser Closing Certificate Section 9.2(d) Purchaser Indemnitees Section 10.1(a) Purchaser Limit Section 10.4(f) Purchaser SEC Reports Documents Section 6.4(a) Purchaser Specified Representations Section 10.4(a) Real Property Leases Section 5.12(a) Reference Date Section 5.7 Resignations Section 3.2(b) Second Earn-Out Period Section 2.5(a) Securities Act Section 4.7(a) Company Securities Seller Preamble Seller Indemnitees Section 4.2(a10.2(a) Company Shares Seller Representative Preamble Seller Specified Representations Section 10.4(a) Sellers Preamble Signing Date Non-Compete Agreements Recitals Confidentiality Agreement Specified Representations Section 10.4 Current Company D&O Insurance 10.4(a) Stock Price Section 7.8(c2.4(f) Customs Laws Sub-Account Section 4.22(a10.4(g) Debt Financing Dispute Sub-Deductible Section 10.9(a10.4(c) DGCL Recitals Dissenting Company Shares Survival Period Section 3.7(c)(i10.4(a) EAR Surviving Claims Section 4.22(a10.4(a) Effective Time Termination Date Section 3.2 Enforceability Exceptions 11.1(b) Third Party Claim Section 4.4 Environmental Permits 10.3(a) Transaction Consideration Disbursement Schedule Section 4.15(b2.1(a) Exchange Fund Transfer Section 3.8(b2.6 11 Transfer Taxes Section 8.8(g) Expiration Time Units Preamble Warranty Breach Section 2.1(d)(i10.4(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)ARTICLE II
Appears in 1 contract
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each indicated below: [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the capitalized terms below: Term Securities Exchange Act of 1934, as amended. Act Section Reference Acceptable 3.d.i. of Exhibit B Agreement Preamble Auditor Section 3.5.2 Bankruptcy Code Section 2.3.1 BPCIA Section 3.d.ii. of Exhibit B Canakinumab CV Indication Non-Exclusive License Section 2.1.1 Canakinumab Exclusive License Section 2.5 Canakinumab Exclusive License Effective Date Section 2.5 Canakinumab Non-CV Indication Non-Exclusive License Section 2.1.1 Claims Section 7.1 Competing Infringing Activities Section 3.f. of Exhibit B Competing Program Section 4.b. of Exhibit B Confidential Information Section 5.1 CV Indication Recovery Section 3.g. of Exhibit B [*] Section [*] Disclosing Party Section 5.1 [*] Section [*] Effective Date Preamble Exclusive Negotiation Period Section 2.4 Exclusive Option Section 2.5 Existing Confidentiality Agreement Section 6.2(e)(iii5.1 Future IP Section 4.1.2 HSR Filing Section 2.5 IL-1 License Section 2.1.1 Indemnified Party Section 7.3.1 Indemnifying Party Section 7.3.1 Losses Section 7.1 Novartis Preamble Novartis Indemnitees Section 7.2 Novartis Interest Notice Section 2.5 Parties Preamble Party Preamble Payment Breach Section 8.2 Product Marks Section 4.5 Receiving party Section 5.1 Rights Definition of ‘Control’ in ARTICLE I ROFN Notice Section 2.4 Royalty Term Section 3.3.2(a) Acquisition Proposal Sales & Royalty Report Section 6.2(e)(i) Acquisition Sub 3.3.2 [*] Section [*] Selling Party Definition of ‘Net Sales’ in ARTICLE I Servier Definition of ‘Servier Loan’ in ARTICLE I [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Term Section 8.1 [*] Section [*] Trade Control Laws Section 10.6 XOMA Preamble Adverse Recommendation Change XOMA Indemnitees Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement 7.1 [*] Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In [*] XOMA Third Party Agreements Section 4.16(g3.2.2(c) Company License-Out Agreements XOMA Third Party Obligations Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c3.2.2(c)
Appears in 1 contract
Samples: Target License Agreement (XOMA Corp)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section Reference Acceptable Confidentiality 10.7 [**] Section 8.6(b)(iii) Accounting Standards Exhibit D Acquirer Program Section 8.6(b)(v)(D) Additional Revenue Exhibit D DEFINITION SECTION Additional Study Section 3.3 Additional Study Approval Section 3.3(c) Advertising and Market Research Expenses Exhibit D Affiliate Master Agreement Agios Preamble Agios Clinical-Scale Manufacturing Responsibilities Section 6.2(e)(iii4.1(a) Acquisition Proposal Agios Commercial-Scale Manufacturing Responsibilities Section 6.2(e)(i4.1(a) Acquisition Sub Agios Indemnified Parties Section 13.1(a) Agios Opt-Out Notice Section 2.3(a) Agios Opt-Out Date Section 2.3(b) Agios Pharmaceuticals Preamble Adverse Recommendation Change Agios Program Assets Section 6.2(c)(i) 12.4 Agreement Preamble Alternative Acquisition Annual Net Sales Exhibit D Antitrust Law Master Agreement Audit Team Section 6.2(c)(ii9.8(a) Antiboycott Rules Audit Rights Holder Section 4.22(a9.8(e) Board Recommendation Auditee Section 2.2(b9.8(e) Cancelled Company Shares Bankruptcy Code Section 3.7(a)(ii8.8 Business Day Master Agreement Celgene Preamble Celgene Corp. Preamble Celgene RIVOT Preamble Celgene Indemnified Parties Section 13.2(a) Certificate of Merger Celgene Clinical-Scale Manufacturing Responsibilities Section 3.2 Certificates 4.1(c) Celgene Commercial-Scale Manufacturing Responsibilities Section 3.8(c4.1(c) Changes Celgene Manufacturing Responsibilities Section 1.1 Closing 4.1(c) Challenge Section 3.3 Closing Date 14.3(d) Challenging Party Section 3.3 COBRA Section 4.11(d14.3(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseCo-Co Buy-In Agreements Section 4.16(g3.4 Combination Product Exhibit D Commercialization/Commercialize Master Agreement Commercialization Expenses Exhibit D Commercialization Budget Section 6.2(a)(i) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Commercialization Plan Section 4.11(c)6.2(a)(i) Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Cover/Covering/Covered Master Agreement CPI Exhibit D Cure Period Section 14.3(b)(i) Damages Master Agreement
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii6.2(a) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.3(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Amended and Restated Stockholder Rights Agreement Section 6.2(c)(ii2.1(a)(v) Antiboycott Rules Section 4.22(aArrangements 7.18 Assets 4.14 Banks 7.19(c) Board Recommendation Section 2.2(b) Brookfield Recitals Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCOC EOD 7.19(a) Collective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.4(a) Company Board Recommendation Change 7.4(b) Company Board Recommendation Notice 7.4(e) Company Common Stock Recitals Company Compensation Committee 7.18 Company Disclosure Letter Article ARTICLE IV Company License-In Agreements IP Contract 4.15(b) Term Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Reference Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Continuing Directors 2.3(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.9(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect 1.1 Effective Time Section 3.2 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Financing Notice 7.19(b) Foreign Plans 4.17(l) Fund Guarantee Recitals Go-Shop Extension 6.2(a) Go-Shop Extension Expiration Time Section Date 2.1(d)(ii)(C) Go-Shop Period 6.2(a) Government Entity 4.20(b)(ii) Government Official 4.20(b)(i) Indemnified Persons 7.9(a) Initial Expiration Date 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIT Systems 4.15(h) Leased Real Property 4.13(b) Leases 4.13(b) Major Stockholders Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.9(c) Merger Recitals Merger Condition 8.1(a)(iv) Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cNew Plans 7.10(b) No-Shop Period Start Date 6.2(a) Non-Cancelled Company Shares 3.7(a)(ii) Notice of Superior Proposal 7.4(e) Notice Period 7.4(e)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Graftech International LTD)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aBylaws 3.1 Capitalization Date 3.7(a) Board Recommendation Section 2.2(bCash Replacement Company PSU Amounts 2.8(b)(ii) Cancelled Cash Replacement Company Shares Section 3.7(a)(iiRSU Amounts 2.8(a)(ii) Cash Replacement Option Amounts 2.8(c)(ii) Certificate of Merger 2.2 Certificates 2.9(c) Charter 2.5(a) Table of Contents Term Section 3.2 Certificates Section 3.8(cReference Chosen Courts 9.10(a) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(e)(ii) Company License-Out Agreements Section 4.16(hPlans 6.11(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a9.4 Consent 3.6 Copyrights 1.1(pp) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.10(c) DTC 2.9(d) Effect 1.1(r) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(a) ESPP 2.8(f) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) Intervening Event 5.3(e)(i) IP Contracts 3.16(e) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(pp) Material Contract Section 4.18(aCustomers 1.1(tt)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(d) Notice Period 5.3(e)(ii)(3) Old Plans 6.11(d) Other Required Company Filing 6.3(b) Table of Contents Term Section Reference Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(e)(i) Parent Related Parties 8.3(e)(i) Party Preamble Patents 1.1(pp) Payment Agent 2.9(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(g) Representatives 5.3(a) Requisite Stockholder Approval 3.4 Sublease 3.14(c) Surviving Corporation Article II Tax Returns 3.17(a) Trade Control Laws 3.26(a)(i) Termination Date 8.1(c) Uncertificated Shares 2.9(c) Unvested Company Options 2.8(c)(ii) Unvested Company PSU 2.8(b)(ii) Unvested Company RSU 2.8(a)(i) Vested Option Consideration Section 3.7(a)(i2.8(c)(i) Minimum Condition Section 2.1(a)(iVested PSU Consideration 2.8(b)(i) Multiemployer Plan Section 4.11(c)Vested RSU Consideration 2.8(a)(i) Voting Agreements Recitals
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiACT Section 2.09(a) Acquisition Proposal Section 6.2(e)(iAddressee Section 10.04(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAgreed Amount Section 10.04(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Approvals Section 6.06(d) Antiboycott Rules Section 4.22(aAntitrust Laws Section 6.06(d) Board Recommendation Section 2.2(bArbitration Law Section 10.04(e) Cancelled Company Shares Section 3.7(a)(iiArbitrator Section 10.04(e) Certificate of Merger Section 3.2 Certificates Section 3.8(cAssets Section 3.16(b) Changes Section 1.1 Assumption Date Section 2.04(c) Assumed Options Section 2.04(b)(i) Balance Sheet Date Section 3.08(a) Sellers Basket Amount Section 10.02(d) Benefit Plans Section 3.21(b) Bring-Along Notice Section 2.07(c) Charter Documents Section 3.01(c) Claimed Amount Section 10.04(a)(ii) Closing Section 3.3 Section 2.11(a) Closing Date Section 3.3 COBRA Section 4.11(dSection 2.11(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Rights Section 3.18(a)(2) Company License-Out IP Rights Agreements Section 4.16(hSection 3.18(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aLeased Real Property Section 3.16(a) Company Securities Section 4.2(aMaterial Contract Section 3.13(a) Company-Owned IP Rights Section 3.18(a)(3) Company's Financial Statements Section 3.08(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Significant Customer Section 3.17 Company D&O Insurance Section 7.8(cSignificant Supplier Section 3.17 Company Source Code Section 3.18(a)(5) Customs Laws Section 4.22(aCompensation Package Section 3.21(a) Debt Financing Delivering Party Section 10.04(a) Confidential Information Section 3.18(p) Consideration Warrants Section 2.02(c)(iii) Consideration Securities Section 4.08(a) Contested Amount Section 10.04(b) Dispute Section 10.9(aPeriod Section 10.04(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEGM Notice Section 6.09 Electing Holder Section 6.08(a)(ii) Exchange Fund Section 3.8(bAct Section 5.25(g) Expiration Time Section 2.1(d)(iExecuting Shareholders Section 2.07(a) Expected Revenues Section 5.09(f) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bDate Section 5.09(b) Recitals Recitals FIS Articles Section 2.07(a) FIS Assumed Options Section 2.04(b)(i) FIS Closing Section 2.11(a) FIS Closing Certificate Section 8.03(d)(i) FIS Closing Date Section 2.11(a) FIS Consideration Shares Section 2.02(c)(ii) FIS Conversion Ratio Section 2.04(a)(i) FIS End Date Section 9.01(b) FIS Executing Shareholders Section 2.07(a) FIS Selling Shareholder Closing Certificate Section 8.03(d)(ii) Formula and Kardan Side Letter Section 8.03(d)(v) Formula Systems Section 8.03(d)(vi) Formula Vision Section 8.03(d)(v) IDIT Articles Section 2.07(a) IDIT Assumed Options Section 2.04(a)(i) IDIT Closing Section 2.10(a) IDIT Closing Certificate Section 8.04(d)(i) IDIT Closing Date Section 2.10(a) IDIT Consideration Shares Section 2.02(b) IDIT Conversion Ratio Section 2.04(a)(i) IDIT Executing Shareholders Section 2.07(a) IDIT Purchase Price Section 2.02(b) IDIT Selling Shareholder Closing Certificate Section 8.04(d)(ii) Indemnified Persons Section 7.8(aParty Section 10.03(a) Inventions Section 1.1 Indemnifying Party Section 10.04(a) Insider Receivables Section 3.08(e) Intellectual Property Section 3.18(a)(1) XXX Section 8.03(d)(vi) ISA Section 5.01(a) Israeli 104(h) Tax Ruling Section 6.08(a)(ii) Israeli Options Tax Ruling Section 6.08(a)(i) Israeli Securities Exemption Section 6.06(b) Kardan Section 7.06 Leased Assets Section 3.16(c) Leased Contracts Section 3.16(c) Malicious Code Section 3.18(s) Material Contract Section 5.13(a) Menora Revenues Section 5.09(f) Non Executing Shareholders Section 2.06 Nondisclosure Agreement Section 7.05 Offering Section 5.25(a) Officer’s Claim Certificate Section 10.04(a) Open Source Materials Section 3.18(q) Other Interested Party Section 6.02 Parent Assets Section 5.16(b) Parent Benefit Plans Section 5.21(b) Parent Confidential Information Section 5.18(n) Parent's Financial Statements Section 5.09(a) Parent FIS Closing Certificate Section 8.05(d)(i) Parent Foreign Filings Section 5.01(a) Purchaser Basket Amount Section 10.03(c) Purchaser Indemnified Parties Section 10.02(a) Purchaser Fundamental Representations Section 10.01(c) Purchaser IDIT Closing Certificate Section 8.06(d)(i) Purchaser Survival Date Section 10.01(c) Parent IP Rights Section 5.18(a)(1) Parent IP Rights Agreements Section 5.18(f) Parent Leased Assets Section 5.16(c) Parent Leased Contracts Section 5.16(c) Parent Leased Real Property Section 5.16(a) Parent-Owned IP Rights Section 5.18(a)(1) Parent Material Contract Section 5.13(a) Parent Real Property Lease Section 5.16(a) Parent Related Person Section 5.22 Parent SEC Documents Section 5.01(a) Parent Significant Customer Section 5.17 Parent Significant Supplier Section 5.17 Parent Source Code Section 5.18(a)(3) Payment Day Section 2.08(b) Purchaser FIS Closing Certificate Section 8.05(d)(i) Purchaser IDIT Closing Certificate Section 8.06(d)(i) Purchaser Indemnified Parties Section 10.02(a) Real Property Lease Section 3.16(a) Rep Letters Section 8.03(m) Registrar Section 8.03(l) Regulation D Investor Section 4.08(b) Regulation S Investor Section 4.08(b) Related Person Section 3.22 Releasee and Releasees Section 7.07 Response Notice Section 10.04(b) Restricted Parties Section 6.10 Section 4.18(a102 Section 3.21(b) Maximum Annual Premium Section 7.8(c401(a) Merger Recitals Merger Consideration Section 3.7(a)(iSection 3.21(b) Minimum Condition Section 2.1(a)(iSellers Fundamental Representations Section 10.01(a) Multiemployer Plan Section 4.11(cSelling Shareholders Indemnified Parties Section 10.03(a) Stipulated Amount Section 10.04(d) Sellers Survival Date Section 10.01(a) TASE Approval Section 6.06(c) TASE Certificate Section 8.05(j) Tax Certificate Section 2.08(b) Third Party Intellectual Property Rights Section 3.18(a)(4) Transfer Taxes Section 7.04(b) Warrants Shares Section 2.02(c)(iii)
Appears in 1 contract
Samples: Share Purchase Agreement (Kardan Technologies Ltd.)
Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections of this Agreement set forth opposite each section of the capitalized terms Agreement indicated below: Term Definition Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAAA 2.5(b)(iii) Actual 2008 Revenues 2.6(a)(ii) Acquisition Proposal Section 6.2(e)(i6.3(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAffiliated Indebtedness 4.30(a)(iii) Agreement Preamble Alternative Acquisition Recitals Arbitrator 2.5(b)(iii) Assignment of Inventions Agreement Section 6.2(c)(ii6.1(o) Antiboycott Rules Section 4.22(aCash Escrow 2.4(a)(ii) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 Closing Date Working Capital 2.5(b)(i) COBRA Section 4.11(dCoverage 4.25(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gTax Returns 4.14(a) Company LicenseRecitals Consulting Agreement 6.1(l) Employment Agreement 6.1(k) Escrow Agent Escrow Agreement Escrow Agent’s Wire Transfer Instructions 2.4(a)(ii) Escrow Agreement 2.4(c) Escrow Shares 2.4(a)(ii) Estimated 2008 Revenues 2.6(a)(i) Final Post-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iClosing Revenue Report 2.6(a)(iii) Financial Statements Incipio Incipio Merger 4.9 Leases 4.21(e) License Agreements 4.22(g) Material Contract(s) 4.12(a) Non-Competition and Non-Solicitation Agreement Section 4.7(b6.1(j) Non-Disclosure Agreement 8.2 Post-Closing Revenue Report 2.6(a)(ii) Products 4.31 Purchase Price 2.2 Purchaser Recitals Recitals Purchaser’s Accountants 2.6(a)(ii) Purchaser Indemnified Persons Section 7.8(a7.3 Reference Balance Sheet Date 4.9 Reference Working Capital 2.5(a) Inventions Section 1.1 Material Contract Section 4.18(aRelease(s) Maximum Annual Premium Section 7.8(c2.4(b)(ii) Merger Revenue Dispute Notice Period 2.6(a)(iii) Revenue Disputed Matters 2.6(a)(iv) Revenue Dispute Resolution Period 2.6(a)(iii) Revenue Notice of Disagreement 2.6(a)(iii) Revenue-Related Adjustment 2.6(a)(v)(A) Revenue-Related Adjustment Reduction 2.6(a)(v)(A) SEC 5.6 Seller and Sellers Recitals Merger Consideration Section 3.7(a)(iSellers’ Accountant 2.5(b)(ii) Minimum Condition Section 2.1(a)(iSellers’ Indemnified Persons 7.4 Sellers’ Representative 2.7(a) Multiemployer Plan Section 4.11(c)Seller Wire Transfer Instructions 2.4(a)(i) Share(s)s Recitals Survival Date 7.1(b) Upfront Payment 8.14 Tangible Personal Property 4.23(a) Third Party Claim 7.7 Working Capital Dispute Notice Period 2.5(b)(ii) Working Capital Dispute Resolution Period 2.5(b)(ii) Working Capital Disputed Matters 2.5(b)(iii) Working Capital Notice of Disagreement 2.5(b)(ii) ARTICLE II
Appears in 1 contract
Samples: Stock Purchase and Sale Agreement (Orchid Cellmark Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)
Appears in 1 contract
Samples: Agreement and Plan of Merger (Mill Road Capital II, L.P.)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings meaning ascribed thereto to such term in the respective sections of this Agreement Article or Section set forth opposite each of the capitalized terms belowsuch term: Term Article/Section Reference Acceptable Agreement Preamble Arbitration Firm 3.3(b) Assumed Contracts 2.1(a)(vi) Assumed Liabilities 2.2(a) Basket Amount 10.3(a) Business Recitals Buyers Preamble Claim Dispute Notice 10.5 Closing 3.1 Closing Date 3.1 Closing Working Capital 3.3(a) Closing Payment 3.2(a) Commencement Date 7.8 Confidentiality Agreement Section 6.2(e)(iii7.2 Direct Claim Notice 10.5 Dispute Notice 3.4(d) Acquisition Proposal Section 6.2(e)(iDrop Dead Date 8.4(b)(i) Acquisition Sub DSI Preamble Adverse Recommendation Change Section 6.2(c)(iDSI Limited Preamble Effective Time 3.1 Employee Plan 4.14(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiEstimated Working Capital 3.2(b) Antiboycott Rules Section 4.22(aExcluded Assets 2.1(c) Board Recommendation Section Excluded Liabilities 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Final Allocation 3.5 Final Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iPayment 3.3(d) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b4.4 Fundamental Representations 10.1 Governmental Authority 4.2(b) Recitals Recitals Indemnified Persons Section 7.8(aParty 10.4(a) Inventions Section 1.1 Indemnifying Party 10.4(a) Latest Balance Sheet 4.4 Leased Real Property 4.7(a) Leases 4.7(a) Licensed Shareholder Intellectual Property 2.1(b) Major Client 4.21 Material Contract Section 4.18(aContracts 4.10(a) Maximum Annual Premium Section 7.8(cObjection Notice 3.3(b) Merger Recitals Merger Organizational Documents 2.1(c)(iii) Party/Parties Preamble Permits 4.19(b) Permitted Liens 4.8(a) Post Closing Consideration Section 3.7(a)(i3.4(a) Minimum Condition Section 2.1(a)(iPost Closing Period 3.4(a) Multiemployer Plan Section 4.11(cPreliminary Allocation 3.5 Proposed Final Allocation 3.5 Purchase Price 3.2(a) Purchased Assets 2.1(a) Regulations 7.9 Seller Systems 4.11(e) Sellers Preamble Seller Intellectual Property Rights 4.11(a) Seller Parties Preamble Shareholders Preamble Shareholders’ Representative Preamble Third Party Claim 10.4(a) Transferred Employees 7.8 Transfer Taxes 9.3(a) UK Employees 7.9 Working Capital Statement 3.3(a)
Appears in 1 contract
Samples: Asset Purchase Agreement (Heidrick & Struggles International Inc)
